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Summary
Mitogen activated protein kinase (MAPK) cascades are evolutionarily conserved signaling
modules in eukaryotes, starting from unicellular Saccharomyces cerevisiae to humans. These
modules respond to a variety of extracellular stimuli and convert them into defined cellular re-
sponses, such as proliferation, differentiation or apoptosis. Different phenotypic responses de-
pend on the diverse dynamical spatio-temporal activity profiles of MAPKs, which are inherent
in the hierarchical architecture of MAPK signaling cascades. Specificity of the spatio-temporal
activity profiles is thus effected by the integration of the MAPK module into networks of reg-
ulatory proteins such as scaffolds, which then effect specific responses. While the temporal
regulation and function of MAPK activity has been widely studied, quantitative information
about the spatial organization of MAPK activity in mammalian cells has been inaccessible due
a lack of suitable imaging approaches. However, imaging of MAPK activity is crucial for
understanding how their signaling can be specified for the global function in transcriptional
regulation in the nucleus and specific local functions in the cytoplasm. The spatial partitioning
of the MAPK activation cycle into phosphorylation at the plasma membrane and dephospho-
rylation in the cytoplasm was postulated to generate spatial activity gradients, which emanate
from the PM [Brown & Kholodenko, 1999].
A versatile and quantitative approach for the mapping of MAPK activity was established
in this work to pursue the spatial profiling of MAPK activity. In particular, the universality
of the phosphoprotein-binding compound Phos-Tag was combined with Förster resonance en-
ergy transfer-fluorescence lifetime imaging microscopy (FRET-FLIM) to obtain a quantitative
and specific read-out of the MAPK activity state, referred to as PTag-FLIM [Kinoshita et al.,
2006]. Furthermore, PTag-FLIM is the first universal approach to quantitatively image the
phosphorylation of every fluorescently-tagged protein.
This novel method was used to confirm the known activity gradient of the MAPK Fus3 in
yeast cells forming a projection tip [Maeder et al., 2007]. Moreover, a newly identified negative
feedback from Fus3 on upstream MAPKKK Ste11 was shown to decrease the decay length of
the Fus3 activity gradient [Hecker et al., 2014]. A constitutively active Ste11 mutant in which
the negative feedback was impaired resulted in an increase in the amplitude and decay length
of the Fus3 activity gradient. These results provide the first experimental insight into how the
network architecture influences MAPK activity gradients.
The application of the PTag FLIM approach on human cell lines HeLa and MCF-7 demon-
strated that the active MAPKK Mek1 and MAPK ERK2 indeed emanate in gradients from the
plasma membrane. Nuclear ERK2 was also found to be distributed in an activity gradient,
emanating from the nuclear membrane into the interior of the nucleus. The confinement of
ERK activity to the nuclear envelope correlates with known roles of ERK2 in heterochromatin
remodeling, transcriptional activation and cell cycle progression.
In the breast cancer cell line MCF-7 cells, stimulation with EGF causes transient ERK2 ac-
tivity leading to proliferation, while HRG induces sustained ERK2 activity in the cytoplasm
which causes differentiation [Nagashima et al., 2007]. In this thesis EGF and HRG growth fac-
tors were shown to induce comparable gradients of Mek1 activity, whereas HRG stimulation
demonstrably induced steeper ERK2 activity gradients in comparison to the EGF stimulation.
The correlation between persistent cytoplasmic activity of ERK2 and increased steepness of the
ERK2 activity gradient in the cytoplasm upon HRG stimulation suggest that ERK2 is main-
tained in the cytoplasm by the cofinement of ERK2 activity in steep gradients. The differential
spatio-temporal activity profiles of Mek1 and ERK2 by EGF and HRG obtained here support
1
the hypothesis that the scaffold KSR1 is integrated in the HRG-induced MAPK network. Ec-
topic expression of KSR1 indeed distributed Mek1 activity, but confined active ERK2 to the
plasma membrane. The cumulative evidence indicates that regulatory proteins may differenti-
ate MAPK functions in distinct cellular locations by promoting steep MAPK activity gradients.
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Zusammenfassung
Mitogen-aktivierte Proteinkinase (MAPK) Kaskaden sind eukaryotische Signaltransduktion-
smodule, welche von der einzelligen Saccharomyces cerevisiae bis zum Mensch evolutionär
konserviert sind. Diese Module werden durch verschiedenste extrazelluläre Stimuli aktiviert,
welche sie in definierte Zellantworten, wie Proliferation, Differenzierung und Apoptose umset-
zen. Diese unterschiedlichen phänotypischen Zellantworten werden durch vielfältige dynamis-
che Aktivitätsprofile der MAPK in Zeit und Raum ermöglicht, welche auf dem hierarchis-
chen Aufbau von MAPK Signalwegen basieren. Die Spezifizierung des Zeit-Raum-Profils von
MAPKAktivität, und somit die Zellantwort, erfolgt durch die Integration desMAPKModuls in
ein Netzwerk regulatorischer Proteine, wie z.B. Gerüstproteine (englisch “scaffold”). Während
die zeitliche Regulation und Funktion von MAPK Aktivität gut untersucht sind, konnte die
räumliche Organisation der MAPK Aktivität aufgrund fehlender Bildgebungsverfahren nicht
betrachtet werden. Die Untersuchung der räumlichen Organisation von MAPK Aktivität ist
jedoch unabdingbar um zu verstehen, wie die globale Funktion der MAPK in der Aktivierung
der Transkription im Zellkern und spezifische lokale Funktionen im Zytoplasma differenziert
werden können. Anhand von Computermodellen wurde gezeigt, dass die räumliche Tren-
nung des Aktivierungszyklus der MAPK in Phosphorylierung an der Plasmamembran und De-
phosphorylierung im Zytoplasma zu Aktivitätsgradienten führt [Brown & Kholodenko, 1999].
Um herauszufinden, ob diese Aktivitätsgradienten tatsächlich auftreten und wie diese gegebe-
nenfalls die Differenzierung der MAPK Funktionen im zellulären Raum ermöglichen, wurde
in der vorliegenden Arbeit eine vielseitig einsetzbare und quantitative Methode zur Bildge-
bung der MAPK Aktivität entwickelt. Diese Methode basiert auf der Detektion der Phospho-
rylierung von MAPKs als Reporter ihrer Aktivität und kombiniert dafür das Reagenz Phos-
Tag, welches universell an phosphorylierte Proteine bindet, mit Forster Resonanzenergietrans-
fer/Fluoreszenzlebenszeit (FRET/FLIM)Messungen, im folgenden bezeichnet als PTag-FLIM.
Als Nebenprodukt ermöglicht PTag-FLIM als erste Methode spezifisch die Phosphorylierung
jedes Fluorophore-fusionierten Proteins zu verbildlichen.
Mit PTag FLIM konnte der bekannte Aktivitätsgradient der MAPK Fus3 in der Konjuga-
tionsspitze von Hefen bestätigt werden [Maeder et al., 2007]. Darüberhinaus wurde gezeigt,
dass eine kürzlich identifizierte negative Rückkopplung von Fus3 auf die höherliegende MAP-
KKK Ste11 zu einer Fokussierung des Fus3 Aktivitätsgradienten führt [Hecker et al., 2014].
Eine Mutante von Ste11, welche die negative Rückkopplung verhindert und konstitutiv aktiv
ist, führte zu einem Anstieg der Amplitude sowie einer Verlängerung des Gradienten.
Außerdem wurde mit PTag-FLIM gezeigt, dass die aktiven MAPKK Mek1 und MAPK
ERK2 in den humanen Zelllinien Hela und MCF-7 tatsächlich in Gradienten ausgehend von
der Plasmamembran verlaufen. Überraschenderweise wurde auch ein nuklearer Gradient von
aktivem ERK2 beobachtet, welcher von der Zellkernmembran ins Zentrum des Kerns verlief.
Die räumliche Begrenzung der ERK2 Aktivität im Zellkern korreliert mit bekannten Funktio-
nen von ERK2 an der Kernhülle (englisch “nuclear envelope”), wie die Umstrukturierung von
Heterochromatin, die Aktivierung der Transkription sowie die Fortführung des Zellzyklus.
In der Brustkrebszelllinie MCF-7 wurde gezeigt, dass die Wachstumsfaktoren EGF und
HRG vergleichbare Aktivitätsgradienten von Mek1 verursachen, während der ERK2 Aktiv-
itätsgradient steiler nach HRG als nach EGF Stimulation war. Diese Beobachtung korreliert
mit der bekannten anhaltenden Aktivität von ERK2 im Zytoplasma nach HRG Stimulation
und deutet daraufhin, dass der steilere ERK2 Aktivitätsgradient nötig ist, um die ERK2 Ak-
tivität im Zytoplasma zu halten. Die kumulierten Ergebnisse führen zu der Hypothese, dass
3
das Gerüstprotein KSR1 in das HRG-induzierte MAPK Netzwerk intergriert wird. Tatsächlich
begünstigte die ektopische Expression von KSR1 zu einer Ausbreitung der Mek1 Aktivität und
einer Begrenzung der ERK2 Aktivität an die Plasmamembran.
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1 Introduction
About one third of the human proteome is predicted to become reversibly modified by phos-
phorylation on Serine (Ser), Threonine (Thr) or Tyrosine (Tyr) residues with a respective ratio
of 1800:200:1 [KREBS & FISCHER, 1955, Cohen, 2002]. This covalent modification can
potentially induce a conformational change in the protein due to the double-negative charge
at physiological pH and the capacity of forming electrostatic interactions and hydrogen-bonds
[Johnson & Lewis, 2001]. Phosphorylation can therefore alter the catalytic activity or change
the accessibility of interaction sites, which in turn can affect the protein localization and sta-
bility or mark the protein for further modification. Kinases, making up 2% of the human
genome, transfer the phosphate anion from adenosine triphosphate (ATP) to its substrate, while
phosphatases catalyze protein dephosphorylation [Burnett & Kennedy, 1954, Manning et al.,
2002, Lander et al., 2001].
Protein phosphorylation plays an essential cellular role in the cellular signal transduction.
Central to many signal transduction pathways are kinase cascades, which provide a large spec-
trum of spatio-temporal signaling modes. Major phosphorylation cascades are the highly con-
served mitogen activated protein kinases (MAPKs), which convert information from the extra-
cellular space into fundamental cell responses, like proliferation, differentiation, and apoptosis
[Chen et al., 2001]. Germline mutations causing the dysregulation of MAPK activity drive
developmental disorders, while acquired MAPK dysregulation is frequently found in cancer
[Schubbert et al., 2007, Roberts & Der, 2007]. The first identified and best examined MAPK
pathway is the Ras-Raf/Mek/ERK cascade which is deregulated in up to 30% of human cancer
types [Roberts & Der, 2007].
MAPK activity has been widely studied by measuring its phosphorylation in large cell popu-
lations using chromatography-based approaches, like gel-electrophoresis followed by Western
blotting or mass spectrometry. These have revealed detailed temporal response profiles of
MAPKs [Olsen et al., 2006, Olsen et al., 2010]. However, the precise spatial organization of
MAPK activity remained subject to computations, which predict that the spatial partitioning of
activation at the plasma membrane from deactivation in the cytosol would generate a gradient
of MAPK activity [Brown & Kholodenko, 1999]. This activity gradient is supposed to emanate
from the plasma membrane (PM) and be restricted to membrane-proximal regions. Based on
that, further theories have been proposed how the signal can nevertheless be propagated to in-
tracellular locations, like the nucleus [Kholodenko, 2006]. However, the verification of these
theories in mammalian cells has been experimentally inaccessable due to low dynamic range
or substrate-based measures of MAPK activity.
To pursue the spatial profiling of MAPK activity, we developed a cytochemical approach
based on Phos-Tag and Förster resonance energy transfer-fluorescence lifetime imaging mi-
croscopy (FRET-FLIM), which allows to quantitatively visualize the phosphorylation of fluorophore-
tagged MAPKs as read-out for their activity with subcellular resolution. The reagent Phos-Tag,
which is coupled to a dye via Streptavidin as acceptor in FRET, binds universally to phospho-
monoesters and therefore to all phosphorylated amino acids. The technique presented in this
thesis expands the hitherto universal pTyr imaging approach to all, and therefore the majority,
of phosphorylated proteins [Bastiaens & Squire, 1999, Grecco et al., 2010].
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1.1 Signaling components of the ERK cascade
MAPK pathways are evolutionaryly conserved signaling modules in eukaryotes, from humans
down to unicellular Saccharomyces cerevisiae (hereafter named “yeast”). These pathways
transmit signals from cell-surface receptors, which are activated by extracellular stimuli, e.g.
growth factors (GF), hormones, cytokines or high osmolarity and starvation. The MAPKs are
organized in cascades, consisting of three to four serially phosphorylated, and thereby acti-
vated, protein kinases. The proteins are formally named after their position in the cascade
with the terminal MAPK being phosphorylated by MAP kinase kinase (MAPKK), and so forth
[Chen & Thorner, 2007]. The terminal MAPK links the signal transmission with the conversion
into essential cellular responses, like proliferation, differentiation or apoptosis [Wolf & Seger,
2002, Chen & Thorner, 2007]. Additionally to the extracellular-signal-regulated kinase (ERK)
cascade, there are three further well characterized MAPK modules in mammalian cell lines,
which are (named after their terminal MAPK) Jun N-terminal kinase (JNK), p38 and ERK5,
with about 20 MAPK molecules in total [Chen et al., 2001, Roberts & Der, 2007].
Surprisingly, in some cases the same cascade can induce different cell fates, depending on the
stimulus. In PC-12 cells for instance, the ERK cascade can trigger differentiation upon NGF
stimulation or proliferation after EGF treatment [Nguyen et al., 1993, Traverse et al., 1994].
The respective cellular responses arise from the GF-specific signaling network architecture,
which encodes time, localization and amplitude of MAPK activity [Santos et al., 2007].
Signal transduction via the ERK cascade is usually associated with receptor tyrosine ki-
nase (RTK) activation (figure 1.1). However, the stimulation of G-protein coupled receptors
(GPCRs) can also trigger ERK activation, either by transactivation of RTKs or signal integra-
tion via adaptor proteins like β -arrestin [Chen et al., 2001, Waters et al., 2004]. In the case
of most RTKs, ligand binding induces receptor homo-/heterodimerization and autophospho-
rylation of intracellular tyrosine residues. Receptor activation leads to recruitment of adaptor
proteins like Grb2 and the Ras-guanine nucleotide exchange factor (GEF) son-of-sevenless
(SOS), which changes the Ras nucleotide state from GDP to GTP [Simon et al., 1993, Nada
et al., 1993, Lowenstein et al., 1992]. GTP-bound Ras transduces the signal to the MAPK
cascade by interacting with the MAPKKK Raf.
1.1.1 The MAPKKK Raf
Raf was first identified as viral oncogene (v-Raf) which has in comparison to cellular, non-
transforming Raf (c-Raf) a capped N-terminus and is constitutively active [Rapp et al., 1983,
Patschinsky & Bister, 1988, Heidecker et al., 1990]. In human cell lines two further isoforms,
A-Raf and B-Raf, were found. Raf activation and dimerization has been studied extensively
in the last decade, as B-Raf mutations account for 43% of melanomas and new potent B-Raf
inhibitors paradoxically induced ERK1/2 activation [Poulikakos et al., 2010, Heidorn et al.,
2010, Lavoie et al., 2013, Hatzivassiliou et al., 2010].
While inactive, a region in the N-terminal kinase domain of B-Raf is constitutively phos-
phorylated, flanked by two acidic residues. In contrast, the corresponding c-Raf motif is hy-
drophobic and intramolecularly occludes the kinase domain. This closed state is clamped by a
14-3-3 dimer binding to a C-terminal and an internal pSer, maintaining c-Raf cytosolic [Light
et al., 2002]. Upon growth factor stimulation the activity of the phosphatases PP1 and PP2A
is induced, which dephosphorylate the internal pSer site. Hence, 14-3-3 is only bound to the
C-terminal pSer site [Abraham et al., 2000, Rodriguez-Viciana et al., 2006]. The free Raf
N-terminus can specifically bind the GTP bound Ras via its Ras binding domain (RBD) and
additionally interact with Ras independently of its guanine-nucleotide state through a cysteine-
rich domain (CRD) [Herrmann et al., 1995]. The collective Ras-Raf interactions recruit Raf to
the plasma membrane, leading to conformational changes in Raf, which in turn induce homo-
and hetero-dimerization of Raf proteins [Luo et al., 1996, Weber et al., 2001, Garnett et al.,
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Figure 1.1: Signal transduction via the ERK cascade and associated human cancers. An
extracellular ligand (EGF) binds to a cell surface receptor (EGFR) and induces its
activation. This information is transduced via Ras to Raf and in a phosphorylation
cascade from Raf to Mek and from Mek to ERK. Active ERK induces a transcrip-
tional program in the nucleus. Boxes indicate the human cancers associated with
the oncogenes EGFR, Ras and Raf (adapted from [Roberts & Der, 2007]).
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2005, Rajakulendran et al., 2009]. 14-3-3 dimers support dimerization by bridging the two
monomers. In hetero-dimers of c- and B-Raf, the polar N-terminus of B-Raf induces in c-
Raf allosterically a “hydrophobic” spine, with a “DFG-in” conformation guiding the c-Raf
activation loop in an active conformation, which is then intramolecularly autophosphorylated
[Kornev et al., 2008, Hu et al., 2011, Hu et al., 2013]. Thereby, c-Raf achieves full kinase activ-
ity and becomes independent of B-Raf stabilization and phosphorylates the MAPKK Mek1/2
[Hu et al., 2013]. In a feedback, Mek1/2 in turn phosphorylates the designated N-terminal
motif on c-Raf, which was also reported to be phosphorylated by Src, PAK and PKC family
kinases [Hu et al., 2013, Zang et al., 2008]. This N-terminally phosphorylated c-Raf is able to
transactivate other Rafs in the next cycle of dimerization. B-Raf therefore acts as a catalyst of
c-Raf activation, which explains why B-Raf is much less abundant in the cell than c-Raf. This
suggests a pivotal role for a scaffold function of B-Raf in the onset of GF signaling, supported
by the fact that B-Raf is the only oncogene of the Raf family.
Raf activation requires asymmetric Raf dimers with one molecule acting as allosteric ac-
tivator and the other as receiver. Unveilling the Raf activation this mechanism explains how
potent B-Raf inhibitors can paradoxically activate the MAPK pathway: These inhibitors are
ATP-analogues, which bind selectively to B-Raf-Val600Glu/Lys mutants and inhibit their ki-
nase activity. However, the binding of the inhibitor induces a stable, closed conformation of
the kinase domain which serves as a steady dimerization interface for another Raf molecule,
for example c-Raf [Lavoie et al., 2013]. The inhibited Raf can therefore still serve as part of
the activation mechnism for other wild-type Raf proteins.
1.1.2 The MAPKK Mek1/2
The Mek1/2 proteins become activated by phosphorylation on Ser218 and Ser222 in their acti-
vation segment through Raf [Howe et al., 1992, Dent et al., 1992, Kyriakis et al., 1992, Zheng
& Guan, 1994]. The interaction with Raf is mediated by a MAI-motif in Mek1/2, which is also
involved in binding to kinase suppressor of ras-1 KSR1 [McKay et al., 2009]. Mek1 binds pref-
erentially to KSR1, while the association with B-Raf is weak and interaction with c-Raf below
the detection limit [McKay et al., 2009]. The Ser/Thr-kinase PAK1, involved in cytoskeletal
reorganization, phosphorylates Mek1 on Ser298 which induces a sustained duration of Mek1
activity [Coles & Shaw, 2002, Slack-Davis et al., 2003]. Mek1 is negatively regulated by a
feedback phosphorylation from ERK on residue Thr292, which prevents the phosphorylation
by PAK1, while Mek2 is independent from this feedback as the corresponding site is mutated
to a proline [Eblen et al., 2004]. However, Mek1 and Mek2 form constitutive heterodimers and
the negative feedback from ERK induces the dephosphorylation of both MAPKKs [Catalanotti
et al., 2009]. Inhibition of the feedback or deletion of Mek1 causes prolonged Mek2 phospho-
rylation and ERK activity. This regulation might also be involved in the embryogenic lethality
of Mek1 deficient mice, which cannot be compensated for by Mek2. The negative regulation of
Mek1 by phosphorylation of Thr292 was also reported from the cell cycle factor Cdcd2 in vitro
[Rossomando et al., 1994]. Additionally, Mek1 is negatively regulated by phosphorylation on
Ser212, since a phosphomimetic amino acid substitution completely abolished Mek activation
[Gopalbhai et al., 2003]. Mek1/2 proteins are actively exported out of the nucleus due to a
“nucleus-export-sequence” (NES) and hence mainly cytosolic [Fukuda et al., 1996, Adachi
et al., 2000].
1.1.3 The MAPK ERK
In resting cells, Mek1/2 and other proteins like PEA-15 maintain ERK in the cytoplasm by
binding to the C-terminal common docking () domain [Tanoue et al., 2000, Fukuda et al.,
1997]. Ectopic overexpression of ERK in cells therefore requires the coexpression of Mek to
retain ERK in the cytoplasm [Adachi et al., 2000]. Upon pathway stimulation, Mek1/2 phos-
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phorylate ERK on Thr183 and Tyr185 on a conserved Thr-Xxx-Tyr motif (Thr-Glu-Tyr for
ERK proteins) in the activation segment [Payne et al., 1991, Robbins et al., 1993]. Activation
of ERK leads to the dissociation of the Mek-ERK dimer and simultaneously to the association
of ERK homodimers [Canagarajah et al., 1997, Fukuda et al., 1997, Tanoue et al., 2000]. Mek-
ERK dimers and ERK homodimers are mutually exclusive, as both interactions involve the CD
domain in ERK [Fukuda et al., 1997, Tanoue et al., 2000]. A conformational change in the du-
ally phosphorylated protein renders ERK1/2 fully active and gives access to the DEF domain,
to which many interaction partners and targets with the complemeting Phe-Xxx-Phe-Pro motif
bind [Tanoue et al., 2000, Lee et al., 2004, Reményi et al., 2006].
Active ERK1/2 transiently accumulates in the nucleus and induces transcription. The de-
tailed mechanism of the translocation has been a controverse point. One group has identified
a nuclear translocation signal (NTS) encompassing a nine amino-acid-long sequence with two
phosphorylation sites Ser-Pro-Ser in ERK, Mek and other signaling proteins [Chuderland et al.,
2008]. This NTS is thought to become phosphorylated subsequent to the Thr-Glu-Thr motif by
Casein Kinase2 (CK2) and autophosphorylation of ERK. The phosphorylated NTS then sup-
ports the nuclear translocation by the association with importin-7 [Chuderland et al., 2008, Plot-
nikov et al., 2011]. However, the existence of a NTS motif in ERK is not recognized by others
[Caunt &McArdle, 2010, Lidke et al., 2010]. The only consensus is that the enzymatic activity
of ERK is not required for the stimulus-induced nuclear accumulation, which was shown using
the inactive mutant ERK-Lys52Arg. Other theories are based on the conformational change
in ERK upon activation which changes the accessibility of ERK motifs, for instance to the
DEF domain, and potentially enables dimerization. These changes in the ERK conformation
might influence either the affinity for substrates or the import and/or export kinetics through
the nuclear membrane. The nuclear accumulation of ERK indeed positively correlates with the
phosphorylation on the activation segment [Caunt & McArdle, 2010]. However, the single cell
variation in the dose-response of ERK phosphorylation is high with a range of 30-fold, while
the ratio of nuclear to cytoplasmic localization of ERK ranges only 3-fold [Caunt & McArdle,
2010]. While this study’s authors attribute this discrepancy to an uncoupling of phosphoryla-
tion and translocation, it can also be explained by the fact that not the fold-change in single cells
but only the absolute phosphorylation of ERK in fixed cell was measured [Caunt & McArdle,
2010]. The influence of interactions on the nuclear accumulation of ERK was investigated us-
ing either DEF or CD domain mutants [Yazicioglu et al., 2007, Caunt &McArdle, 2010]. These
publications show contradictory results: one study found significant changes only for CD do-
main mutants while the other only for DEF site mutants [Caunt & McArdle, 2010, Yazicioglu
et al., 2007]. An explanation for the stimulus-induced accumulation of ERK would however
depent on a DEF site-based mechanism, because this motif becomes accessible only upon ERK
activation. De novo protein synthesis of, for instance, nuclear substrates was demonstrated not
to be involved in ERK nuclear acccumulation. The mobility of ERK in the cytoplasm and the
nucleus is invariably high before and after stimulation, which was determined by fluorescence
correlation spectroscopy (FCS) [Lidke et al., 2010]. Therefore, either the interactions in the
nucleus are transient or the complexes of ERK and its binding partners are mobile. One way
that ERK nuclear import and export is mediated, is by nucleoporins to which ERK can bind
in either activation state [Matsubayashi et al., 2001]. The import of active ERK is enhanced
in an energy-dependent fashion, while the export of inactive ERK is facilitated by the binding
to MEK which is exported via its NES. Older studies claimed that ERK dimers are actively
transported into the nucleus, but this could not be confirmed in a study using dimerization de-
ficient ERK mutants and fluorescence recovery after photobleaching (FRAP) [Adachi et al.,
1999, Khokhlatchev et al., 1998, Lidke et al., 2010]. In this recent study the activation of ERK
by phosphorylation was again shown to influence the transport kinetics. In summary, it is prob-
ably the combination of altered affinities and transport kinetics upon stimulation, that induce
the translocation and retention of ERK in the nucleus.
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The ERK translocation into the nucleus is a prerequisite for the induction of the transcrip-
tional response and proliferation [Brunet et al., 1999, Torii et al., 2004]. A major part of the
ERK induced transcriptional response are genes under the control of the serum response ele-
ment (SRE). In order to activate it, ERK phosphorylates the p90-ribosomal-S6-kinase (RSK)
and the ternary complex factors (TCFs) Elk-1, Net-1 and Sap [Yoon & Seger, 2006, Buch-
walter et al., 2004, Anjum & Blenis, 2008]. RSK phosphorylates the serum response factor
(SRF) which binds together with one of the TCFs to the SRE in the promoter of immediate
early genes (IEG), like Fos, Myc, Fra-1 and Egr-1 [Buchwalter et al., 2004, Anjum & Blenis,
2008, Murphy et al., 2002]. Among these IEGs are transcription and cell cycle factors which
in turn activate delayed early genes (DEGs) so that the response is further specified [Avraham
& Yarden, 2011]. In order to investigate the correlation of ERK activity and proliferation, Al-
beck and colleagues did steady-state live-cell experiments with a substrate-based ERK activtiy
sensor EKAR-EV [Albeck et al., 2013]. This sensor comprises an ERK substrate phosphosite
and a phosphosite recognition motif, which are sandwiched between two fluorophores. This
sensor detects the activtiy of ERK indirectly by a change in FRET upon phosphorylation of the
construct [Komatsu et al., 2011]. This sensor showed stochastic ERK activitiy pulses which
increase in frequency and duration with increasing EGF concentration [Albeck et al., 2013].
This group determined that the entry into S phase and therefore the progress in cell cycle is
dependent on the integrated ERK activity [Albeck et al., 2013]. Another group confirmed the
occurence of ERK pulses with the same sensor, but observed a correlation between pulse fre-
quency and proliferation rate [Aoki et al., 2013]. In this study it is further demonstrated that
ERK activity decreases with increasing cell density [Aoki et al., 2013]. Using chemical inhi-
bition or dominant negative mutants, they found that EGFR, Ras, Rac and the cytoskeleton are
required for the ERK pulses, but activity pulses of Ras and Rac could not be measured [Aoki
et al., 2013]. The application of Raf inhibitors strongly prolonged the ERK activity pulses,
while the inhibition of Mek decreased the number of pulses [Aoki et al., 2013]. Raf and Mek
are therefore involved in the pulse generation and regulation [Aoki et al., 2013]. In combination
with a light-inducible Raf it was further demonstrated that ERK activation is propagated from
cell to cell. The lateral propagation is thought to depend on ERK-induced ADAM17 which
cleaves surface-bound EGF. The free EGF then activates EGFR in neighbouring cells.
Additionally to the transcriptional regulation in the nucleus, ERK has essential functions in
the cytoplasm and organelles as well, like cytoskeletol rearrangements, endosomal traffic or mi-
tochondrial transcription [Yoon & Seger, 2006, Casar et al., 2009, Galli et al., 2009, Torii et al.,
2004]. In support of this notion, about half of the 160 ERK substrates are non-nuclear [Yoon
& Seger, 2006]. Using the ERK activity sensor EKAR-EV, [Albeck et al., 2013] demonstrated
that cytoplasmic and nuclear ERK activity pulses are concurrent and equally strong. Concern-
ing the cytoplasmic function of ERK, dimerization is again subject to controverse debate. One
group showed that ERK dimers are bound by scaffolds and that these complexes are essential
for the phosphorylation of cytoplasmic substrates [Casar et al., 2008]. Further, the prevention
of ERK dimerization using ERK mutants prohibited proliferation [Casar et al., 2008]. How-
ever, another group which investigated the ERK function in the mitochondria found dimers in
the mitochondria and the nucleus, but not in the cytoplasm [Galli et al., 2009]. In vivo obser-
vation of ERK dimers in the cytoplasm also failed in studies using various other techniques
[Burack & Shaw, 2005, Wilsbacher et al., 2006, Lidke et al., 2010].
ERK inactivation is catalyzed by phosphatases of the MAPK phosphatase (MKP) family
which has 10 members [Owens & Keyse, 2007, Britson et al., 2009, Caunt & Keyse, 2013].
Some of these dual-specificity phosphatases (DUSPs) are either specific for ERK (DUSPs 5, 6,
7 and 9) or for p38/JNK, while others are non-specific. MKPs can be localized to the nucleus,
the cytoplasm and or throughout the cell. Phosphatases have a strong impact on ERK signalling
as some are induced by ERK which generates a negative feedback.
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Figure 1.2: Scaffolds colocalize signaling proteins in a cell. Scaffolds, e.g. Ste5 in yeast or
KSR for the ERK cascade, tether the MAPKs to the activated receptor at the PM
and assemble the three-tiered MAPK cascade in a complex. The involvement of
scaffolds facilitates signal transduction by colocalization of the signaling molecules
in the 3-dimensional cellular space (adopted from [Good et al., 2011]).
1.1.4 Scaffolds and Regulatory Interactors of MAPK proteins
The first MAPK scaffold Sterile5 (Ste5) has been identified in yeast [Printen & Sprague,
1994, Hartwell, 1980]. Ste5 has binding sites for each protein of the yeast pheromone MAPK
cascade (figure 1.2). Derived from the first investigations on Ste5, scaffolds were originally
defined as passive “meeting places” which have binding sites for at least two proteins, e.g.
enzyme and substrate, but no catalytic activity [Elion, 1995]. The assembly of specific pro-
teins in a fixed geometric arrangement on the scaffold locally increases the concentration of
the substrate and therefore enhances reaction rates [Bardwell et al., 2001]. In this process,
the stoichiometry between scaffold and its binding partners is critical: Too low of scaffold
abundance hampers signaling fidelity, while an excess of scaffolds to binding proteins would
isolate enzyme and substrate on different scaffold molecules and thereby abrogate the signal
transduction (see also 1.3.3.1) [Chapman & Asthagiri, 2009, Witzel et al., 2012]. Scaffolds
can further localize signaling molecules to distinct cell compartments like activated receptors
at the PM or organelles (figure 1.2). The clustering of a subset of proteins on a scaffold can
either insulate a pathway from others or positively regulate pathway cross-talk. Additionally
to these passive roles, scaffolds were later found to be allosteric regulators of the activation of
interacting partners (Ste5) or to exhibit catalytic activity (KSR1/2) [Good et al., 2009].
Among the regulatory interactors are scaffolds (KSR, arrestin, Sef, IQGAP), modulators
(RKIP and PEA15) and adaptors (MP1), whereby the transitions between classes are gradual.
1.1.4.1 KSR1/2
Kinase suppressor of Ras (KSR) was first identified in Drosophila and C. elegans as suppressor
of active Ras with two orthologues in mammals, KSR1 and KSR2 [Therrien et al., 1995, Ko-
rnfeld et al., 1995, Sundaram & Han, 1995, Dougherty et al., 2009]. KSR proteins have five
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domains, CA1 to CA5. CA1 contains a CC-SAM motif required for RTK-induced membrane
localization, CA2 is proline-rich, CA3 binds to phospholipids in membranes, at least one mo-
tif for binding to the activity-dependent DEF domain in ERK1/2 is found in CA4 and CA5
constitutes a kinase domain which has mutations in the key residues regarded as essential in
kinase activity [Therrien et al., 1995, Zhou et al., 2002, Kornfeld et al., 1995, Brennan et al.,
2011, Koveal et al., 2012].
In quiescent cells, KSR is phosphorylated by C-TAK on Ser297 and Ser392, which are
bound by 14-3-3 proteins, keeping KSR1 with constitutively bound Mek in the cytosol [Xing
et al., 1997, Denouel-Galy et al., 1998, Cacace et al., 1999, Müller et al., 2001]. Upon RTK
activation, PP2A dephosphorylates KSR1 at the 14-3-3 binding sites, enabling KSR to translo-
cate to the plasma membrane [Ory et al., 2003]. Here, KSR proteins form heterodimers with
Raf proteins which are sufficient to allosterically activate Raf [Rajakulendran et al., 2009].
A KSR mutant was developed with inhibited ATP binding capacity, which is stabilized in its
active conformation enabling the separate investigation of scaffolding function and kinase ac-
tivity [Hu et al., 2011]. While this mutant constitutively bound to Raf and Mek, it did not
show kinase activity, compared to wild-type KSR1, which phosphorylated Mek1 in vitro when
immuno-precipitated from induced Raf-KSR dimers [Hu et al., 2011]. A structural study re-
vealed that Mek1 and the KSR2 kinase domain interact by facing each other’s catalytic site in
a mirror-imaged formation that mutually constrains the activation loop in an inactive position
[Brennan et al., 2011]. Upon pathway activation KSR2 forms a heterodimer with B-Raf, induc-
ing an allosteric chain reaction unfolding an active conformation of KSR2 and subsequently
of MEK [Brennan et al., 2011]. The accessible Mek activation segment can then become
phosphorylated by a second Raf molecule in trans [Brennan et al., 2011]. Homology mod-
eling of the equivalent KSR kinase domain-Mek1 interaction revealed that the amino acids
involved in Raf and Mek binding are conserved and therefore the binding mode between Mek
and KSR1 or KSR2 is supposedly highly similar [Sibilski et al., 2013]. The ternary interplay
of KSR1-Raf-Mek1 is furthermore regulated by phosphorylation of KSR1-Tyr728, which is in
KSR2mutated to a histidine. The mutant KSR1-Y728F exhibits stronger Raf, but weakerMek1
interaction and produces stronger Mek1 phosphorylation supporting the model of KSR1-Raf
dimer as catalytic platform [Sibilski et al., 2013]. KSR1 is like Raf a target of negative feed-
back phosphorylation by active ERK [Razidlo et al., 2004, McKay et al., 2009, Canal et al.,
2011]. ERK binds to KSR at its DEF domain and phosphorylates B-Raf and KSR1 leading
to the dissociation of the heterodimer BRaf-KSR and the release from the membrane [McKay
et al., 2009]. Mutation of the KSR1 phosphosite leads to a change in the MAPK response
from transient to sustained, as signaling from Raf-KSR1 dimers cannot be attenuated [Razidlo
et al., 2004, Canal et al., 2011]. A further positive feedback between MAPK signaling and
KSR1 action was found recently [Cullis et al., 2014]. The activation of MAPK signaling was
shown to induce the expression of the Rho GEF GEF-H1, which is in quiescent cells bound
to microtubuli. Surprisingly, this protein associates transiently with KSR1 upon growth factor
stimulation and stimulates the dephophorylation of KSR1 on S392 by PP2A in a mechanism
independently of its GEF activity. The dephosphorylation causes the membrane association of
KSR1 and GEF-H1 as wells the induction of MAPK signaling. It was further shown that the
KSR1 and GEF-H1 are required for Ras/BRaf dependent cell transformation.
1.1.4.2 β−arrestin 2
β−arrestin 2 is responsible for desensitization and internalization of GPCRs, but also links
GPCR signaling to RTK activation. While GPCR activation generally causes transient ERK1/2
activity leading to ERK1/2 translocation into the nucleus, the involvement of β−arrestin 2
targets Raf/Mek/ERK signaling in early endosomes, resulting in sustained, cytoplasmic activity
of ERK1/2 [Perez-Aso et al., 2013, DeFea et al., 2000, Ahn et al., 2004]. β−arrestin 2 further
regulates signaling of JNK and Src-PI3K-AKT pathways [Luttrell et al., 1999, Luttrell et al.,
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1.1.4.3 IQGAP 1
The IQ motif-containing GTPase activating protein 1 (IQGAP) binds to more then 90 proteins
and is involved in cytoskeletal processes like regulation of cell-cell adhesion, polarity, and mi-
gration [Johnson et al., 2009, White et al., 2012]. It modulates EGFR activation and positively
regulates ErbB2 expression, phosphorylation and signaling in breast cancer cells [McNulty
et al., 2011, White et al., 2011]. IQGAP’s interactions include Raf, Mek and ERK, and it
was shown to regulate the latter two proteins in their activity [Roy et al., 2004, Roy et al.,
2005]. Although IQGAP1 is non-essential, a recent study reports that ERK activity-dependent
tumorigenesis can be attenuated by titrating the IQGAP1 - ERK2 interaction with a peptide
which binds to the WW domain of IQGAP [Li et al., 2000, Jameson et al., 2013]. The ERK
activity dependent proliferation of breast, colorectal or skin tumor cells conferred by either
EGFR overexpression, KRas or BRaf mutation, was impaired by the WW binding peptide,
without being toxic to wild-type cells [Jameson et al., 2013]. Application of the WW peptide
furthermore terminated growth of established tumors and PLX4032 resistant B-Raf-Val600Glu
cells [Jameson et al., 2013]. Despite numerous IQGAP interactions, ERK is the only protein
reported to bind the IQGAP WW domain [Roy et al., 2004]. Therefore, as IQGAP is not re-
quired for normal development, but essential in ERK mediated tumorigenesis it seems to be a
promising anti-carcinogenic target.
1.1.4.4 Sef
Sef is a transmembrane protein, originally found as inhibitor of fibroblast growth factor (FGF)-
induced Ras/ERK signaling in embryogenesis of zebrafish. It has orthologues in different
vertebrates including humans, exerting a negative regulatory role in RTK activation [Fürthauer
et al., 2002, Tsang et al., 2002, Yang et al., 2003, Xiong et al., 2003]. Sef inhibits ERK nuclear
translocation by binding to active Mek and ERK as homodimers, restraining them to the Golgi,
ER and plasma membrane without altering ERK activity [Torii et al., 2004, Casar et al., 2009].
1.1.4.5 RKIP
The Raf kinase inhibitor protein (RKIP) is able to bind c-Raf and B-Raf, Mek and ERK. The
binding sites for Raf and Mek partially overlap so that binding is mutually exclusive and hence,
RKIP physically separates the two kinases [Yeung et al., 1999]. Additionally, RKIP is a com-
petitive inhibitor for Raf, suppressing the phosphorylation of Mek and therefore the signal
transduction [Yeung et al., 2000], [Park et al., 2005]. RKIP-Raf dissociation is initiated by
PKC phosphorylation on RKIP Ser153, inducing RKIP dimerization [Lorenz et al., 2003],
[Corbit et al., 2003], [Deiss et al., 2012]. The RKIP dimer inhibits G protein receptor kinase 2
(GRK2) which in turn enables the activation of a GPCR and couples RTK to GPCR activation
[Deiss et al., 2012], [Corbit et al., 2003], [Park et al., 2005].
In PC-12 cells RKIP is the distinctive factor resulting in differentiation or proliferation via
the ERK cascade upon NGF or EGF treatment (for more information see chapter 1.3.2) [Santos
et al., 2007].
1.1.4.6 PEA-15
Phosphoprotein enriched in astrocytes (PEA-15) is a small regulatory protein localized to the
cytoplasm, where it anchors ERK1/2. Hence, with increasing PEA-15 abundance nuclear entry
of ERK1/2 can be prevented [Formstecher et al., 2001, Whitehurst et al., 2004, Glading et al.,
2007, Gaumont-Leclerc et al., 2004]. However, cases of PEA-15 supporting tumor growth
have also been reported [Sulzmaier et al., 2012, Eckert et al., 2008]. A recent crystallographic
13
study revealed that PEA-15 bound to phosphorylated ERK2 sets the activation loop of the
active ERK allosterically in an inactive conformation [Mace et al., 2013]. PEA-15 therefore
sequesters and retains active ERK2 [Mace et al., 2013]. The exact mechanism of ERK2 release
from the complex is still unsolved but involves PEA-15 phosphorylation [Mace et al., 2013].
An accumulation of ppERK1/2 in cells overexpressing PEA-15 hints towards a protection from
phosphatases [Eckert et al., 2008]. A continuous retardation of active ERK1/2 can potentially
lead to sustained cytoplasmic ERK1/2 activity.
1.1.4.7 MP1
MEK partner 1 (MP1) specifically binds to Mek1/2, supporting Erk1/2 activation and MAPK
signaling in vivo [Schaeffer et al., 1998, Teis et al., 2002]. MP1 is part of a trimeric protein
complex with p14 and the lipid raft adaptor protein p18 in which p14 bridges between Mek1
and p18, which anchors the p14-MP1 complex to late endosomes [Teis et al., 2002, Nada et al.,
2009]. p14 and p18 are each essential during early mouse embryogenesis. Additionally, mouse
embryonic fibroblasts (MEFs) lacking p14 or p18 show distorted endosome and lysosome dis-
tribution, as well as endosome sorting defects, accompanied by decreased Mek1/2 and ERK1/2
activity [Teis et al., 2006, Teis et al., 2002, Nada et al., 2009]. MP1 associates with PAK to
enhance PAK-dependent Mek1 activation, connecting MAPK signaling with cell migration and
spreading via Rho [Pullikuth et al., 2005]. The Mp1-p14-p18 complex has further been shown
to be essential in the amino acid dependent mTORC1 activation at lysosomes [Sancak et al.,
2010].
1.2 Saccharomyces cerevisiae MAPK pathways
In S. cerevisiae (budding yeast), four MAPK pathways are well known [Gustin et al., 1998,
Chen & Thorner, 2007]. In contrast to mammalian cell lines, yeast has an easily modifiable
genome, enabling the study of MAPK signaling without altering expression levels [Janke et al.,
2004]. Using engineered interactions the transition to synthetic biology has been accomplished
[Bashor et al., 2008, Peisajovich et al., 2010].
The yeast MAPK cascades are induced by starvation, osmotic shock, pheromone stimulation
or cell wall stress. Under each condition specific cell surface receptors transmit the informa-
tion to the activation of a certain terminal MAPK protein; these are Kss1 (kinase suppressor
of Sst2), Hog1 (high osmolarity/glycerol), Fus3 (fusion) and Slt2 (suppressor of LYT2). How-
ever, in three of the four pathways the signal from receptor to MAPK is transduced via shared
components. Pheromone and starvation pathways share the MAPKK Ste7 (sterile), the MAP-
KKK Ste11 and PAK Ste20. The two latter kinases function additionally in a third pathway,
the osmotic shock cascade (figure 1.3). To ensure the correct cellular response despite the use
of the shared intermediary signaling components, scaffolds connect the signal from the recep-
tor to the activation of the appropriate MAPK. In the case of pheromone stimulation or high
osmolarity, these are the scaffolds Ste5 and Pbs2. They are required additionally to an active
Ste7 or Ste11 to activate the MAPKs Fus3 or Hog1. If solely an intrinsically active Ste7 or
Ste11 mutant is expressed, Kss1 from the starvation response becomes activated as a default
response.
During mating of haploid yeast, the different pathways need to cooperate in order to maintain
the cell’s homoeostasis: The mating-specific cell response is generated via the yeast pheromone
pathway. One aspect of the mating response is polarized growth of the otherwise round yeast
cell. The polarized morphology is called “shmoo”. Hereby, the cell wall stress pathway is
required to support the cell wall remodeling during polarized growth. Further, it was recently
shown that subsequent to polarized growth, the intracellular osmolarity is balanced by the Hog1
pathway [Baltanás et al., 2013].
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Figure 1.3: Scaffolds specify signals from shared components in yeast MAPK pathways.
Three of the four yeast MAPK pathways share the small GTPase Cdc42, the PAK
Ste20 and and MAPKKK Ste11 (brown). The pheromone (blue) and starvation
(green) pathways further share the MAPKK Ste7 (turquoise). To achieve signal
specificity, the pheromone and high osmolarity pathways utilize scaffolds (Ste5 and
Pbs2), which connect a pathways specific upstream component, e.g. the receptor,
to the specific MAPK Fus3 or Hog1.
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1.2.1 Signaling components of the pheromone MAPK cascade
Yeast exists in two sex types, Mata and Matα . They secrete short peptides, either C-terminally
farnesylated 12-amino-acid or unmodified 13-amino-acid long, which are named pheromone or
a- and α- factor, respectively. The pheromone binds to a Mat type-specific GPCR Ste2 or Ste3,
inducing the dissociation of the G protein α-subunit from βγ-subunit [Klein et al., 2000]. The
free Gβγ is able to bind a p21-activated protein kinase (PAK) Ste20 and a scaffold protein Ste5,
which has binding sites for each of the pheromone pathway MAPKs [Choi et al., 1994, Inouye
et al., 1997, Feng et al., 1998]. Processes involving the small GTPase Cdc42 activate Ste20,
initiating the activation of the MAPK cascade [Wiget et al., 2004, Winters & Pryciak, 2005].
The MAPKKK Ste11 is phosphorylated by Ste20 on three activation loop sites S302, S306 and
T307 [van Drogen et al., 2001]. Active Ste11 in turn phosphorylates MAPKK Ste7 on the two
activating sites S359 and T363 [Zheng & Guan, 1994]. Ste7 has six further phosphorylation
sites of unknown function [Maleri et al., 2004]. Ste7 phosphorylates the MAPKs Fus3 and
Kss1 on Thr180 and Tyr182 (Fus3 nomenclature) of the conserved Thr-Glu-Tyr motif in the
activation loop. Kss1 can assume up to 10% of the function of Fus3 [Elion et al., 1991, Cook
et al., 1997, Farley et al., 1999].
Signaling of Fus3 leads to a cell cycle arrest to align the potential mating partners, a specific
transcriptional program and polarized growth in direction of the highest pheromone concentra-
tion [Chang & Herskowitz, 1990, McCaffrey et al., 1987]. The cell cycle arrest in G1 phase
is conferred by Fus3 phosphorylating Far1, which in turn inhibits the cyclin dependent kinase
1 (CDK1). In other stages of the cell cycle CDK1 inhibits the cell cycle arrest by phospho-
rylating Ste5, which impairs the Ste5 membrane association [Strickfaden et al., 2007]. Other
targets of Fus3 are the transcription factors Ste12 and Dig1/2, whose phosphorylation results
in the expression of Fus1 among others. Fus1 expression is commonly used as reporter for
pheromone pathway activation. Finally, haploid cells of opposite mating types fuse and build
a diploid yeast cell.
1.2.2 Regulatory mechanisms of the pheromone MAPK cascade
The regulatory mechanisms of the pheromone pathway are required to ensure pathway insu-
lation, orientation in the extracellular pheromone concentration field and the robustness of the
mating response. Pathway insulation is necessary to translate the activation of the pheromone
receptor into the mating response instead of one of the other MAPK responses. Fus3 is in-
trinsically a poor substrate for its MAPKK Ste7, which prevents Fus3 activation upon starva-
tion signaling [Good et al., 2009]. To achieve activation of Fus3, a complex of Fus3, Ste7
and a domain of Ste5 is required. Ste5 allosterically “unlocks” the activation loop of Fus3,
which increases the activity of Ste7 towards Fus3 5000-fold [Good et al., 2009]. To prohibit
cross-activation from the pheromone into the filamentous growth pathway, Fus3 phosphorylates
the filamentous-specific transcription factor Tec1, causing its ubiquitin-dependent degradation
[Chou et al., 2004, Bao et al., 2004]. The requirement for Ste5 as catalyst for full Fus3 acti-
vation ensures additionally to pathway insulation a localized activation of Fus3 at the site of
pheromone receptor activation. In pheromone-stimulated cells which form a shmoo, a gradient
of active Fus3 emanates from the shmoo tip towards the nucleus (figure 1.4) [Maeder et al.,
2007]. This Fus3 activity gradient was speculated to ensure the correct shmoo morphology
and position of the nucleus (for more information see chapter 1.3.3.3) [Maeder et al., 2007].
The gradient might further serve as an intracellular morphogen to link receptor activation with
polarized cell growth. The orientation of the projection tip in the direction of the highest
pheromone concentration enables the cell to fuse with the closest potential mating partner and
thereby preserve energy. Economic viability also defines a minimum pheromone concentration
upon which yeast cells start the mating program. The pheromone concentration sensed by a cell
can be interpreted as the distance to the secreting mating partner. Below a certain pheromone
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Figure 1.4: Yeast pheromone pathway and MAPK Fus3 phosphorylation gradient. (A)
Schematic representation of the yeast pheromone MAPK module. (B) FLIM of
phosphorylated Fus3 in stimulated yeast. Yeast expressing Fus3-GFP was fixed
and stained with Cy3 labeled anti-ppFus3 antibody. Images show intensity and
lifetime distribution with false-color look-up-table (left side) with corresponding
distribution from shmoo tip to end (adapted from [Maeder et al., 2007]).
concentration threshold, the mating partner is too far away and growth in this direction would
consume too much energy. However, if the pheromone concentration is sufficiently high, the
mating response is initiated in a switch-like manner [Malleshaiah et al., 2010]: In vegetatively
growing yeast, Ste5 allosterically supports the autophosphorylation of Fus3 on Tyr182, which
increases Fus3 activity by factor 25 (doubly phosphorylated Fus3 shows an 120-fold increase
in activity) [Bhattacharyya et al., 2006]. Partially activated Fus3 in turn phosphorylates Ste5
on four Thr and Ser sites, thereby strengthening the interaction between Fus3 and Ste5 [Bhat-
tacharyya et al., 2006, Malleshaiah et al., 2010]. Upon pheromone stimulation with sufficiently
high concentration, Ste5 is dephosphorylated by the phosphatase Ptc1, leading to the switch-
like dissociation of Fus3 from Ste5 [Malleshaiah et al., 2010]. The switch-like mating decision
is potentially essential for the robustness of the mating response despite cell-to-cell variability
in protein stoichiometry [Malleshaiah et al., 2010, Paliwal et al., 2007].
1.3 Regulation of the ERK network
While MAPK pathways in yeast share single signaling components, some mammalian cells
employ the complete Raf/Mek/ERK cascade for differential cell responses. This chapter will
explain how signaling specificity can still be achieved by dynamic regulation of the ERK re-
sponse.
The utilization of the ERK cascade for the GF-specific induction of the differential cell fates
differentiation and proliferation in the same cell line has been described in the following ex-
amples: NGF vs. EGF in PC12 cells, HRG and FGF vs. EGF in MCF-7 and PDGF vs. EGF
in fibroblasts [Nguyen et al., 1993, Nagashima et al., 2007, Wosikowski et al., 1993, Razidlo
et al., 2004, Thottassery et al., 2004]. The differential cellular outcome is determined by the
ligand-specific environment of signaling; each GF binds to a different receptor which addi-
tionally recruits other regulatory interactors to the MAPK cascade, like GTPases or scaffolds
(see 1.3.1). This receptor specific protein network constitutes a unique set of interactions and
spatio-temporal activity profiles (see 1.3.2). The incoming signal is processed through the com-
plex network and focussed in the ERK activity. However, ERK is not the endpoint or a passive
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receiver in the signal processing, it participates by phosphorylating upstream network proteins
in a feedback or inducing transcriptional feedbacks. simultaneously, ERK, like all MAPKs,
links the signal procession with the execution into a cell response. Differential regulation of
ERK response properties results in the activation of distinct substrates and effects differential
between cell fates.
1.3.1 Ligand-specific context of signaling
The ERK cascade is integrated in a ligand-specific protein network. Each ligand binds to a dif-
ferent receptor which in turn recruits and activates a different set of regulatory interactors. The
network composition is further determined by the cellular state and the spatio-temporal activity
profile of the receptor, as each receptor has differential recycling and degradation kinetics. The
internalization of the active receptor in endosomes can generate intracellular signaling plat-
forms. At these endosomes certain regulatory interactors are available, for instance β -arrestin
in early and MP1 at late endosomes. So in this context, the ERK cascade interacts with dif-
ferent proteins than at the PM. Additionally, ERK activated at endosomes can penetrate more
deeply into the cytosol and reach for instance the nucleus, although phosphatases in the cytosol
restrain the spreading of phosphorylated ERK (see chapter 1.3.3.3). Targeted trafficking of en-
dosomes to organelles delivers active molecules to accomplish local functions, like migration
at focal adhesions.
Additionally to the diverse functions of the regulatory interactors described in chapter 1.1.4,
also differential activation dynamics of GTPases can regulate the activation of the MAPK cas-
cade. The ERK-induced transcription can change the stochiometry of network proteins after
20-60 minutes of stimulation. Particularly phosphatase transcription is induced by ERK. Phos-
phatases deactivate the kinases in the cytosol which constitutes a negative feedback [Bhalla
et al., 2002].
1.3.2 Network topology
Dynamic MAPK signaling arises from the differential composition of the surrounding network
and the underlying individual interactions. The entirety of positive and negative interactions
(e.g. activation and deactivation) in a network is defined as the network topology. Additionally
to the linear sequence of signal transduction, a pathway output (e.g. active MAPK) can modify
its own input (e.g. MAPKKK), which is referred to as feedback (positive or negative). Another
network motif is the feedforward loop, here a network component influences a target, which
is at least two levels downstream. Therefore, the target is modified by its direct upstream and
additionally by the two-level upstream (indirect) component.
In MAPK pathways, the signal is channeled through the terminal MAPK. Therefore, the
specific protein network and its topology find expression in the activity of the terminal MAPK.
However, the MAPK exerts feedback by phosphorylating upstream proteins and is therefore
involved in its own regulation.
1.3.3 Dynamic responses of signaling networks
The differential response of ERK, although always always part of the same three-step cas-
cade, has been explained with differential protein network compositions and their individual
topology. These influence amplitude, duration and localization of ERK activity. However, ev-
ery spatio-temporal activity profile relies on a specific dose-response relation. Therefore, the
behavior of a network component can be either investigated as spatio-temporal dependence
induced by a constant stimulus, or as dose-dependence at steady-state. A reversible, cova-
lent modification process, like protein phosphorylation, exhibits a variety of dose-response
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behaviours. In this chapter the kinetics of protein phosphorylation and different network archi-
tectures are described and how they shape the spatio-temporal ERK activity profile.
1.3.3.1 Dose-response relations of MAPK phosphorylation
The presented mechanisms of stimulus-phosphorylation relations apply for every reversible
and covalent modification cycle. The prevalence of phosphorylation over other modifications in
many cellular functions can be attributed to its stability under physiological conditions, which
requires for enzymatic regulation [Westheimer, 1987, Kamerlin et al., 2013].
In general, the dose-response behaviour of a certain protein with multiple phosphorylation
sites depends on the following conditions: the concentrations of the converter enzymes (ki-
nase and phosphatase) relative to the substrate, the affinities of the converter enzymes for each
phosphorylation state of the substrate and the kinetics of the catalytic steps [Salazar & Höfer,
2009].
The kinetics of phosphorylation can roughly be divided into cooperative orMichaelis-Menten
type. If the first phosphorylation of a protein with at least two phosphorylation sites increases
the probability for further modification, a cooperative mechanism takes place. The first phos-
phorylation therefore accelerates the second one. A cooperative mechanism is represented by a
sigmoidal relation of dose and response, referred to as ultrasensitivity [Goldbeter & Koshland,
1981]. The response is amplified relatively to the input, if the stimulus concentration is above a
certain threshold. Such a behaviour supports the maintenance of the proportional activity from
one cascade level to the next, if the substrate is in excess relative to its enzyme, which applies
to Mek and Raf (measured concentration of Mek 1.4 µM to 0.013 µM for Raf [Fujioka et al.,
2006]). The suppression of signals below the threshold filters out spurious signals.
There are three major mechanisms which cause ultrasensitivity: inhibitor ultrasensitivity,
multi-step ultrasensitivity (like cooperativity) or zero-order ultrasensitivity [Goldbeter &Koshland,
1981, Huang & Ferrell, 1996, Ferrell Jr, 1996]. For MAPKs, the zero-order mechanism is
specifically important. Here, the converter enzymes which catalyze the (de-)phosphorylation
operate near saturation. Therefore, a small increase in stimulation, equivalent with an increase
in the concentration of active kinase, will cause a steep response because the constant phos-
phatase level remains saturated.
The dual phosphorylation required to activate a MAPK was considered a multi-step mecha-
nism enabling ultrasensitivity for a long time [Goldbeter & Koshland, 1981, Huang & Ferrell,
1996, Ferrell Jr, 1996]. More recent studies find that multisite phosphorylation alone consti-
tutes a sufficient threshold, upon which active molecules begin to accumulate, but not a switch
[Gunawardena, 2005]. However, in combination with cooperativity, switch-like responses can
still be generated by biphosphorylation processes. Thereby, the rate of the first phosphoryla-
tion of aMAPKK is determined by the linearly increasing concentration of the activating kinase
MAPKKK* (* indicates MAPKKK is active). The substrate concentration, the unphosphory-
lated protein MAPKK, stays constant because it is in excess. The second phosphorylation of
MAPKK-P is a second-order reaction, because the concentrations of activating kinase MAP-
KKK* and the substrate, MAPKK-P, both increase linearly. This applies only for a distribu-
tive phosphorylation process [Goldbeter & Koshland, 1981, Huang & Ferrell, 1996, Ferrell Jr,
1996]. In a distributive process only one site is modified per binding event, while in a pro-
cessive catalysis both phospho-sites are modified upon a single interaction. However, in the
crowded environment of the cytoplasm both cases, distributive and processive phosphorylation
will take place [Humphreys et al., 2013].
In a cascade with multiple levels, like the three-step MAPK cascade, the response was
demonstrated to become more sensitive with every cycle of phosphorylation and dephosphory-
lation (figure 1.5) [Huang & Ferrell, 1996].
Scaffolds are thought to favour a processive reaction because binding and rebinding of kinase
and substrate to the scaffold are assumed to be unlikely [Burack & Shaw, 2000, Takahashi &
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Figure 1.5: Sensitivity amplification in a cascade. Semi-logarithmic dose-response plot for
each level of a three-tiered cascade with distributive phosphorylation steps. The
dose-response of the MAPKKK follows Michaelis-Menten-kinetics, expressed by
a Hill-coefficient of nH = 1. Ultrasensitivity increases with each cascade level.
Adapted from [Huang & Ferrell, 1996].
Pryciak, 2008]. Consequently, scaffolds promote a graded dose-response behaviour, which is
more sensitive at low doses. Simulations demonstrate further that scaffolds can increase the rate
of MAPK activation and increase the steady-state concentration of active MAPK [Levchenko
et al., 2000]. In order to amplify the activation of a bound MAPK, the scaffold concentration
within a certain range, relative to its binding partners [Bray & Lay, 1997, Chan et al., 2012]. At
too high concentrations, enzyme and substrate will be physically separated on different scaf-
folds so that signaling will be attenuated, an effect termed “pro-zone” or “combinatorial inhibi-
tion” [Bray & Lay, 1997, Levchenko et al., 2000]. Too low concentrations are not sufficient to
effectively support the signal transduction. However, scaffolds are conversely also involved in
a mechanism which can produce an ultrasensitive dose-response in conjunction with multisite
phosphorylation. This model discusses the sequestration and protection of the active substrate
from (de-)phosphorylation [Serber & Ferrell, 2007, Liu et al., 2010, Dushek et al., 2011]. The
protecting environment can be a protein, a membrane or an organelle. Here, the ultrasensitivity
arises from the (supra-)molecular structure serving as a sink for the (un-)phosphorylated pro-
tein. For example, unlike the phosphorylated Ste5, the unphosphorylated Ste5 has an increased
affinity to the PM, which results in reduced availability for both forward and backward reac-
tion. Once the unphosphorylated Ste5 leaves the membrane, the first phosphorylation decreases
the possibility of Ste5 rebinding to the PM and therefore promotes further phosphorylation and
maintenance in the cytosol. So, under utilization of the membrane as sink for unphosphorylated
Ste5, the multisite phosphorylation generates a switch-like dose-response of Ste5 phosphory-
lation and membrane dissociation [Serber & Ferrell, 2007]. That way, scaffolds can either
promote a graded or an ultrasensitive response. The respective outcome is again dependent on
affinities, kinetics and the relative concentrations of the relevant proteins (see above) [Locasale
et al., 2007, Liu et al., 2010, Levchenko et al., 2000].
The combination of a non-linear dose-response, like ultrasensitivity, and either a positive or
a double-negative feedback can generate bistability (see figure 1.6) [Ferrell & Xiong, 2001].
A bistable system can flip between two steady-states, but not remain in an intermediate state
[Ferrell, 2002]. The ultrasensitive behaviour keeps the system in an “off” state below a certain
concentration of stimulus, while upon crossing the threshold the positive feedback immedi-
ately amplifies the sigmoidal response and the system is directly in the “on” state [Ferrell &
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Figure 1.6: Bistability and hysteresis. (A) A reversible, bistable system is “on” as long as
the stimulus is present. The switching threshold between “on” and “off” states
depends on the initial point. (B) An irreversible, bistable system stays “on”, also if
the stimulus is withdrawn. Adapted from [Ferrell, 2002].
Xiong, 2001]. A property of bistable responses is hysteresis. Either the switching point shifts,
depending on the initial stimulus concentration, or, the system becomes stuck in the “on” state,
once it is flipped and is hence irreversible [Ferrell & Xiong, 2001]. Multi-site phosphorylation
alone can cause bistability without a feedback, if the converter enzymes fulfill certain kinetic
characteristics [Markevich et al., 2006, Ortega et al., 2006, Thomson & Gunawardena, 2009].
These conditions can be supported by the involvement of scaffolds [Chan et al., 2012].
1.3.3.2 Network responses − in time domain
Most recent results from ERK activity sensors in live cells demonstrate that network responses,
cumulated in the ERK activity, might be − unsurprisingly − more complex than assumed
[Albeck et al., 2013, Aoki et al., 2013]. These publications showed that ERK activity pulses
occur stochastically during a cell cycle in dependence on the cell density [Albeck et al., 2013,
Aoki et al., 2013]. Cell division seems to be proportional to the frequency of activity pulses
[Aoki et al., 2013]. Here, the basic network responses adaptation, oscillation and bistability
and their downstream interpretation are described.
In an adaptive response, the ERK activity increases upon a fold-change in the stimulus con-
centration, but is thus downregulated, despite a constant stimulation of the receptor (figure 1.7
B). Adaptation to the stimulus is typically caused by a negative feedback. Repeated increase
of the stimulus concentration causes further transient periods of ERK activity in the range of
one to ten minutes. This transient MAPK activity results in the initiation of protein synthesis
of immediate early genes (IEGs).
An ultrasensitive, negative feedback with a time delay can lead to sustained oscillations (fig-
ure 1.7 C). The time delay can be accomplished by the suppression of a component which is at
least two steps upstream, e.g Raf in the case of ERK. The ultrasensitivity in the feedback is nec-
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Figure 1.7: Temporal dynamics of ERK activity in different network motifs. (A) Response
of ERK in a solely linear cascade. (B) ERK activity is transient, if a negative
feedback is present. (C) ERK activity can oscillate if the negative feedback is
delayed. Adapted from [Kholodenko et al., 2010].
essary to prevent a dampening of the amplitudes [Asthagiri & Lauffenburger, 2001, Brightman
& Fell, 2000, Kholodenko, 2000, Avraham & Yarden, 2011].
An irreversible response is for instance important in the cell cycle or in the decision to dif-
ferentiate [Huang & Ferrell, 1996]. Prolonged duration of MAPK activity additionally effects
the post-translational phosphorylation of the protein after 30-60 minutes, constituting a “logic
AND gate” or a coherent feedforward loop (CFL) for proteins which are intrinsically unstable
[Murphy et al., 2002, Mangan et al., 2003, Nakakuki et al., 2010]. This kind of network motif
follows the mechanism of multi-step ultrasensitivity as well.
1.3.3.3 Network responses − in spatial domain
Additionally to the temporal regulation of ERK activity, the spatial control allows for further
variations of the ERK response, although time and space profiles are not independent from
each other. In this paragraph the influence of dose-response relations and network motifs on
the spatial activity distribution are described.
The binding of an extracellular ligand to a receptor induces the recruitment and activation of
signaling proteins to the PM. Furthermore, the relocation from the three-dimensional cytosol
on the two-dimensional membrane increases the concentration of these proteins and potentially
their reaction rate. A spatial partitioning of activation and deactivation takes place, because the
deactivating phosphatases cannot bind to the PM and reside in the cytoplasm. The PM is
therefore the source of active signaling molecules, while the cytosolic phosphatases constrain
the signal propagation in the axial direction. So, how do active molecules attain intracellular
locations, especially the nucleus? Computational modeling of the activity distribution of a
soluble substrate which is activated and deactivated in separated areas results in a gradient
[Brown & Kholodenko, 1999, Bastiaens et al., 2006]. The distance λ , to which the gradient
decays to 1e of its initial intensity is thereby dependent on the dephosphorylation rate kDephos
with kDephos = c(phosphatase) · kM(phosphatase) and the diffusion D of the active molecule:
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Figure 1.8: Relation of cell shape and gradient length determines local phosphorylated
fraction. Concentration profile (look-up table on the right) of the phosphorylated
form of the substrate are shown for parameters: λ = 1µm, kkin = 50s−1. A) Planar
slice through a cylindrical cell (radius = 8µm, height = 5µm) with a filopodium
(radius = 0.5µm, length = 8µm). Owing to the different radii of cylindrical cell and
filopodium, the phosphorylated fraction in the filopodium is high, while the conce-
tration of phosphorylated substrate in the cytoplasm is low. B) The phosphorylated
fraction increases at a site of polarization because the distance between membranes
is small relative to the gradient length. Shown are 5 planar slices of a cell with
width = 20 µm, length = 20 µm, height = µm. Adapted from [Meyers et al., 2006].
λ (µm) =
√
D(µm2s−1)
kDephos(s−1)
The concentration of the phosphorylated form of a protein at the PM, which is the amplitude
of the phospho-gradient, mainly depends on the reaction rate of the activating kinase [Brown
& Kholodenko, 1999].
In order to determine the resulting global concentration of the phosphorylated protein, the
gradient length has to be set in relation to the three-dimensional cell shape [Meyers et al., 2006].
The surface-to-volume ratio and local membrane proximity determine the global and local
phosphorylated fraction. Cell protrusions and flat cell edges exhibit higher phosphorylated
fractions than regions around the cell’s center because gradient length and membrane distances
are on the same scale (see figure 1.8) [Meyers et al., 2006].
From these considerations the following consequences for the activity distribution of the
MAPK elements can be derived. Raf must bind to Ras-GTP at the membrane for activation.
Its spatial activity profile is a steep gradient which defines then the area of Mek activation.
The Mek activity profile is therefore extended in axial direction and the area of ERK acti-
vation is accordingly even broader. Modeling the activity distribution of each cascade level
with Michaelis-Menten-kinetics reveals gradients for each active component which become
extended and shallower down the cascade (figure 1.9 A) [Kholodenko, 2006]. The derived de-
cay length of active ERK is sufficiently extended to enable active ERK to enter the nucleus and
therefore overcome the range of the phosphatases.
However, under ultrasensitive conditions, the substrate gradient’s extent does not substan-
tially exceed the gradient length of its converting enzyme (figure 1.9 C and B) [Markevich et al.,
2006, Melen et al., 2005, Semenov et al., 2013]. The detailed influence of the (de-)phosphory-
lation mechanism (processive or distributive) and positive or negative feedback from ERK to
Ras on the spatial propagation of ERK activity is shown in figure 1.10. Negative feedback from
ERK to Ras reduces the amplitude and extent of the ERK activity gradient [Sun et al., 2014].
23
MAPK
MAPKK
MAPKKK
Ph
os
ph
or
yl
at
ed
 k
in
as
es
BA
pp
M
A
PK
 (n
M
)
C
D
E
C D E
D
C, E
pp
M
A
PK
K
 (n
M
)
d (μm)
0              3               6               9
0 
   
   
   
   
   
   
  1
50
  
Figure 1.9: Influence of the cascade’s dose-response on the spatial distribution of
ppMAPK. (A) Phosphogradients of serially activated enzymes become shallower
with each level if the enzymatic steps follow Michaelis-Menten kinetics. (B) Spa-
tial distributions of ppMAPK in steady-state corresponding to the dose-responses
from (C-E). Inset: Corresponding distributions of ppMAPKK. (C-E) Different
dose-responses shown each for Ras - ppMAPK and the subordinated input-output
ppMAPKK - ppMAPK. (C) Amplified ultrasensitivity in the cascade. (D) Ultra-
sensitivity from ppMAPKK to ppMAPK and bistability in the Ras - ppMAPK re-
lationship generated by a positive feedback from ppMAPK to Ras. (E) Bistabil-
ity in the ppMAPKK - ppMAPK dose-response. Adapted from [Markevich et al.,
2006, Kholodenko, 2006].
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In any network motif, a slight degree of processivity in the dephosphorylation steps abolishes
the spreading of active ERK so that processive dephosphorylation seems unlikely [Sun et al.,
2014]. The processivity of the kinase however changes the ERK distribution explicitly only in
combination with a negative feedback.
In steady-state, a bistable dose-response between cytosolic proteins Mek and ERK nearly ho-
mogenizes the distribution of active ERK throughout the cytoplasm, although Mek activity is
still restrained to the PM-proximal region (figure 1.9 E and B) [Markevich et al., 2006]. Obser-
vation of the time-resolved activity distribution between stimulation and steady-state reveals
a wave of phosphorylation which travels through the cytosol. This wave rapidly propagates
the signal from the PM to intracellular locations which is especially important to cover large
distances where diffusion would be too slow.
Bi- or multistability during signal transduction at the membrane generates spatial inho-
mogenity. Depending on the local stimulus concentration, e.g. the receptor occupancy, the
response can result in any stable steady-state, for instance “on” or “off” in bistability. These
disparities at the membrane are involved in pattern formation and polarization, for example in
differentiation.
The location of differential signaling can be controlled by the stimulus-induced recruitment
of scaffolds, like Ste5 and KSR, to connect a spatial landmark at the PM to the activation of
MAPKs. This accumulation may optimize scaffold concentration in locally restricted mem-
brane patches and prevent scaffold-enhanced signaling in the cytoplasm, if the cytoplasmic
scaffold concentration is unfavourable [Levchenko et al., 2000]. As discussed above, scaffolds
can influence the sensitivity and signal procession in multiple ways. The scaffolded signaling
domains may therefore either contribute to the propagation of MAPK activity towards the nu-
cleus or direct the MAPK to local functions. MAPK activity can be guided towards the locally
available targets either by global restriction or confined activation, respectively, for instance by
signaling endosomes [Ge et al., 2003]. Signaling endosomes relocate MAPK activation from
the PM into the intracellular space [Ginty & Segal, 2002]. The described spatial propagations
of MAPK activity occur in the same manner from signaling endosomes, but the distances in
axial direction are shorter so that active MAPK can penetrate further in direction of the cell’s
center.
In the case of yeast, the scaffold Ste5 is a prerequisite to yield fully phosphorylated Fus3.
As the scaffold accumulates at the prospective mating tip by binding to the active receptor, it
connects a spatial landmark to the localized activation of Fus3. Fus3 therefore builds a primary,
steep gradient. However, the extent of its gradient is sufficient for the dimensions of a yeast
cell, at least in the beginning of the tip growth, to reach the nucleus and start the transcriptional
program (diameter of yeast is about 5-10 µm, HeLa cell about 50 µm).
1.3.4 Case studies of dynamic signaling via the ERK cascade
The best-investigated case of differential signaling via the ERK cascade is the NGF-induced
differentiation and EGF-induced proliferation in PC-12 (rat pheochromocytoma) cells. Upon
EGF stimulation ERK1/2 show transient activity, while NGF induces sustained ERK1/2 activ-
ity. Different mechanisms have been found for this dynamic behaviour. First, the activation of
different GTPases Ras or Rap1 were identified as decisive factors [York et al., 1998, Sasagawa
et al., 2005]. Also the differential internalization and degradation dynamics of EGFR and
the NGF receptor were thought to be responsible [Schoeberl et al., 2002]. Later however, it
was found by modular response analysis (MRA) that ERK exhibits upon EGF stimulation a
negative and upon NGF stimulation a positive feedback on Raf, thereby attenuating or promot-
ing its own activity [Santos et al., 2007]. Additionally to the different network topologies, it
was shown that the positive feedback is mediated via PKC which is integrated in the NGF-
dependent MAPK network. PKC phosphorylates RKIP, thereby impairing a negative feedback
from RKIP on Mek activation [Yeung et al., 1999, Corbit et al., 2003]. A positive feedback
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Figure 1.10: Predicted influence of different network topologies on MAPK activity gradi-
ents. Computational modeling demonstrating gradients of doubly-phosphorylated
MAPK in a three-step cascade generated by (A) a linear cascade or (B) with pos-
itive feedback from ERK to Ras or (C) with negative feedback from ERK to Ras.
Distributions of ppMAPK are calculated for distributive (Dis) enzymatic steps or
different degrees of processivity for phosphorylation (k) and dephosphorylation
(p) steps. Adapted from [Sun et al., 2014].
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from ERK on Raf is recovered, leading to sustained ERK activity [Balan et al., 2006]. Having
identified PKC as distinctive factor, it was possible to rewire the cellular outcome by activation
or inhibition of PKC additionally to GF stimulation [Santos et al., 2007]. Later it was shown
that ERK could phosphorylate RKIP directly on a different site than PKC, also inhibiting the
suppression of Raf by RKIP [Shin et al., 2009]. Therefore, the recruitment of PKC might not
be necessary to switch between positive and negative feedback.
MCF-7 (Michigan Cancer Foundation-7) is a human breast adenocarcinoma cell line ex-
hibiting estrogen-dependent tumorigenicity [Clarke et al., 1990]. MCF-7 cells express all four
members of the epidermal growth factor receptor (EGFR) (or human epidermal growth factor
receptor (HER) or erythoblastosis oncogene B (ErbB)) family, [Goldenberg et al., 1989, Tavas-
soli et al., 1989, Fiddes et al., 1995]. This protein family comprises receptor tyrosine kinases
(RTKs), which become activated by binding of a ligand [Cohen et al., 1980] to the recep-
tor’s extracellular domain, leading to homo- and heterodimerization between members of the
EGFR family, followed by mutual crossphosphorylation [Cohen, 1983, Yarden & Schlessinger,
1987, Cochet et al., 1988, Wada et al., 1990, Graus-Porta et al., 1997]. Partial exceptions are
on the one hand the orphan receptor ErbB2, for which no ligand was found and which is solely
activated by heterodimerization, and secondly ErbB3, which has no enzymatic activity [Sli-
wkowski et al., 1994, Roskoski Jr., 2014]. The ligands for the EGFR family include EGF and
the three isoforms of heregulin (HRG) which are coded by the gene neuregulin. The three HRG
isoforms have an EGF-like domain in common, which is sufficient to induce receptor activation
[Meyer et al., 1997]. While EGF binds to EGFR, HRG is a ligand of ErbB3 and ErbB4, lead-
ing to the heterodimerization with ErbB2 but also EGFR [Carraway et al., 1994, Fiddes et al.,
1995, Graus-Porta et al., 1997]. While EGFR is downregulated upon ligand binding via the
Ubiquitin kinase Cbl, ERB-B2 and -B3 are preferentially recycled upon ligand binding [Wa-
terman et al., 1998, Lenferink et al., 1998, Levkowitz et al., 1998]. Furthermore, ERB-B2 and
-B3 activate additionally to the ERK pathway also the phosphatidylinositide 3-kinase (PI3K) -
Akt pathway and phospholipase-Cγ (PLCγ) [Peles et al., 1992, Peles et al., 1991].
In MCF-7 cells, stimulation with EGF causes proliferation, while HRG induces differenti-
ation [Dong et al., 1992, Wosikowski et al., 1993, Nagashima et al., 2007]. However, in both
cases the signal is channeled through the Raf/Mek/ERK cascade. Analoguesly to the case of
PC-12 cells, a difference in the spatio-temporal ERK activity regulation was determined: The
cytoplasmic ERK activity is transient upon EGF stimulation but sustained after HRG induction
[Thottassery et al., 2004, Nagashima et al., 2007, Nakakuki et al., 2010]. The nuclear ERK ac-
tivity is transient for both stimuli [Nakakuki et al., 2010]. Only sustained ERK activity leads to
phosphorylation and stabilization of the IEG cFos, triggering differentiation in contrast to pro-
liferation upon transient ERK activity. However, cFos mRNA is always temporarily abundant,
independent of the ERK1/2 activity duration. Nakakuki et al. revealed that an unknown ERK
activity-dependent, transcriptionally-activated repressor is responsible for the transient cFos
mRNA transcription [Nakakuki et al., 2010]. The distinctive mechanisms of how the EGF vs.
HRG stimulation guide the ERK activity into different cell fates is unknown. The costimulation
of MCF-7 cells with EGF and PKC activator PMA led to sustained activtiy of ERK [Nakakuki
et al., 2010]. However, PKC may activate MAPK signaling also directly by activating Raf in-
stead of inhibiting the negative feedback from RKIP on Mek1 activation [Kolch et al., 1993].
In oder to demonstrate that PKC determines the ERK activity duration also in EGF vs. HRG,
it would be necessary to show that the inhibition of PKC in the presence of HRG induces a
transient ERK activity and proliferation.
1.4 Fluorescence Microscopy
Light microscopy is a tool for directly visualizing the morphology of cells. Conventional light
microscopy generates a magnified image of the object near the microscope objective’s focal
27
plane. Structures like the cell membrane or the nucleus can be resolved from their (liquid)
surrounding by a differential transmission or reflection (i.e. contrast) of the illuminating white
light. Dissolved molecules cannot be localized due to a lack of contrast against its environment
and most notably the limitation of light microscopy (about 200 nm). Fluorescence microscopy
techniques overcome both of these issues by labelling the protein of interest with a fluorescent
molecule. Fluorescence is the characteristic absorption of photons of a certain energy to ex-
cite an electronic transition in an atom or molecule and subsequent re-emission (spontaneous
emission) of a new photon which has either equal or lower energy than the absorbed one. The
emitted photon is then detected and localizes the labelled protein as a bright spot in the image
against dark background.
Protein fluorophores, like green fluorescent protein (GFP), provide the interface between the
physical demands for a fluorophore and the biological compatibility. A protein of interest can
be fused on the genetic level with a protein fluorophore, which allows to study the character-
istics of molecules inside living cells in a way that is minimally invasive [Shimomura et al.,
1962, Chalfie et al., 1994]. Variants of GFP from jellyfish and anthozoas have been isolated
and developed to span the entire range of the visible spectrum with optimized fluorescence
properties, e.g. enhanced brightness and photostability [Verkhusha & Lukyanov, 2004, Shaner
et al., 2007]. Different approaches exploit the diverse chemical and physical qualities of the flu-
orophores: fluorophore maturation time (time until chromophore is built after protein transla-
tion) and spectral changes of the fluorophore until its degradation are used to study the turnover
of a protein of interest simultaneously to its localization [Terskikh et al., 2000, Subach et al.,
2009, Tsuboi et al., 2010, Khmelinskii et al., 2012]. The measurement of light depolariza-
tion allows for quantitative analysis of oligomerization of proteins or the rigidity of the local
protein-fluorophores environment.
1.4.1 Förster Resonance Energy Transfer (FRET)
The phenomenon of Förster resonance energy transfer (FRET), on which all microscopy ex-
periments in the present work are based, is the non-radiative transfer of energy from an excited
chromophore (donor) to a chromophore in the ground state (acceptor) which may occur under
certain spectroscopic and spatial conditions [Förster, 1948]. In principle, two fluorophores are
able to resonantly exchange energy if their transition dipoles oscillate with the same frequency
in each others nearfield. The rate of energy transfer kT is thereby dependent on the donor’s
fluorescence lifetime τD, which is defined by the excited state decay profile, the Förster ra-
dius R0, which is unique for every donor-acceptor pair and combines spectroscopic and dipole
orientation parameters, and the distance r.
kT =
1
τD
(
R0
r
)6
with
R0 = 9.78 ·103(κ2 ·n−4 · J(λ ) ·QD)1/6
Here, κ is the relative dipole-dipole orientation factor, n the index of refraction, the spectral
overlap J(λ ) and the quantum yield of the donor QD. For efficient energy transfer the dipoles
are aligned in parallel, while a perpendicular relative orientation impedes energy transfer; for
freely rotating molecules an average orientation of κ = 2/3 is used for calculations of R0. For
fluorophores, the possible energy transitions are encoded in the absorption and emission spec-
tra. The overlap integral between donor emission and acceptor excitation spectra therefore
represents the probability of matching energy, or frequency, of the transition dipoles [Clegg,
2006]. The fluorescence of a molecule is characterized by the quantum yield Q, which is the
ratio between emission and absorption of photons, and the fluorescence lifetime τ , i.e. the time
28
Donor Acceptor
spectral 
overlap
em. exc. em. exc.
λ
kT
FRET
S0
S1
donor 
fluorophore
acceptor 
fluorophore
S1
S0
A B
Figure 1.11: Spectral overlap of donor emission and acceptor excitation is essential for
FRET. (A) Jablonski diagramm showing the energy transitions in FRET. A donor
fluorophore is excited from the ground state S0 to a vibrational level of the first
excited energy state S1 by absorption of a photon (blue arrow) declining into the
ground state of the first electronic state. If the emission wavelength (green arrow)
matches the excitation wavelength of the acceptor, FRET can occur, leading to
induced emission of the acceptor (orange arrow). (B) Schematic representation of
overlapping donor and acceptor spectra, depicting the energy resonance.
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Figure 1.12: Distance dependence of FRET efficiency.
in the excited state. Common values of R0 for protein fluorophores are in the range of about
5 nm and limit the radius for efficient transfer to less than 10 nm. Considering that a GFP
molecule has a Stokes radius of 2.82 nm, the detection of FRET allows for measurement of
protein interaction below the resolution limit of light microscopy [Terry et al., 1995].
The efficiency of FRET is defined in analogy to the quantum yield as the fraction of trans-
ferred to absorbed photons by the donor fluorophore
E =
kT
τ−1+ kT
replacing kT reveals
E =
R60
R60+ r6
showing that the Förster radius R0 defines 50% effiency for the case r = R0.
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1.4.2 Fluorescence lifetime imaging microscopy (FLIM)
FRET reduces the donor fluorescence intensity and its excited state lifetime τD, and further
induces the emission of acceptor fluorescence. Therefore, FRET can be measured by different
approaches, based on changes either of donor and acceptor fluorescence intensity or of the
excited state lifetime τD.
For the intensity-based technique “ratiometric imaging”, the donor intensity decrease and ac-
ceptor intensity increase upon excitation of the donor fluorophore are measured. This method
can be applied in case donor and acceptor are in a one-to-one ratio, for instance in a sensor
construct. It is a fast approach and therefore well suited for live-cell imaging. Accordingly,
“sensitized emission” can be applied, which also measures the FRET dependent donor inten-
sity decrease and acceptor intensity increase. Here, corrections for the bleed-through from the
donor in the acceptor channel, and the direct excitation of the acceptor from the donor channel
are conducted, which make this method very sensitive to noise. For “acceptor photobleach-
ing”, the difference of donor intensity before and after acceptor photobleaching is measured.
The intensity-based techniques for FRET detection are sensitive for bleedtrough or “bleed-
excitation” between donor and acceptor channels and therefore have to be corrected. Further-
more, sample drift, different photostability of donor and acceptor fluorophore and in live cells
the fluctuating local fluorophore concentration can falsify FRET measurements.
The measurement of the change in the excited state decay profile as read-out for FRET is
more reliable, because the lifetime is an intrinsic property of the fluorophore, independent of the
fluorophore’s concentration. Environmental conditions like temperature and pH influence the
excited state lifetime, but these are constant over the course of the experiment. The excited state
lifetime of a donor fluorophore τD can be reduced by radiative and non-radiative (collisional
quenching) processes (kr and knr) and additionally by resonance energy transfer with kFRET in
presence of the acceptor, yielding the lifetime τDA.
τD =
1
kr+ knr
> τDA =
1
kr+ knr+ kFRET
The excitation of a fluorophore sample with an infinitesimally short light pulse causes the
emission within a certain time period, following a single exponential decay.
I(t) = I0 · e−t/τ
If some molecules undergo FRET with an acceptor fluorophore, this fraction of molecules
will have a faster intensity decay. If donor and acceptor interact in one fixed geometric ar-
rangement, the resulting decay is bi-exponential, comprising τD and τDA. However, in most
cases donor and acceptor can interact in multiple spatial configurations, which is expressed
in a multi-exponential decay, which sums the decays for all lifetimes τi, weighted by their
fluorescence amplitude fi at timepoint t = 0.
I(t) =
n
∑
i=1
fi · e−t/τi
The fractional contribution of each decay is defined by αi with
αi =
fiτi
∑ f jτ j
1.4.3 Measurement and Analysis of FLIM data
Excited state decay profiles can be either measured in the “time-domain” or in the “frequency-
domain”. In time-domain measurements, ultra-short laser pulses are applied, while in the
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Figure 1.13: Global analysis of biexponential lifetime data. Plot of real and imaginary parts
of the Fourrier coefficients (R) illustrates that all possible mono-exponential de-
cays lie on a semi-circle, like donor-only lifetime τD and FRET lifetime τDA corre-
sponding decays (green and orange circles). Pixels corresponding to biexponential
decays with mixtures of τD and τDA are scattered along the secant between τD and
τDA. The secant’s intercept of each pixel represents the contribution αi (adapted
from [Grecco et al., 2010]).
frequency- domain approach continuous, intensity-modulated light is used to excite the flu-
orophore. Both methods are based on a known, fixed property of the excitation light, which is
either the frequency of the pulses or the frequency of modulation. They are used as reference to
calculate the excited state decay profile from the emission light. Frequency-domain measures
the phase-shift and demodulation of the emission light. In time-domain measurements, the time
period between emission of a single photon and the laser pulse is recorded (time-correlated sin-
gle photon counting (TCSPC)) yielding a histogram of the number of photons versus time. To
evaluate the corresponding excited state lifetime the histogram is fit with appropriate decay
models.
A further approach named “global analysis” for bi-exponential decay data calculates the
fraction αi of donor molecules bound to acceptor molecules in each pixel, in addition to the
excited state lifetime. The theory of global analysis requires that the investigated FRET pair
exhibits only two invariant lifetimes τD and τDA leading to maximally a bi-exponential decay.
From this, the contribution αi can be calculated, which represents the respective fraction of
lifetimes in each pixel and therefore the fraction of donor in complex with the acceptor. The
sum of the fractions αD+αDA in each pixel is normalized to one and all pixels are analyzed
simultaneously with invariant lifetimes conferring the result global character [Verveer et al.,
2000, Grecco et al., 2009]. Plotting the Fourier coefficients (R) of the fluorescence emission
in the complex plane reveals that all possible mono-exponential decays lie on a semicircle
including the two observed decays for τD and τDA 1.13. The secant cutting the two points rep-
resents all possible fractions of donor molecules in interaction with the acceptor. The relative
location of a pixel on this line reveals the fraction of molecules in complex with the acceptor,
represented by α , from which an image was reconstructed.
In reality, the excited state lifetimes are in most cases not invariant in presence of the acceptor
due to multiple possible binding geometries between donor and acceptor. An antibody for in-
stance has two binding sites and can therefore adopt two possible binding configurations, each
exerting a different distance between donor and acceptor fluorophores. If multiple antibody
epitopes are accessible, e.g. different phosphorylation sites, the fluorescence decay is further
split. However, if the investigated system ideally adopts two states, for instance phosphorylated
or unphosphorylated, the approximation of invariant lifetimes is valid.
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1.4.4 Imaging MAPK activity
As discussed in chapter 1.3.3.3, MAPK activity is predicted to be distributed in intracellular
activity gradients. To map the activity distribution of different MAPKs, like Mek, ERK and
Fus3, a universal kinase assay is required, which provides high dynamic range and a specific
and quantitative read-out for the kinase of interest.
A described kinase assay ultilizes γ -phosphate-modified ATP which allows to track the
phosphorylation of a labeled kinase substrate by measuring the induced change in the FRET
signal [Green & Pflum, 2007, Green & Pflum, 2009]. However, this approach was only used in
cell extracts. This indirect approach has various disadvantages. The tracking of the substrate
requires that the substrate be specific for the kinase of interest and not phosphorylated by
other kinases. Additionally, the substrate has different diffusion and transport kinetics than the
kinase, so that the spatial distribution of the phosphorylated substrate likely differs from the
distribution of the active MAPK. Furthermore, the ATP-conjugate concentration would have
to be in the range of mM, comparable to the endogenous ATP, which is difficult to implement
experimentally.
Enzyme-substrate (ES) imaging measures the interaction between labeled enzyme and la-
beled substrate by the change in FRET [Yudushkin et al., 2007]. Here, it is required that only
the active kinase binds to the substrate. However, Mek1 and Fus3 bind their substrate inde-
pendently of their activity state over docking sites. ES imaging would therefore not be suited
for these MAPKs. Additionally, the ratio between enzyme and substrate concentration has to
be constant in all cellular compartments in order to derive quantitative spatial differences of
kinase activity. Furthermore, to generate a significant FRET change and preferably exploit the
full dynamic range, the substrate concentration needs to saturate the enzyme. However, the
substrate concentration is required to be as low as 100 µM - 1 mM, which is barely feasible
[Klüßendorf, 2011]. Beyond that, this approach requires specific substrates for every kinase
and is therefore not universally applicable.
Common to all MAPKs is their activation by phosphorylation. The residues which become
phosphorylated are however different: While MAPKs are modified on Thr and Tyr, MAPKKs
are phosphorylated only on Ser and MAPKKKs on Ser and Thr. A suitable technique would
have to detect all of these different phosphorylated amino acids. However, there are no antibod-
ies or binding domains which bind universally to phosphate-monoesters, or the different phos-
phorylated amino acids with equal affinity. Commonly, generic antibodies or binding domains
are only available for pTyr. Here, the Src-homology-2 (SH2) domain, expressed as fluorophore-
fusion, has been utilized as a generic phospho-Tyr (pTyr) sensor for a fluorescently-tagged
protein of interest in a FRET-based approach. Accordingly, phospho-Tyrosine-binding (PTB)
domains were used as generic pTyr sensors or as part of a specific activity sensor for the epi-
dermal growth factor receptor (EGFR) [Sato et al., 1999, Sato et al., 2002, Offterdinger et al.,
2004]. pSer and pThr have a variety of binding domains which include are FHA, MH2, WW
and 14-3-3. However, these are all dependent on the sequence surrounding the phosphosite,
precluding their usage as a generic tool [Heldin et al., 1997, Lu et al., 1999, Hammet et al.,
2003]. The same applies for antibodies, which can be selective for pTyr but not for pSer/pThr
residues. The affinity of pSer/pThr antibodies depends on the sequence surrounding the phos-
phosite [Grønborg et al., 2002].
The only commercially available chemical reagents, which bind to phosphorylated amino
acids in general are the gel stain ProQ Diamond and Phos-Tag [Martin et al., 2003, Kinoshita
et al., 2004]. Phos-Tag is a polydentate ligand which chelates two dinuclear metal ions, Zn2+
or Mn2+ [Kinoshita et al., 2004]. It is the only known substance which universally binds
phosphate-monoesters with high selectivity in aqueous solution at neutral pH (the phenyl phos-
phate dianion is bound with a Kd of 25 nM).
Therefore, phosphorylated proteins are detected by Phos-Tag irrespectively of the amino
acid that is modified. Phos-Tag was originally used as phosphate capture molecule for matrix-
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Figure 1.14: Binding mode and selectivity of the Phos-Tag dizinc(II) complex for
phosphate-monoesters. A) Structural formula of the Phos-Tag ligand as Biotin
compound. (MW: mass weight). B) The binding mode of the Phos-Tag diz-
inc(II) complex (1,3-bis[bis(pyridin-2-ylmethyl)amino]propan-2-olato dizinc(II))
to an immobilized phosphorylated protein. C) Selectivity of the Phos-Tag dizinc
complex for phosphate-monoesters.
assisted light desorption ionisation-time of flight (MALDI-TOF) and later developed as agarose-
, acrylamide- and biotin conjugates for the use in gel electrophoresis andWestern blots [Takeda
et al., 2003, Kinoshita et al., 2004, Kinoshita et al., 2006]. In a FRET experiment, the phos-
phorylation of AMCA-labeled peptides was measured in vitro using covalently FAM-linked
Phos-Tag [Takiyama et al., 2009]. The labeling of Phos-Tag with an acceptor fluorophore
would facilitate the detection of a phosphorylated, donor-labeled protein of interest in a cy-
tochemical FRET approach. This technique necessitates the fixation and permeabilization of
cells, so that only selected time points can be observed. The application of such a generic pro-
tein phosphorylation-detecting reagent to monitor the activity state of a protein would suffer
from being sensitive also to non-activating phosphorylations. However, if the kinase of interest
is labeled with a fluorophore and its phosphorylation is tracked via a cytochemical approach
with a fluorophore-labeled phospho-binder, this can serve as a universal kinase imaging assay.
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2 Rationale and aims of the thesis
MAPK activity regulates transcription in the nucleus, but also has specific local roles in the
cytoplasm, such as cytoskeleton remodeling. Computational models have predicted that the
active MAPKs are patterned in gradients that emerge from the plasma membrane, which in
turn define the activity range of the MAPKs. The specificity of the spatial MAPK activity
range could be conferred by differential regulation of the MAPK module by various regulatory
proteins, which would then focus or distribute the MAPK activity. The major objective of
this work was to elucidate if MAPK activity gradients occur and if so, how they regulate the
local vs. the global MAPK functions. To accomplish this task it was therefore required to
develop a universal method to image MAPK activity in mammalian, as well as yeast cells.
This method should combine the generic phosphoprotein-binding compound Phos-Tag with
FRET-FLIM to enable a quantitative and specific read-out of the MAPK activity state, referred
to as PTag-FLIM.
Using the PTag-FLIM approach, the following questions were addressed:
Regarding the yeast pheromone pathway:
• Recently, a negative feedback from Fus3 to Ste11 was identified. How does this
specific network architecture affect the Fus3 activity gradient? This was in particu-
lar studied in yeast mutant cells upon impairing the negative feedback phosphory-
lation from Fus3 to Ste11.
• How is the inherent hierarchical structure of the mating MAPK-module reflected
in the spatial distribution of the MAPK-module components?
Regarding the ERK cascade in mammalian cells:
• Do the MAPK ERK2 and MAPKK Mek1 exhibit activity gradients? If so, how are
they related to each other?
• How is the differential ERK2 activity duration in the cytoplasm induced by EGF
and HRG related to the Mek1 and ERK2 activity gradients? Which conclusions
can be drawn regarding the network architecture?
• Is the MAPK scaffold KSR1 an important factor to maintain these gradients?
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3 PTag-FLIM to map phosphorylation in
cells
3.1 Principle of PTag-FLIM
MAPKs are activated by phosphorylation on different amino acids, comprising Ser, Thr and
Tyr. In order to detect the different phosphorylated residues of MAPKs as read-out for their
activity, the phosphate-monoester binding compound Phos-Tag was chosen. Due to the univer-
sality of Phos-Tag, it will bind to every available phosphate-monoester in the cell (for further
information on Phos-Tag see chapter 1.4.4). Phosphate-monoesters are terminal phosphates
which occur for instance in proteins, DNA, RNA or nucleotides. In order to specifically de-
tect the phosphorylation of the kinase of interest, the Phos-Tag was complexed to an acceptor
dye for FRET-FLIM of the kinase which is genetically fused to a donor fluorophore. Using
FRET-FLIM, the molecular proximity between the phosphorylated kinase and the Phos-Tag-
Dye complex is measured (for information on FRET-FLIM see chapter 1.4). This approach
facilitates specific and quantitative imaging the phosphorylation of the kinase of interest.
The functional PTag-Dye complex was built by conjugation of a Phos-Tag-Biotin compound
to an acceptor fluorophore labeled with Streptavidin (STV). The Biotin-STV bond is one of
the strongest non-covalent interactions known. The complex between Phos-Tag-Biotin and
labeled STV was stable in aqueous solution. In particular, STV was labeled with a ratio of
5-7 molecules Cy3.5 per STV as acceptor fluorophore for mCitrine-tagged kinases in FRET-
FLIM. Compared to an antibody, which has typically a size of about 150-200 kilo-Dalton, STV
is rather small (55 kilo-Dalton) rather small and therefore has better accessibility to phospho-
sites. In order to exploit the full dynamic range of PTag-FLIM and label the phosphorylated
kinase with high occupancy, the cellular phosphosites have to be saturated by excess PTag-Dye.
However, FLIM is a donor-based and intensity-independent FRET approach and therefore not
affected by the excess of acceptor fluorophores.
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Figure 3.1: PTag-FLIM Overview. (A) Streptavidin (STV) is labeled on free amino groups
using a N-Hydroxysuccinimide (NHS) ester conjugate of a CyDye. To obtain the
PTag-Dye complex, STV-Dye is incubated with Phos-Tag-Biotin. (B) Left side:
The protein of interest (POI) is genetically tagged to a fluorescent protein (donor
fluorophore), for instance mCitrine, which is excited by laser pulses of the appropri-
ate wave length (hν). The emission of the donor fluorophore is represented by the
yellow circles which indicate for FRET important properties: the emission wave-
length (yellow), the donor intensity and the radius R0 for which FRET is detectable.
In the absence of the FRET acceptor PTag-Dye or if the POI is unphosphorylated
(X), no FRET occurs, which is measured by FLIM revealing a long donor lifetime
τD in the decay profile at the bottom. If the POI is phosphorylated (pX) in the pres-
ence of the FRET acceptor, the FRET acceptor binds to the phosphorylated residue.
If donor and acceptor fluorophore are sufficiently close, FRET occurs and reduces
the donor lifetime to τDA.
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3.2 In vitro validation of PTag-FLIM
In order to demonstrate that PTag-Cy3.5 quantitatively reports protein phosphorylation by
FRET-FLIM, an in vitro experiment with phosphorylated and non-phosphorylated versions of
a mCitrine-tagged protein was performed. Purified ephrin receptor tyrosine kinase 3 (EphA3),
which has several phosphorylation sites (www.phosphonet.ca), was incubated with ATP for full
phosphorylation. mCitrine-EphA3 (U) and its phosphorylated version (P) were mixed in ratios
of 4:0, 3:1, 2:2, 1:3 and 0:4. Aliquots of the protein mixtures were subjected to native PAGE as
independent assay to ascertain the fraction of phosphorylated EphA3 derived from the FLIM
experiment in figure 3.2. In native PAGE the protein charge is not shielded by SDS, so that
proteins are separated by size and polarity.
The gel in figure 3.2 and the quantification in C show the relative fraction of unphosphory-
lated to phosphorylated protein (U:P) in every protein mix. The sample of EphA3, that was
incubated with ATP (U:P = 0:4) contains more than a fifth of unphosphorylated protein. Still,
the fractions of phospho-EphA3 range between nearly zero and 0.75, which should provide a
sufficient range of phosphorylated fraction to validate PTag FLIM. In figure 3.2B the distri-
butions of the excited state lifetime τ corresponding to the EphA3 mixtures above are shown.
The higher the phosphorylated fraction, the more PTag-Cy3.5 should bind and reduce the ex-
cited state lifetime τ . As expected, with increasing phosphorylated fraction, τ decreases. The
fractions of phosphorylated EphA3 derived from PTag-FLIM and native PAGE can be fit to a
linear function with a slope of 1.0 and a correlation coefficient of R2= 0.996, indicating that the
fractions derived from native PAGE and PTag-FLIM are consistent. Therefore, the complex of
Phos-Tag-Biotin bridged via STV to Cy3.5 can be used in FRET-FLIM as quantitative read-out
for protein phosphorylation.
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Figure 3.2: Validation of PTag-Cy3.5 complex as acceptor for mCitrine-tagged proteins in
vitro. Phosphorylated (P) and unphosphorylated (A) mCitrine-EphA3 kinase were
mixed in ratios of 4:0, 3:1, 2:2, 1:3 and 0:4 and measured by native PAGE (A) or
FRET-FLIM (B). In (A) proteins were separated in a 10% native gel and stained
by Coomassie Blue. (B) For FLIM, protein mixtures were incubated with beads
and washed with blocking buffer to prevent unspecific binding of the PTag-Cy3.5
complex to the beads. (C) The fraction of phosphorylated EphA3 as measured
by FRET-FLIM was determined by global analysis. Correlation coefficient R2 =
0.996, linear equation y= 1.09067x±0.01869x−0.03688±0.00952.
3.3 Mapping EGFR - Tyr phosphorylation by PTag-FLIM
In order to quantitatively image a phosphorylated protein in cells by PTag-FLIM, cells were
fixed after stimulation. The protocol of cell fixation, permeabilization and staining was adapted
from immuno-cytochemical applications for the use with PTag-Cy3.5: Steps applying phos-
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phate buffers were exchanged for Tris buffers to prevent PTag-Cy3.5 saturation by binding to
excess phosphate in the solution (for further information see chapter 8.6.4).
To test the application of PTag-FLIM in cells, with EGFR a target of known spatio-temporal
activation profile was chosen, which enables the comparison of the PTag-FLIM profile with the
known one [Wouters & Bastiaens, 1999]. Upon EGF stimulation, EGFR becomes phosphory-
lated on 6 Tyr sites.
In starved and fixed cells (figure 3.3, 0 min EGF), PTag-Cy3.5 localized mainly to the nu-
cleus and to a lesser extend to the cytoplasm. After EGF treatment, the overall fluorescence
intensity increased, which indicates an elevated level of phosphorylation and hence signaling
in the cell. Additionally, a strong localization of PTag-Cy3.5 to the PM could be observed,
which can be attributed to EGFR phosphorylation after EGF binding and downstream phos-
phorylation processes.
The phosphorylation of EGFR-mCitrine upon EGF treatment is reported by the decrease
in the excited state lifetime τ which originates from FRET due to binding of PTag-Cy3.5 to
phosphorylated EGFR-mCitrine. Based on the observed time points of EGF treatment, EGFR-
mCitrine phosphorylation reached a maximal phosphorylation level at ten minutes and then
declined to a steady-state level at 30 minutes after EGF stimulation. After five and ten minutes
of EGF stimulation, phosphorylated EGFR-mCitrine was mostly localized to the PM and de-
clined gradually towards the cell’s center. At the 30 minutes time point, phosphorylated EGFR
could be observed in endosomes.
The derived spatio-temporal profile of EGFR activation after EGF treatment measured by
PTag-FLIM is consistent with previous data using a pTyr antibody [Wouters & Bastiaens,
1999]. The consistence of both profiles despite the use of different phospho-acceptors can
be attributed to the fact that EGFR activation is predominantly Tyr phosphorylation.
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Figure 3.3: PTag-Cy3.5 is a suitable phosphoacceptor for a mCitrine-fused Tyr-
phosphorylated protein. (A) HeLa cells expressing EGFR-mCitrine were starved
for 24 hours, stimulated with 100 ng/ml EGF for the indicated time points, fixed,
permeabilized and stained with PTag-Cy3.5. Fluorescence intensity distributions
of EGFR-mCitrine and PTag-Cy3.5 are shown in the top rows, the distribution of
the fluorescence lifetime τ with false-colour look-up table is pictured in the bottom
row. (B) Average lifetimes from several images are plotted against the specified
time points of EGF stimulation with n = 5 for each time point.
3.4 Mapping Mek1 - Ser/Thr phosphorylation by PTag-FLIM
In order to show that PTag-Cy3.5 also detects pSer and pThr, the phosphorylation of MAPKK
Mek1, which has only Ser/Thr phosphorylation sites, was examined. Mek1 becomes acti-
vated by phosphorylation of Ser218 and Ser222, but harbors also the deactivating phosphosites
Thr286 and Thr292 (chapter 1.1.2). It is known that the stimulation of cells with EGF induces
the transient phosphorylation on the activating sites of Mek1. On the contrary, the phosphoryla-
tion of the deactivating threonines is sustained [Eblen et al., 2004]. Therefore, the investigation
of the EGF induced temporal Mek1 phosphorylation profile can deliver information about the
phosphosites, which contribute to a decrease in the excited state lifetime of mCitrine-Mek1 in
PTag-FLIM. This contribution depends on the extent of phosphorylation of each site and the
geometrical parameters of each donor - acceptor pair. In particular, these geometrical parame-
ters are the steric accessibility of the phosphosite for the PTag-Cy3.5 complex, as well as the
distance and average orientation between donor and acceptor fluorophore for each phosphosite.
A transient phosphorylation profile would hint towards a major contribution of the activating
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phosphosites, while a sustained profile would suggest that other sites are also phosphorylated
to a significant extent.
The spatial distribution of phosphorylated mCitrine-Mek1 was investigated in HeLa cells,
which were treated with EGF, fixated, permeabilized and stained with PTag-Cy3.5. As shown
in figure 3.4, mCitrine-Mek1 was localized to the cytoplasm, excluding the nucleus due to a
NES and was recruited to membrane ruffles after 5-10 minutes of EGF stimulation [Fukuda
et al., 1996]. After thirty minutes of stimulation, Mek1 was again homogeneously distributed
over the cell.
The time profile of mCitrine-Mek1 phosphorylation reported by PTag-FLIM followed a tran-
sient trend with a maximal phosphorylation at 5-10 minutes. Therefore, PTag-FLIM of Mek1
can be interpreted as a read-out for Mek1 activity.
At any time, mCitrine-Mek1 was stronger phosphorylated at PM-proximal regions than close
the the nucleus. To quantify the spatial distribution of Mek1 phosphorylation, α profiles were
recorded in a rectangle from the PM to the nucleus of 5-10 cells per time point. These were
normalized in length and the average profiles over several cells calculated. Interestingly, gradi-
ents of Mek1 activity could be observed at 0-10 minutes of stimulation that emanated from the
plasma membrane (3.4 C). The gradient dissipated at the thirty minute time point. While the
gradient’s profile shape did not change significantly between 0 and 5-10 minutes, the overall
amplitude from PM to nucleus was elevated at 5-10 minutes of EGF stimulation which extends
Mek activity in the direction of the nucleus.
Using PTag-FLIM, for the first time an intracellular activity gradient of a MAPKK could be
demonstrated, indicating that the predicted spatial distribution of MAPK activity in gradients
occurs [Brown & Kholodenko, 1999].
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Figure 3.4: pMek1 gradient emanates from the PM. FLIM-FRETmeasurements using PTag-
Cy3.5 in fixed HeLa cells expressing mCitrine-Mek1. (A) Top: Fluorescence inten-
sity distributions of mCitrine-Mek1. Middle: Fluorescence intensity distribution of
PTag-Cy3.5. Bottom: Spatial distribution of the fraction of interacting molecules α
as determined by global analysis of FLIM data. False-color look-up table indicates
the fraction α of phosphorylated protein. (B) Average α values of several images
(N = 3-6) with s.d. plotted against the specified time points of EGF stimulation.
(C) Quantification of the Mek1 gradient at different time points of EGF treatment.
α profiles were obtained within rectangulars that spanned from the PM to the nu-
cleus of 5-10 cells per time point. These were normalized and the average profiles
calculated.
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3.5 Mapping ERK2 - Thr/Tyr phosphorylation by PTag-FLIM
ERK1/2 is activated by phosphorylation on Thr183 and Tyr185 in its activation loop. Human
ERK2 has further Ser/Thr phosphorylation sites, but these are not reported to be modified upon
EGF stimulation [Zhang et al., 2005, Daub et al., 2008, Lorenz et al., 2009].
While the cytoplasmic mCitrine-ERK2 was subtly prephosphorylated, the increase of nu-
clear mCitrine-ERK2 phosphorylation coincided with ERK2 nuclear translocation at five min-
utes of EGF stimulation (figure 3.5). The time profile of ERK2 phosphorylation after EGF
stimulation derived from PTag-FLIM in figure 3.5 B exhibits the known transient behavior.
To determine if the decrease in the excited state lifetime of mCitrine-ERK2 is due to binding
of PTag-Cy3.5 to the activating phosphorylation sites instead of binding to other ERK2 phos-
phosites, a control was generated by mutating the two activating phosphorylation sites Thr183
and Tyr185 in Citrine-ERK2 to non-phosphorylatable amino acid Ala. As shown in figure 3.5,
the mutant mCitrine-ERK2-T183A,Y185A was barely phosphorylated upon five minutes EGF
treatment and the fraction of phosphorylation is below the phosphorylation of mCitrine-ERK2
in starved cells. The residual phosphorylation must be attributed to other phosphorylation sites
of ERK2. Therefore, the main contribution to the phosphorylation measurement under the in-
vestigated conditions deliver the activating sites Thr183 and Tyr185. Furthermore, PTag-Cy3.5
binds selectively to the phosphorylated protein under the conditions of this cytochemical ap-
proach.
The ERK2 activating protein Mek1 showed an activity gradient (figure 3.4), which defines
a spatial probability distribution for ERK2 activation. Therefore, ERK2 activity should ex-
hibit a secondary gradient which is accordingly extended in direction of the nucleus. Indeed,
mCitrine-ERK2 phosphorylation declines from the PM and spreads almost to the nucleus, so
that it is broader than the ppMek1 gradient. The presented experiments in figures 3.4 and 3.5
confirm for the first time the predicted cytoplasmic restriction in gradients of MAPK activity
in mammalian cells.
Additionally, a phosphorylation gradient of ERK2 emanating from the nuclear membrane
into the nucleoplasma could be observed, which implies a spatial regulation of ERK2 activ-
ity also in the nucleus. A nuclear gradient has not been expected, because ERK2 activating
proteins do not reside at the nuclear membrane.
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Figure 3.5:Mapping mCitrine-ERK2 phosphorylation reveals a gradient of ppERK ema-
nating from the PM. (A) FLIM-FRET measurements in fixed HeLa cells express-
ing mCitrine-ERK2 or mCitrine-ERK2-T183A,Y185A stimulated with 100 ng/ml
EGF for the indicated time points. For each sample, the fluorescence intensity of
mCitrine-ERK2 (donor), the fluorescence intensity of PTag-Cy3.5 (acceptor) and
the spatial distribution of the fraction of interacting molecules α as determined by
global analysis of FLIM data are shown. False-color look-up table indicates the
fraction of phosphorylated protein. (B) Average α values from several images (N
= 3-6) with s.d. plotted against the specified time points of EGF stimulation.
3.6 Dark acceptor QC1
While in intensity-based FRET, the measurement needs to be corrected for bleed-through or
bleed-excitation, in FLIM exclusively the donor’s fluorescence is recorded. Hence, at least
either the donor fluorophore excitation or detection must be separated from spectra of additional
fluorophores in the sample. Accordingly, FLIM of two or even three donor fluorophores is
accomplishable, if separate excitation or detection, respectively, allows to discriminate their
fluorescence. Naturally, it is also necessary that the fluorophores or their tags do come in
46
close proximity and thereby affect each others excited state lifetime due to energy transfer.
In multi-donor FRET, the excitation spectrum of the acceptor fluorophore needs to span the
emission spectra of all donor fluorophores without its emission leaking into one of the donor’s
emission. To reduce the number of spectra, it is advantageous to use an acceptor which is
itself non-fluorescent, referred to as “dark”. The absorption of IRDye QC-1 spans nearly the
complete visible range, while itself is dark. Therefore, this small dye was tested as acceptor
fluorophore in PTag-FLIM with three different donor fluorophores. STV was labeled with
QC-1 following the protocol in chapter 8.5.3 with a ratio of 10 dyes per STV.
In figure 3.6 a FRET-FLIM measurement between EGFR-mCitrine or EGFR-mTFP is de-
picted, which demonstrated that QC-1 is a potent acceptor for donor fluorophores in the range
of 480-520 nm (mTFP) or 510-550 nm (mCitrine). In unstimulated cells, the complex of
PTag-QC-1 did not reduce the lifetime of EGFR-mCitrine, showing that PTag-QC-1 bound
specifically to the phosphorylated protein.
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Figure 3.6: QC1 as acceptor for mCitrine and mTFP in a FRET-FLIM experiment. HeLa
cells were transfected with EGFR-mCitrine (A) or EGFR-mTFP (B), starved, stim-
ulated with 100 ng/ml EGF and fixed. For each sample the fluorescence intensity of
EGFR-mCitrine or EGFR-mTFP and the distribution of the fluorescence lifetime t
with false-colour look-up table (in ns) is shown. The acceptor fluorophore QC-1
does not emit light so its localization cannot be visualized.
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Figure 3.7: QC1 as acceptor for mKate2. To test the ability of QC-1 to undergo FRET with
a red fluorescent protein, cells were transfected with EGFR-mKate2 alone or addi-
tionally co-transfected with EGFR-mCitrine. mCitrine was excitated at 470 nm and
emission recorded at 517-533 nm. mKate2 was excitated at 532 nm and emission
recorded between 610-680 nm.
To test the PTag-QC-1 also as acceptor for a red donor fluorophore, EGFR-mKate2 and ad-
ditionally a dual donor measurement including EGFR-mCitrine and EGFR-mKate2 was set up
(figure 3.7). EGFR-mKate2 alone or in co-expression with EGFR-mCitrine had an average
lifetime of 2.54 ns, which was only subtly changed upon addition of the PTag-QC-1 complex.
The induced EGFR phosphorylation by treatment with EGF, however, was reported by PTag-
QC-1 with a lifetime change of 0.4-0.6 ns. Therefore, PTag-QC-1 can be applied to monitor
the phosphorylation of proteins in a multi-donor FLIM approach.
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4 Phospho-gradients in the yeast
pheromone response
4.1 Influence of a Negative Feedback on the Fus3 Activity
range in the Yeast Shmoo
4.1.1 Background
In yeast, an extracellular pheromone gradient is translated via the cell surface receptor occu-
pation into an intracellular activity gradient of the MAPK Fus3 [Maeder et al., 2007]. The
determining factors and the cellular role of this cytoplasmic ppMAPK gradient are still un-
known. The Fus3 activity gradient might serve as an intracellular distance meter which aligns
the nucleus and therefore maintains cell proportions [Maeder et al., 2007]. However, it is
known that active Fus3 links the activation of the pheromone receptor to the polarization of the
actin cytoskeleton [Matheos et al., 2004]. Therefore, the Fus3 activity distribution could define
a spatial probability profile of growth and accordingly orient the mating projection.
In this chapter, the influence of the yeast MAPK network architecture on the Fus3 activ-
ity gradient was investigated using yeast strains in which a negative feedback phosphorylation
from Fus3 on Ste11 is impaired [Hecker et al., 2014]. These mutant cells form broader, less
well polarized mating projections and furthermore build more frequently a second mating pro-
jection [Hecker et al., 2014]. As described in chapter 1.3.3.3, computations on predictions on
the activity gradients of single network elements show that the network architecture influences
MAPK activity gradients. As described in chapter 1.3.3.3, an active molecule is distributed in a
gradient, if forward and backward reaction of the activation cycle are spatially separated. Com-
putational calculations on this spatial separation of the de-/activation cycle show that the spatial
propagation of the active molecules also depends on the surrounding network architecture. A
negative feedback can cause a lower amplitude and steeper decline of the gradients compared
to cells without negative or with positive feedback (see figures 1.9 B-E and 1.10). Therefore,
the impairment of the negative feedback in Ste11 mutant strains could cause the spreading of
active Fus3. A correlation between the spatial Fus3 activity distribution and morphological
changes during the pheromone response might point at a causal connection of these processes.
The negative feedback phosphorylation occurs in vegetatively growing cells on Ste11 Ser243
and Thr596, and is relieved in early time points after pheromone stimulation [Hecker et al.,
2014]. Mutating the sites Ser243 and/or Thr596 in Ste11 to phospho-mimicking amino acids
renders yeast insensitive to pheromone, while yeast expressing non-phosphorylatable Ste11
mutants react hypersensitive to pheromone [Hecker et al., 2014].
The non-phosphorylatable mutant Ste11-T596I was previously described as being consti-
tutively active [Stevenson et al., 1992]. The phosphorylation of Ste11-Ser243 by Fus3 was
shown to prevent the binding of Ste11 to scaffold Ste5 [Hecker et al., 2014]. The interac-
tion Ste11-Ste5 is required for the recruitment of Ste11 to the active receptor and is thought
to enhance the signal transduction to Ste7. The negative feedback from Fus3 to Ste11 there-
fore sets an activation threshold for the mating pathway which determines the sensitivity to
pheromone. The negative feedback from Fus3 on Ste11, which impairs the association of
Ste11 to Ste5, is therefore a further mechanism to prevent unspecific Fus3 activation by sub-
threshold concentrations of pheromone, Ste11 activation during cell cycle phases other than G1
or by other cross-talk signals (see also chapter 1.2). Additionally, the inhibition of the negative
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feedback on Ste11-Ser243 renders the typically switch-like mating decision into a graded re-
sponse. In conjunction with the ultrasensitive Ste5-Fus3 dissociation and Ste5 PM association
upon pheromone stimulation, the regulated Ste5-Ste11 interaction optimizes the dose-response
and the morphological transitions of the pheromone pathway.
In this context, the influence of the negative feedback from Fus3 on Ste11 on the spa-
tial distribution of Fus3 activity was investigated in yeast expressing either the single mutant
Ste11-S243A or the double mutant Ste11-S243A,Thr596I.
4.1.2 Imaging the Spatial Distribution of ppFus3
In order to measure the spatial distribution of Fus3 phosphorylation in yeast cells by FRET-
FLIM, two phospho-specific Fus3 antibodies were tested in immunofluorescence as potential
phospho-acceptors (figure 4.1).
Wild type (WT) yeast cells expressing Fus3- yeast enhanced monomeric (yem) -Citrine from
the endogenous promoter were stimulated with 100 nM pheromone for 2.25 hours and fixed,
as described in chapter 8.6.6. The anti-ppFus3 antibody from R&D Systems (AF1018) showed
a clear projection tip and weak nuclear localization, while the Cell Signaling antibody strongly
localized to the nucleus with a weak staining of the polarization tip, as shown in figure 4.1.
As the R&D Systems anti-ppFus3 antibody was shown before to bind specifically the doubly
phosphorylated form of Fus3, the strong nuclear localization of the Cell Signaling antibody
might reflect affinity for the mono-phosphorylated Fus3 [Maeder et al., 2007]. Accordingly,
AF1018 was labeled with Cy3.5 as acceptor fluorophore for FLIM of yemCitrine-tagged Fus3.
Two batches of AF1018 were labeled with a 10 and 13 times excess of mono-functional dye
Fus3-
yemCitrine
AF1018
Alexa 596
Cell Signaling
9101
Alexa 596
Fus3-
yemCitrine
Figure 4.1: Immunostaining of phosphorylated Fus3. Yeast cells expressing
Fus3-yemCitrine from the endogenous promoter were stimulated with 100 nM
pheromone for 2.25 hours and subsequently fixed and permeabilized. To visualize
ppFus3, cells were first incubated with anti-ppFus3 antibodies AF1018 from
R&D Systems or 9101 from Cell Signaling and then with Alexa546-conjugated
anti-rabbit antibody. Left half: Fluorescence intensity of Fus3-yemCitrine and
Alexa546 after staining with ppFus3 antibody 9101 from Cell Signaling of
three different cells. Right half: Fluorescence intensity of Fus3-yemCitrine
and Alexa546 after staining with ppFus3 antibody from R&D Systems of three
different cells.
as described in chapter 8.5.3, resulting in a dye per protein ratio of 4 and 7, respectively.
Both labeled antibodies localized unspecifically to yeast cells (data not shown), showing that
the antibody’s binding affinity was lost during the labeling process.
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Owing to the encountered issues with an antibody-based FRET-FLIM, which are the avail-
ability of suitable phospho-specific antibodies and the antibody’s compatibility to the labeling
process, PTag-FLIM was developed. PTag-FLIM enables the mapping of any phosphorylated
protein with high signal-to-noise ratio but is simultaneously unselective for the accessible phos-
phosites in the protein of interest.
4.1.3 Influence of Network Architecture on Fus3 Activity Gradient
In order to map the Fus3 activity in WT, Ste11-S243A and Ste11-S243A,T596I yeast strains,
the cells were stimulated for 3 hours with 100 ng/ml pheromone, fixed and stained as described
in chapter 8.6.6. To quantify the distribution of Fus3 and ppFus3, cross-section profiles of
intensity, excited state lifetime τ and phosphorylated fraction α were obtained from tip-to-end
of the cell. Profile lengths of single cells were normalized to preserve cell proportions thus
enabling the calculation of average profiles of intensity, lifetime τ and fraction α .
4.1.3.1 ppFus3 gradient detected by PTag-FLIM
Using PTag-FLIM, a steep ppFus3 gradient in the mating projection of WT yeast cells was
detected (figure 4.2). The observed Fus3 phosphorylation gradient is consistent with previ-
ous data [Maeder et al., 2007], except for the detection of nuclear Fus3 phosphorylation. The
newly obtained data showed an average difference in the lifetime τ between tip and cytoplasm
of about 0.5 ns, in contrast to a difference of about 0.15 ns in the prior data [Maeder et al.,
2007]. Theoretically, differences between the excited state lifetime maps using either PTag or
the ppFus3 antibody could result from the detection of mono-phosphorylated Fus3 by the uns-
elective PTag. The detection of phosphorylated Fus3 in the nucleus by PTag-FLIM is however
supported by the result of the immunostaining with the anti-ppFus3 antibody AF1018 in figure
4.1 and can therefore be attributed to the high dynamic range of PTag-FLIM. The application
of PTag-FLIM for Fus3 has therefore a superior signal-to-noise ratio and does not suffer from
the unspecificity of PTag. PTag-FLIM is eminently suited to measure potentially subtle effects
from changes in the MAPK network architecture on the ppFus3 gradient.
4.1.3.2 Inhibition of Feedback from Fus3 to Ste11 Extends the ppFus3 Gradient
The ppFus3 gradient in the shmoo region of Ste11-S243A expressing cells had a similar am-
plitude as in WT cells showing that the mutation S243A does not directly target the activity
of Ste11 (figure 4.2 C and D). In the Ste11-S243A strain, the gradient’s slope was slightly
shallower than in the WT strain. Accordingly, the Fus3 activity gradient in Ste11-S243A cells
extended further in the direction of the nucleus than in WT cells. Active Fus3 is therefore less
constrained if the negative feedback on Ste11-S243 is impaired.
In the Ste11-S243A,T596I yeast strain, the phosphorylation of Fus3 is significantly elevated
across the profile, relative to WT and Ste11-S243A cells. The increase in Fus3 phosphorylation
can be attributed to mutation Ste11-T596I which renders Ste11 constitutively active. Like in
Ste11-S243A cells, in Ste11-S243A,T596I cells the ppFus3 gradient’s profile is extended to
at least 20% of the cell’s length. The results of the Ste11-S243A,T596I strains confirm the
predictions that a relief of a negative feedback increases the basal level of phosphorylation and
decreases the steepness of the gradient.
In regard of the shmoo morphology, the polarization tips in both Ste11 mutant expressing
strains appeared to be broader than in WT cells. The intensity profiles of the different strains
showed that the relative position of the nucleus seems to remain unchanged.
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Figure 4.2: Inhibition of Feedback Fus3 to Ste11 extends ppFus3 gradient. (A) FLIM
of phosphorylated Fus3 in stimulated WT (n = 20), Ste11-S243A (n = 9) or
Ste11-S243A,T596I (n = 18) cells expressing Fus3-yemCitrine. Fixed and per-
meabilized yeast cells were incubated with the PTag-Cy3.5 complex. For each
sample, the fluorescence intensity of Fus3-yemCitrine (donor), the distribution of
donor fluorophore lifetime t and the spatial distribution of the fraction of interact-
ing molecules α as determined by global analysis of FLIM data are shown. The
false-color look-up table indicates the lifetime τ in ns or the fraction of phospho-
rylated protein, respectively. The tip-to-end profile of the fraction of phosphory-
lated Fus3, α , (B), donor fluorophore lifetime in ns (C) or the donor fluorophore
intensity (D) averaged over several cells are shown with s.d. as function of the nor-
malized distance. Asterisks indicate the probability of an unpaired, two-tailed t-test
if the difference between WT and Ste11-S243A,T596I (blue) or Ste11-S243A and
Ste11-S243A,T596I (red) are significant with p ≤ 0.05 (1 asterisk), p ≤ 0.01 (2
asterisks) or p ≤ 0.001 (three asterisks). The average region of the nucleus and the
shmoo tip are indicated.
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Figure 4.3: Deletion of Kss1 strengthens effects of feedback impairment on the spa-
tial ppFus3 profile. (A) FLIM of phosphorylated Fus3 in stimulated (100 nM
pheromone, 3h) ∆KSS1 (n = 18) , ∆KSS1, Ste11-S243A (n = 18) or ∆KSS1,
Ste11-S243A,T596I (n = 13) cells expressing Fus3-yemCitrine. Fixed and per-
meabilized yeast cells were incubated with the PTag-Cy3.5 complex. For each
sample, the fluorescence intensity of Fus3-yemCitrine (donor), PTag-Cy3.5 (ac-
ceptor), the distribution of donor fluorophore lifetime τ and the spatial distribution
of the fraction of interacting molecules α as determined by global analysis of FLIM
data are shown. The false-color look-up table indicates the lifetime τ in ns or the
fraction of phosphorylated protein, respectively. The tip-to-end profile of the the
donor fluorophore intensity (B), donor fluorophore lifetime in ns (C) or fraction
of phosphorylated Fus3, α , (D) averaged over several cells are shown with s.d.
as function of the normalized distance. The average position of the nucleus and
the shmoo tip are indicated. α values from all datasets excluding the data points
from the nuclear region were fitted with a logistic sigmoidal function and plotted
as dashed lines. Asterisks indicate the probability of an unpaired, two-tailed t-test
if the difference between WT and Ste11-S243A,T596I (blue) or Ste11-S243A and
Ste11-S243A,T596I (red) are significant with p ≤ 0.05 (1 asterisk), p ≤ 0.01 (2
asterisks) or p ≤ 0.001 (three asterisks).
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4.1.3.3 Deletion of Kss1 Strengthens Effects of Feedback Impairment on
ppFus3 Gradient
It was found that if Fus3 homologue Kss1 is deleted, the effects of mutations Ste11-S243A and
Ste11-S243A,T596I on the cell morphology were enhanced [Hecker et al., 2014]. In a ∆KSS1
background, it was investigated if the stronger effect on the cell morphology caused by Ste11
mutations correlates with the Fus3 activity gradient.
Indeed, differences in the spatial Fus3 activity profile between WT and Ste11 mutant strains
were qualitatively similar but more pronounced in strains deleted for Kss1 (compare figures 4.2
and 4.3). The fraction of phosphorylation α was increased for each ppFus3 profile in ∆KSS1
cells.
The steepness of the ppFus3 gradient in the tip region was significantly lower in both Ste11
mutant strains with ∆α = 0.5 than in WT cells with ∆α = 0.6 (figure 4.3). To visualize the
cytoplasmic gradient exclusively, data points eliminating the nuclear region were fitted with a
logistic sigmoidal function. Like in cells with Kss1, in yeast expressing Ste11-S243A,T596I,
Fus3 was more phosphorylated throughout the cell. In the ∆KSS1 background, the Ste11
mutations caused a stronger defect in the morphology which correlated with a stronger affected
Fus3 gradient [Hecker et al., 2014]. This correlation might be due to a causal dependency
between Fus3 activity distribution and morphology.
The intensity profiles of the different strains without Kss1 showed that the relative position
of the nucleus remains unchanged (figure 4.3 B). But, a comparison of intensity distributions
of the WT versus ∆KSS1 background cells uncovers that the nucleus was slightly shifted to the
front in cells lacking Kss1.
Concluding the results from strains with and without Kss1 it can be inferred that the network
architecture is a determining factor of the MAPK activity gradient’s properties. The experi-
ments confirm simulations which predicted that a negative feedback decreases the amplitude
and restricts the extent of the MAPK’s activity. Furthermore, an increase in morphological
defects, namely the formation of broader and more shmoo tips, correlates with an increase in
the range of active Fus3.
4.2 Hierarchical phospho-gradients in the yeast pheromone
response
In vegetatively growing yeast, Ste11 and Ste7 are homogeneously distributed in the yeast cell,
partially excluding the nucleus [van Drogen et al., 2001, Maeder et al., 2007]. Upon pheromone
stimulation both MAPK cascade proteins are accumulated at the projection tip and locally ac-
tivated. Active Ste11 and Ste7 can be expected to be distributed in a phospho-gradient which
emanates from the mating tip. For proteins which are activated in a hierarchical sequence,
the activity gradients become shallower and extend with each hierarchy level (see figure 1.9
A). The activation of downstream Fus3 is however constrained to the PM by membrane-bound
Ste5, which catalytically unlocks Fus3 for phosphorylation by Ste7 [Good et al., 2009]. An
extended, shallower gradient due to a hierarchical effect should therefore appear only for Ste7.
However, mapping of Ste7 and Ste11 phosphorylation by unselective PTag-FLIM might repre-
sent also other phophosites than the activating ones, for instance Ste11-pS243 or Ste11-pT596.
In vegetatively growing cells, Ste5 localizes throughout the cell [Maeder et al., 2007]. Upon
pheromone stimulation it is enriched at the mating tip. The scaffold Ste5 specifies the signal
from the pheromone receptor to Fus3 via regulated association with proteins and the PM. The
Ste5 interactions are regulated by phosphorylation of Ste5 and/or its binding partners. For Ste5
8 CDK-dependent and 4 Fus3-targeted phosphosites are known. The Fus3 dependent sites
become dephosphorylated within the first minutes after pheromone treatment and result in a
switch-like dissociation of Fus3 from Ste5 (see also chapter 1.2). It is however not known if
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Ste5 becomes phosphorylated by Fus3 or other proteins in the process of the mating response.
If Ste5 becomes phosphorylated at the PM, a primary, steep gradient of phosphorylated Ste5
should emanate from the PM. The mapping of phosphorylated Ste5 in shmooing yeast by PTag-
FLIM therefore may deliver a first glance on the spatial regulation of Ste5.
4.2.1 Phospho-mapping of MAPKKK Ste11 and MAPKK Ste7
Ste11 and Ste7 are 5 and 3 times less concentrated then Fus3 (Ste11 approx. 35 nM and
Ste7 70 nm). Due to the low fluorescence intensity of Ste7- and Ste11-yemCitrine fusions the
amounts of detected photons were too low to calculate reliable excited state lifetimes. There-
fore, Ste11-yemCitrine and Ste7-yemCitrine were cloned under the artificial ADH promoter,
which increases the concentration of the protein-FP fusion about 10 times [Chapman & Astha-
giri, 2009]. This artificial increase in concentration of one protein might disturb the stoichiom-
etry within the network of interacting proteins.
Under control of the ADH promoter, Ste7- and Ste11-yemCitrine were enriched at the shmoo
tip and localized throughout the cytoplasm (figure 4.4 A and B). The increase in concentration
did not affect the localization of Ste7- and Ste11-yemCitrine.
Ste11- and Ste7-yemCitrine indeed showed gradients of phosphorylation in the tip region,
as shown in figure 4.4 C and D. The phospho-Ste11 gradient appeared to be very steep at
the tip and decline slowly to a plateau of minimal phosphorylation. After roughly 3 µm the
signal-to-noise ratio of the lifetime profile decreases due to a low fluorescence intensity in the
rear shmoo, see figure 4.4 F. The strong noise impairs the exact determination of a plateau of
Ste11 phosphorylation. The distribution of phosphorylated Ste7 showed a less steep slope in
the projection
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Figure 4.4: Distribution of phosphorylated Ste7-yemCitrine or Ste11-yemCitrine
in shmooing yeast. Yeast expressing Ste7-yemCitrine (A) (n = 8) or
Ste11-yemCitrine (B) (n = 6) from the ADH promoter were stimulated for 3
hours with 100 nM pheromone and subsequently fixed, permeabilized and stained
with PTag-Cy3.5. For each sample, the fluorescence intensity of Ste7-yemCitrine
(donor), PTag-Cy3.5 (acceptor), the distribution of donor fluorophore lifetime τ are
shown. The false-color look-up table indicates the lifetime τ in ns. (C and D) The
tip-to-end profile of the the donor fluorophore lifetime τavg in ns of Ste7-yemCitrine
or Ste11-yemCitrine. (E and F) Tip-to-end profile of the the donor fluorophore in-
tensity in arbitrary units of Ste7-yemCitrine or Ste11-yemCitrine.
tip which extended linearly to a constant level after 0.6 µm. To compare the gradients of the
different yeast pheromone MAPK cascade elements the different profiles are shown in a single
graph in figure 4.6.
4.2.2 Phospho-mapping of scaffold Ste5
Ste5 was over-expressed from the artificial ADH promoter. Unlike Ste5 expressed from its
native promoter, ADH-Ste5-mCitrine was strongly enriched in the nucleus, as shown in figure
4.5 A and B. As expected, Ste5 further accumulated at the shmoo tip. Quantifying the localiza-
tion of phosphorylated Ste5 revealed a steep phospho-Ste5 gradient, which extended over the
first µm (see figure 4.5 C). The basal cytoplasmic phosphorylation level of scaffold Ste5 was
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higher than the phosphorylation level of the kinases of the pheromone MAPK cascade (figure
4.6). PTag-FLIM showed a very good detection sensitivity for the phosphorylation of Ste5.
The obtained data represents however generic information on Ste5 phosphorylation without
the possibility to differentiate between phospho-sites with different functions.
3.8 [ns]
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B C
Figure 4.5: Distribution of phosphorylated Ste5-yemCitrine in shmooing yeast. Yeast ex-
pressing Ste5-yemCitrine from the ADH promoter were stimulated for 3 hours with
100 µM pheromone and subsequently fixed, permeabilized and stained with PTag-
Cy3.5 (n = 6). (A) For each sample, the fluorescence intensity of Ste5-yemCitrine
(donor), PTag-Cy3.5 (acceptor), the distribution of donor fluorophore lifetime τ are
shown. The false-color look-up table indicates the lifetime τ in ns. The tip-to-end
profile of the the donor fluorophore intensity (B) or donor fluorophore lifetime in
ns (C).
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4.2.3 Hierarchical phospho-gradients in the yeast shmoo
In the yeast pheromone MAPK network, Ste11 and Fus3 are activated directly at the PM, while
the area of Ste7 activation is defined by the profile of active Ste11 and therefore extended in
axial direction towards the nucleus. The comparison of phospho-profiles of the four main
network components in the shmoo showed that except the phospho-Ste7 profile, all are steep,
primary gradients as shown in figure 4.6. The Ste5 phosphorylation gradient points towards an
unknown regulation of Ste5 interactions at the PM.
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Figure 4.6: Comparison of phospho-gradients of MAPK elements of the yeast pheromone
response. For details on the data see figures 4.2, 4.4 and 4.5. Each phospho-profile
was fitted with a sigmoidal function.
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5 Spatio-temporal regulation of Mek1 and
ERK2 in MCF-7 cells
5.1 Differentiation of distinct MAPK functions
The core function of ERK1/2 activity is the initiation of transcription. In order to enter the
nucleus on a short time scale, active ERK1/2 has to propagate through the cytoplasm despite
the restriction by phosphatases. In contrast, targeting of ERK1/2 activity to specific functions
in cytoplasm or organelles requires a sustained and localized ERK activity. Potentially mul-
tifaceted mechanisms enable the spatial differentiation of ERK1/2 functions in nucleus and
cytoplasm.
Regarding the signal propagation from the PM to the nucleus within the dimensions of a
mammalian cell, the hierarchical built-up of MAPK cascades may provide the necessary exten-
sion of activity gradients. Default signaling via the linear cascade might therefore be sufficient
for ERK’s global function, the initiation of transcription. However, if local ERK1/2 activity
is required, the ERK1/2 activity range has to be targeted and confined by regulatory interac-
tors. Scaffolds assemble signaling modules and target these to a supramolecular structure. This
scaffolded catalysis of signal transduction within a confined space promotes the restraining of
activity gradients. The use of several scaffolds for the divers cytoplasmic functions of ERK1/2
seems to be likely.
A classical example for the differentiation of MAPK functions is the HRG induced ERK1/2
activity in MCF-7 cells (see also chapter 1.3.4). In MCF-7 cells, stimulation with EGF causes
proliferation, while HRG induces differentiation [Dong et al., 1992, Wosikowski et al., 1993,
Nagashima et al., 2007]. In both cases the signal is channeled through the Raf/Mek/ERK
cascade. The particular cell fate depends on the spatio-temporal ERK activity profile. Cells
undergo proliferation, if the cytoplasmic ERK activity is transient, while sustained cytoplas-
mic ERK activity causes differentiation. The nuclear ERK activity is transient in both cases
[Thottassery et al., 2004, Nagashima et al., 2007, Nakakuki et al., 2010]. The causal link
between spatio-temporal ERK activity profile and cell fate is known: Only sustained ERK
activity leads to phosphorylation and stabilization of the IEG cFos, which triggers differentia-
tion. If cFos is not phosphorylated it becomes degraded and proliferation is programmed. The
particular MAPK network compositions and topologies caused by the different GFs remain
to be elucidated. Known is that EGF activates EGFR (ERB-B1) and HRG activates receptors
ERB-B1, -B2, -B3 and -B4. While the stimulation with EGF causes the homo-dimerization
of EGFR and subsequent endocytosis and degradation, the involvement of ERB-B3 and ERB-
B2 in heterodimers causes the stabilization of these dimers and favours their recycling instead
of degradation [Waterman et al., 1998, Lenferink et al., 1998]. The activation of ERB-B2
and ERB-B3 might therefore provide a mechanism for sustained cellular signaling. The acti-
vation of the whole ERB family by HRG induces additionally to the ERK pathway also the
PI3K/AKT pathway, Rac-PAK signaling, PLCγ and subsequently Rap1 [Peles et al., 1991, Pe-
les et al., 1992, Yang et al., 2006]. PLCγ can activate PKC, which was identified as distinctive
factor for proliferation vs. differentiation in PC-12 cells [Santos et al., 2007]. Activation of
PKC by PMA indeed prolongs ERK activity induced by EGF also in MCF-7 cells [Nakakuki
et al., 2010]. However, PKC may directly activate Raf, so that a proof for PKC being integrated
into the MAPK network upon HRG stimulation remains missing [Kolch et al., 1993].
The scaffold KSR1 has been associated with the determination of the MAPK signal en-
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durance and localization in different cell types. KSR1 was shown to be required to maintain a
prolonged ERK activity upon PDGF stimulation in mouse embryonic fibroblasts (MEFs) [Ko-
rtum & Lewis, 2004]. On the other hand, a negative feedback from active ERK on KSR1 was
shown to promote transient MAPK cascade signaling in MEFs and fibroblasts [Razidlo et al.,
2004, McKay et al., 2009, Canal et al., 2011]. After the homologue KSR2 was found to be
catalytically active as a kinase for Mek1 sites of unknown function, also KSR1 is considered
to be more than a pseudokinase [Brennan et al., 2011, Sibilski et al., 2013]. Regarding the GF-
specific regulation of the scaffolding and the catalytic functions of KSR1 not much is known.
It was however shown that Src can phosphorylate KSR1 on Tyr728 which “may regulate the
transition between the scaffolding and the catalytic function of KSR1” [Sibilski et al., 2013].
KSR1 was shown to be required for localized activity of ERK in hippocampal neurons and
lymphocytes [Canal et al., 2011, Giurisato et al., 2009].
In the first part of this chapter, EGF and HRG induced differential spatio-temporal Mek1 and
ERK1/2 activity profiles were investigated in MCF-7 cells. In the second part the influence of
scaffold KSR1 on EGF and HRG induced Mek1 and ERK2 activity was investigated. These
considerations were approached by western blots (WB) of whole cell lysates detecting specif-
ically Mek1 and ERK1/2 active forms and PTag-FLIM for imaging of active mCitrine-Mek1
and mCitrine-ERK2. The influence of KSR1 was investigated by ectopic overexpression of
pECFP-KSR1, additionally to the endogenous protein.
5.2 Spatio-temporal regulation of Mek1 and ERK2 upon
EGF/HRG stimulation in MCF-7
5.2.1 Temporal regulation of Mek and ERK in cell populations
In order to map Mek1 and ERK2 activity in MCF-7 cells by PTag-FLIM, both proteins were
ectopically expressed as N-terminal mCitrine fusion. To test the functionality of these ectopi-
cally expressed FP fusions, the EGF-induced activation profile of the FP fusion constructs and
the homologue endogenous proteins was compared by WB experiments.
In HeLa cells, EGF stimulation caused the typical transient response of mCitrine-Mek1 and
mTurquoise-ERK2 as well as of the homologue endogenous proteins. The Mek1 and ERK2 FP
fusion constructs were therefore functional. In MCF-7 cells however, the FP-tagged Mek1 and
ERK2 did not show a clear EGF response, although the endogenous proteins showed the tran-
sient activity profile (figure 5.1). Noticeably, mTurquoise -ERK2 showed an offset in its initial
phosphorylation level. Comparing the relative expression levels revealed that the endogenous
and FP-tagged Mek1 and ERK2 are similarly strong expressed in HeLa cells, while in MCF-7
cells the FP-fused proteins were significantly stronger expressed than the endogenous homo-
logues. This strong ectopic overexpression might saturate interacting proteins. Therefore, the
expression levels of Mek1 and ERK2 -FP constructs were reduced in MCF-7 cells.
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Figure 5.1: Strong overexpression of FP-tagged Mek and ERK constructs in MCF-7 cells
impedes their activation during EGF stimulation. MCF-7 and HeLa cells ex-
pressing mCitrine-Mek1 and mTurquoise-ERK2 were stimulated with 100 ng/ml
EGF for the indicated time points. Whole cell lysates of MCF-7 (A) and
HeLa (B) cells were blotted for total and activating phospho-sites of Mek1/2
(pSer217/pSer221) and ERK1/2 (pThr202/pTyr204). The ratio of phosphorylated
to total protein was quantified for MCF-7 (C) and HeLa (D).
The reduction of the expression level lead to comparable response profiles and amplitudes
of ectopically expressed and endogenous Mek1 and ERK2 upon EGF stimulation, as shown in
figure 5.2. Therefore, the EGF induced MAPK network in MCF-7 cells is sensitive to strong
overexpression of Mek1 and ERK2. In subsequent microscopy experiments cells were selected
against high fluorescence intensity. Furthermore, from the differential response profiles of
endogenous and FP-tagged proteins it can be deduced that the FP tag renders the proteins
distinguishable from the endogenous proteins.
Mek1 and ERK1/2 exhibited the known sustained activity profile upon HRG stimulation,
as shown in figure 5.2 [Thottassery et al., 2004]. The FP-tagged proteins showed a sustained
activation profile in response to HRG stimulation but with a lower amplitude than the endoge-
nous proteins. The HRG induced response is therefore more sensitive than the EGF response,
indicating that HRG signaling requires a different network architecture.
Upon EGF stimulation the activity of Mek1 and ERK1/2 reached a maximum after two
minutes, while upon HRG treatment the maximal phosphorylation was shifted to five minutes.
The subtly slower response of Mek1 and ERK1/2 upon HRG stimulation can be explained with
slower activation kinetics of the ERB-B2 - B4 receptors compared to EGFR [Nagashima et al.,
2007].
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Figure 5.2: Transient versus sustained response of Mek1 and ERK1/2 upon EGF or HRG
treatment in MCF-7 cells. Figure legend on the next page.
Figure 5.2: Transient versus sustained response of Mek1 and ERK1/2 upon EGF or
HRG treatment in MCF-7 cells. (A) WB against total protein and activating phospho-sites
of Mek1 and ERK1/2 stimulated with 100 ng/ml EGF or 100 ng/ml HRG for the indicated
time points in MCF-7 cells. Ratios of phosphorylated/total (P/T) protein were calculated for
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Mek1 and ERK1/2 and normalized to the peak value of the WB. (B) The average normalized
ratios P/T of ERK1/2 or Mek1 were quantified between experiments (N = 5). (C) EGF and
HRG cause differential response of ERK2 to the dose of pMek1. Although Mek1 is stronger
activated by HRG, the amplitude of ppERK1/2 is similar.
Relative to the ERK1/2 response, the Mek1 response was stronger after HRG stimulation
than after EGF treatment. In order to show that this differential conversion of Mek1 activ-
ity into ERK2 activity is not due to differential measurement parameter between experiments,
like different antibody dilutions or instrument settings, a WB comprising both EGF and HRG
stimulation time courses was conducted (see figure 5.2 C). This experiment showed that Mek1
is indeed about 2-fold stronger activated by HRG than by EGF. This higher fraction of active
Mek1 is however not converted into a stronger fraction of active ERK1/2. The signal transduc-
tion from Mek1 to ERK1/2 is therefore differentially regulated by EGF and HRG stimulation.
5.2.2 Spatio-temporal regulation of Mek1 and ERK2 in single cells
Using PTag-FLIM, mCitrine-Mek1 and mCitrine-ERK2 activity was mapped in MCF-7 cells.
To resolve nuclear from cytoplasmic activity and compare data from WB and PTag-FLIM,
temporal activity profiles were calculated from the images of the phosphorylated fraction α ,
which was derived from global analysis of FLIM data.
Images were segmented based on the fluorescence intensity of mCitrine-Mek1 or mCitrine-
ERK2 and the DNA stain DAPI to generate masks of the cell, cytoplasm or nucleus. To de-
termine the temporal profile of Mek1 or ERK2 activity measured by PTag-FLIM, cumulative
histograms of the distribution of α were computed and normalized to the peak value.
The EGF induced temporal profile of mCitrine-Mek1 activity followed an overall transient
trend, except to an outlier at 5 minutes of EGF stimulation (compare figures 5.3 with 5.2). This
outlier and the high standard error are likely due to the high biological variance between single
cells, considering the number of measured cells (8-15 cells for each of the EGF stimulation
time points). Despite the starvation of cells prior to stimulation, which is supposed to deprive
cells from constant signaling and align cells in the G0 phase of the cell cycle, the state of each
single cell depends for instance on the local cell density.
The HRG induced response of mCitrine-Mek1 was strong enough to resolve the early peak at
2-5 minutes and a sustained response after 40 minutes of stimulation. PTag-FLIM experiments
therefore confirm a stronger Mek1 phosphorylation upon HRG than after EGF stimulation.
As shown in figure 5.4, the mCitrine-ERK2 response upon EGF stimulation was transient in
nucleus and cytoplasm with a maximal phosphorylation at 2 minutes. The temporal profile of
mCitrine-ERK2 obtained by PTag-FLIM is consistent with WB data shown in figure 5.2.
The HRG induced peak of ERK2 phosphorylation appeared after 5 minutes. In contrast
to EGF stimulation, HRG treatment induced a differential duration of ERK2 activity in nu-
cleus and cytoplasm. The cytoplasmic ERK2 response was sustained within the observed time
course, whereas the nuclear ERK2 response profile showed a bimodal trend. In the nucleus,
the ERK2 response showed a maximal phosphorylation after 5 minutes and a delayed sustained
response which appeared after 20 minutes and increased until 40 minutes of HRG stimulation.
This bimodal activity profile in the nucleus hints towards different pools of active ERK2 in the
cytoplasm induced by HRG stimulation. A sustained nuclear response contradicts results from
a publication which found the nuclear response upon HRG stimulation in MCF-7 cells to be
transient within 60 minutes [Nakakuki et al., 2010]. In this report the nuclear ERK2 activity
was accessed by immunofluorescence, while the cytoplasmic ERK2 activity was determined
by differential centrifugation of cell lysate and subsequent WB. PTag-FLIM is in contrast to
immunofluorescence independent of the local protein concentration and provides a quantita-
tive read-out over the whole cell. The ectopic expression of ERK-FP fusion constructs may
however saturate interacting proteins and cause the release of excessive mCitrine-ERK2 which
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Figure 5.3: EGF-induced Mek1 activity is transient, while HRG-induced MEK1 activity
is sustained in the cytoplasm. Quantification of mCitrine-Mek1 phosphorylation
measured by PTag-FLIM in the whole cytoplasm upon EGF versus HRG stimu-
lation in MCF-7 cells with s.e.m. Images of the phosphorylated fraction α were
segmented for the cytoplasm. For each segmented image, cumulative histograms
of the distribution of α were computed and normalized to the peak value. Number
of cells stimulated either with EGF (0 min n = 27, 2 min n = 15, 5 min n = 9, 10
min n = 12, 20 min n = 9, 40 min n = 8) (top left ) or with HRG (0 min n = 27, 2
min n = 17, 5 min n = 27, 10 min n = 28, 20 min n = 23, 40 min n = 20) (top right).
Bottom: To visualize the temporal profile of Mek1 activity in the cytoplasm, the
center of mass between 0-1 was calculated for each histogram and plotted for each
timepoint.
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subsequently accumulates in the nucleus.
Western blots and FLIM experiments revealed a fast ERK2 response upon EGF treatment
(peak at 2 minutes in nucleus and cytoplasm) and a slow response upon HRG stimulation (peak
at 5 minutes in nucleus and cytoplasm) (figures 5.2 and 5.9). The difference was less clear on
western blots than in FLIM, which can be accounted for by the fixation in case of imaging but
cooling down with ice-cold PBS for WB.
5.2.3 Phospho-mapping of Mek1 and ERK2
Images obtained by PTag-FLIM showed an elevation in the pMek1 fraction after 2 minutes
of EGF stimulation, which was most pronounced at the PM and distributed into the interior
cytoplasm (see figure 5.5). The resolution of such a gradual decrease in the phosphorylated
fraction shows that PTag-FLIM provides a wide dynamic range of mCitrine-Mek1 phospho-
rylation. After 5 minutes of EGF stimulation the amplitude of the pMek1 gradient at the PM
subtly decreased. From 10 minutes on, the pMek1 fraction returned to the initial level (0 min-
utes) and active Mek1 was no longer detected.
HRG stimulation caused after 2 minutes a strong and confined Mek1 activity at the PM (see
figure 5.6). Within 5-10 minutes after HRG stimulation, the region of maximal pMek1 fraction
seemed to spread into the cytoplasm causing a shallower distribution of Mek1. The width of
this maximal pMek1 fraction correlated with the width of lamellipodia which can be observed
in the fluorescence intensity image of mCitrine-Mek1. Upon 20 minutes of HRG stimulation,
the strength of Mek1 activity decreased.
Compared to the EGF stimulation profile of Mek1 activity, HRG induced activity of Mek1
was persistent and stronger confined to the PM within 2-5 minutes. HRG stimulation might
therefore recruit a regulatory interactor which confines MAPK signaling to the PM and there-
fore increases the steepness of a pMek1 gradient. On the contrary, EGF stimulation might
induce default signaling via the linear cascade.
In order to quantify the cellular phospho-gradients, cells were computationally circularized
and segmented into circular sections, as shown in figure 5.7.
The quantification of phospho-Mek1 distributions revealed pronounced gradients which em-
anated from the PM, as shown in figure 5.8. Therefore, Mek1 is generally activated in PM-
proximal regions and the spreading of active Mek1 is constrained by phosphatases. Between
2-5 minutes, the HRG induced Mek1 activity gradients were subtly steeper than after EGF
stimulation, while between 10-20 minutes the Mek1 activity steepness was comparable be-
tween both GF treatments. At 40 minutes of stimulation, the EGF induced Mek1 activity
distribution was very shallow with a low amplitude in contrast to a sustained gradual decrease
of Mek1 activity upon HRG stimulation.
Using PTag-FLIM, images of mCitrine-ERK2 phosphorylation were obtained, which showed
a nuclear and cytoplasmic response of mCitrine-ERK2 between 2-10 minutes of EGF stimula-
tion (shown in figure 5.9). mCitrine-ERK2 was more phosphorylated in the nucleus than in the
cytoplasm.
The nuclear ERK2 phosphorylation was upon both stimuli distributed in gradients which
emanated from the nuclear membrane in direction of the nucleus’ center as shown in figures
5.9 and 5.10. A nuclear gradient has not been expected, because ERK2 activating proteins
do not reside at the nuclear membrane. However, the nuclear import of ppERK2 through the
two-dimensional nuclear membrane might be sufficient to generate a source of high ppERK2
concentration. Several nuclear ERK2 phosphatases, like MKP-1 and MKP-2 are known, which
seem to prohibit the spreading of ppERK to the nucleus’ center [Owens & Keyse, 2007].
In the cytoplasm, active ERK2 was distributed in a shallow gradient at 2 minutes of EGF
stimulation. In the remaining stimulation time course ERK2 was distributed homogeneously
between PM and nuclear membrane. At the 40 minutes time point ERK2 distribution was
depolarized in comparison with the 0 minute time point. ERK2 distribution was shallower than
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Figure 5.4: EGF-induced ERK2 activity is transient, while HRG-induced ERK activity is
sustained in the cytoplasm. Quantification of mCitrine-ERK2 phosphorylation
in the whole cell (top row) cytoplasm (middle row) or nucleus (bottom row) upon
EGF versus HRG stimulation in MCF-7 cells with s.e.m. Images of the phosphory-
lated fraction α were segmented for the respective compartment. For each masked
image, cumulative histograms of the distribution of α of cells stimulated with EGF
(0 min n = 64, 2 min n = 20, 5 min n = 38, 10 min n = 42, 20 min n = 24, 40
min n = 24) (left column) or HRG (0 min n = 64, 2 min n = 43, 5 min n = 44,
10 min n = 40, 20 min n = 45, 40 min n = 27) (right column) were computed and
normalized to the peak value. Middle column: To visualize the temporal profile of
ERK activity in each compartment, the center of mass between 0 -1 was calculated
for each histogram and plotted for each time point.
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Figure 5.5: EGF stimulation causes gradients of Mek1 activity in MCF-7 cells. Representa-
tive images of EGF stimulation (100 ng/ml each) time course of MCF-7 cells trans-
fected with mCitrine-Mek1 measured by PTag-FLIM. For each sample the intensity
of mCitrine-Mek1, PTag-Cy3.5, the fraction of phosphorylated mCitrine-Mek1, α ,
with false-color look-up table are shown.
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Figure 5.6: HRG stimulation causes prolonged gradients of Mek1 activity in MCF-7 cells.
Representative images of HRG stimulation (100 ng/ml each) time course of MCF-7
cells transfected with mCitrine-Mek1 measured by PTag-FLIM. For each sample
the intensity of mCitrine-Mek1, PTag-Cy3.5 and the fraction of phosphorylated
mCitrine-Mek1, α , with false-color look-up table are shown.
Figure 5.7: Cell circularization and gradient quantification. In order to quantify the cellular
phospho-gradients, cells were computationally segmented into 10 circular sections
in the nucleus and 30 sections in the cytoplasm. Shown is an example of 2 cells
expressing mCitrine-Mek1 (left) with the circular segmentation mask (middle) and
the obtained gradients (right).
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Figure 5.8: Gradients of active mCitrine-Mek1 are steeper upon HRG than after EGF
stimulation in MCF-7 cells. To quantify the distribution of phosphorylated
mCitrine-Mek1 in α maps, cells were circularized and segmented. 0 minutes n = 17
cells, 2 minutes EGF n = 13 cells, 5 minutes EGF n = 8 cells, 10 minutes EGF n = 12
cells, 20 minutes EGF n = 7 cells, 40 minutes EGF n = 6 cells. 2 minutes HRG
n = 17 cells, 5 minutes HRG n = 25 cells, 10 minutes HRG n = 24 cells, 20 minutes
HRG n = 20 cells, 40 minutes HRG n = 19 cells.
the Mek1 activity gradients throughout the time course, indicating that upon EGF stimulation
ERK2 activation depends only on Mek1 and is not confined to the PM.
Round vesicles were visible in the mCitrine-ERK2 fluorescence image and the PTag-Cy3.5
channel. These might be endosomes which transport endocytosed receptors to the lysosome for
degradation. In α maps these vesicles showed a subtly higher fraction of phosphorylated ERK2
than their environment. ERK2 might be either activated on these vesicles or ppERK2 which
was activated at the PM is transported with the receptor and the remaining MAPK cascade to
degradation.
HRG stimulation induced after 2 minutes a subtle elevation of the gradient’s amplitude at
the PM. Thereupon, HRG stimulation caused persistent cytoplasmic gradients of ppERK2,
compared to EGF stimulation. Between 10-20 minutes of HRG stimulation the amplitude of
the activity gradients was lower, but restrengthend after 40 minutes. The cytoplasmic ERK2
activity correlated with an increase in the nuclear ERK2 activity within 20-40 minutes. This
result is consistent with the compartmental analysis for nuclear ERK activity which is shown
shown in figure 5.4. Therefore, the late nuclear response might stem from ERK2 activated at
the PM.
The quantification of ppERK2 distributions revealed that EGF caused mainly homogenous
distributions of active ERK. Only after 2 minutes a gradual decrease can be observed. In
contrast, HRG induced clear gradients of ppERK2 from the PM throughout the time course.
The comparison of EGF and HRG induced ppERK distributions indicates that EGF causes
default signaling through the cascade which results in the spatial extension and flattening of
the ERK gradient. In contrast, HRG stimulation seems to restrain ERK2 activation to the PM,
potentially by the recruitment of a scaffold.
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Figure 5.9: ERK2 is transiently distributed in the cytoplasm of MCF-7 cells upon EGF
stimulation. Representative images of EGF stimulation (100 ng/ml each) time
course of MCF-7 cells co-transfected with mCitrine-ERK2 and Mek1 measured by
PTag-FLIM. For each sample the intensity of mCitrine-ERK, PTag-Cy3.5 and the
fraction of phosphorylated mCitrine-ERK2, α , with false-color look-up table are
shown.
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Figure 5.10: HRG stimulation causes persistent and PM-confined ERK2 activity. Repre-
sentative images of stimulation (100 ng/ml each) time course of MCF-7 cells co-
transfected with mCitrine-ERK2 and Mek1 measured by PTag-FLIM. For each
sample the intensity of mCitrine-ERK, PTag-Cy3.5 and the fraction of phospho-
rylated mCitrine-ERK2, α , with false-color look-up table are shown.
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Figure 5.11: Gradients of active mCitrine-ERK2 are steeper upon HRG than after EGF
stimulation in MCF-7 cells. To quantify the distribution of phosphorylated
mCitrine-ERK2 in α maps, cells were circularized and segmented. 0 minutes
n = 30 cells, 2 minutes EGF n = 14 cells, 5 minutes EGF n = 27 cells, 10 minutes
EGF n = 22 cells, 20 minutes EGF n = 18 cells, 40 minutes EGF n = 16 cells. 2
minutes HRG n = 25 cells, 5 minutes HRG n = 21 cells, 10 minutes HRG n = 26
cells, 20 minutes HRG n = 25 cells, 40 minutes HRG n = 16 cells.
5.3 Influence of KSR1 on spatio-temporal Mek1 and ERK2
response
In the first part of this chapter we investigated the differences in the spatio-temporal Mek1
and ERK2 response caused be the growth factors EGF and HRG. In consistence with literature
we found that EGF causes a transient and HRG induces a sustained cytoplasmic response of
Mek1 and ERK2 [Nakakuki et al., 2010]. We also observed that the HRG induced response is
susceptible to changes in the MAPK network stoichiometry, in contrast to the EGF response.
Furthermore, in relation to Mek1 activity, the HRG induced ERK2 response was weaker than
upon EGF stimulation. This suggests that a regulatory interactor, which is sensitive to changes
in the MAP kinase concentration, influences the signal transduction fromMek1 to ERK2. HRG
induced pronounced and persistent phospho-gradients from the PM of Mek1 and ERK2, while
EGF caused shallow distributions of phosphorylated Mek1 and ERK2. Therefore, HRG stim-
ulation seems to recruit a factor which promotes signaling at the PM and adapts the ERK2
response to the Mek1 dose. These differences in the MAPK response profile point at the in-
volvement of KSR1 in the HRG response. KSR1 is a MAPK scaffold which is recruited to the
PM upon GF stimulation and promotes local signaling through the MAPK cascade.
5.3.1 Influence of KSR1 on the temporal response profile of Mek and
ERK
To investigate if KSR1 affects the EGF induced response inMCF-7 cells, KSR1 was ectopically
expressed as ECFP fusion. In order to quantify the KSR1-dependent change in the Mek1 and
ERK2 activity profiles, lysates of cells expressing elevated KSR were loaded with lysates from
WT cells on one gel. ECFP-KSR1was overexpressed to about 80-fold of the endogenous KSR1
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level that furthermore induced the expression of endogenous KSR1 (see figure 5.12). The
overexpression of ECFP-KSR1 caused a 25-fold stronger activation of Mek1 in starved cells.
Probably due to the strong Mek1 preactivation, the EGF induced increase in Mek1 activity
was weaker than in WT cells. KSR1 overexpression led furthermore to the appearance of a
double ppMek1 band. The used antibody detects double as well as single phosphorylation on
the Mek1 activation sites Ser217 and Ser221. The additional band might therefore be assigned
to singly phosphorylated Mek1. The strong Mek activation and the double phospho-band show
that KSR1 itself, or in interplay with Raf, strongly supports the phosphorylation of Mek1. In
contrast, ERK2 was less strongly activated by EGF. Therefore, although Mek1 was strongly1
activated by the ectopic expression of KSR1, active Mek1 was impaired to activate ERK2.
Strong overexpression of KSR was shown before to inhibit the activation of ERK2 due to an
effect termed ’combinatorial inhibition’ [Lin et al., 2009, Levchenko et al., 2000]. A high
amount of KSR1 out-titrates the interaction between Mek1 and ERK2 due to sequestration of
Mek1.
The ectopic overexpression of ECFP-KSR1 caused furthermore a delay of the early response
of Mek1 and ERK1/2 from 2 to 5 minutes upon EGF stimulation. The response profile and the
ratiometric comparison of KSR overexpression to WT show that Mek1 and ERK1/2 activity
decreased slower and maintained a residual activity after 40 minutes of EGF stimulation. KSR1
might therefore indeed alter the temporal response profile of Mek1 and ERK2.
In order to prevent the combinatorial inhibition by strong ECFP-KSR1 expression, the ex-
pression level was lowered to the range of the endogenous proteins.
The expression of ECFP-KSR1 to 1.3-fold of the endogenous KSR1 level caused an elevated
amplitude of the transient EGF response of Mek1 and ERK2 to about 2-fold. As expected, a
subtle elevation of the KSR1 level promotes signaling through the MAPK cascade, in contrast
to strong KSR1 overexpression. The profile peaks were delayed from 2 to 5 minutes, which can
be attributed to the elevation of the response. The transient trend of the EGF response profiles
was however unchanged by the ectopic expression of KSR1.
The HRG stimulation profile of Mek1 and ERK2 in MCF-7 cells was increased between
10-40 minutes by ectopic expression of ECFP-KSR1 (2-fold) (figure 5.14). In contrast to the
EGF response profile, KSR1 strengthened the sustained response of Mek1 and ERK1/2 about
2-fold. KSR1 seems to amplify the Mek1 and ERK1/2 response without altering the trend of
the response, consistent with an observation in T cells [Lin et al., 2009]. Additionally, the Mek1
and ERK1/2 phosphorylation peaks were delayed from 5 to 10 minutes upon HRG stimulation.
5.3.2 Influence of KSR1 on the spatial profile of Mek1 and ERK2
Using PTag-FLIM the influence of ectopic ECFP-KSR1 expression on the spatial distribution
of ppMek1 and ppERK2 upon EGF stimulation was investigated.
mCitrine-Mek1 phosphorylation was elevated in cells with strong pECFP-KSR1 expression
after EGF treatment (figure 5.15). Furthermore, phosphorylated Mek1 seemed to be homoge-
neously distributed throughout the cell in contrast to a clear phosphorylation gradient of Mek1
in WT cells as shown in figure 5.5. The quantification of Mek1 distribution shows that ECFP-
KSR1 indeed distributed pMek1 in the cytoplasm, independently of EGF stimulation, as shown
in figure 5.16. The obtained pMek1 maps may also represent the singly phosphorylated Mek1,
due to Phos-Tag being unselective for different phosphorylated residues.
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Figure 5.12: Overexpression of ECFP-KSR1 elevates the late Mek1 and ERK2 response
upon EGF stimulation in MCF-7 cells. (Top) Representative Western Blot
against total and activating phospho-sites of Mek1 and ERK1/2 in MCF-7 cells
with or without ECFP-KSR1 overexpression (KSR1-OE) (n = 2). After starvation
cell were stimulated with 100 ng/ml EGF for the indicated time points. (Middle)
Quantification of the average normalized ratios of phosphorylated to total (P/T)
ERK1/2 and Mek1 (n = 2). (D, E and I, J) Quantification of the average ratios of
ERK1/2 and Mek1 between cells with or without KSR1 overexpression.
74
ECFP-KSR1
endog. KSR1/2
Mek1
pp-Mek1
ERK1/2
pp-ERK1/2
EGF     0      2      5     10    20    40     0       2      5      10     20   40 
ECFP-KSR1
0 5 10 15 20 25 30 35 40
0,00
0,25
0,50
time EGF [min]
P
/T
0 5 10 15 20 25 30 35 40
0,00
0,25
0,50
0,75
1,00
1,25
1,50
1,75
P
/T
time EGF [min]
ERK2 +KSR
ERK2
ERK1 +KSR
ERK1
Mek1 +KSR
Mek1
Figure 5.13: KSR1 knockdown reduces Mek and ERK response, while a high level of
KSR1 strongly increases the basal level of Mek and ERK activity and delays
their early peak upon EGF stimulation in MCF-7 cells. (A and F) Representa-
tive Western Blot against total and activating phospho-sites of Mek1 and ERK1/2
of MCF-7 cells exhibiting reduced (A), (n = 2), or elevated (F), (n = 2), levels of
KSR1, stimulated with 100 ng/ml EGF or for the indicated time points. (B, C and
G, H) Quantification of the average normalized ratios of phosphorylated to total
ERK1/2 and Mek1 (n = 2) of KSR-KD (B, C) or KSR-OE (G, H) cells. (D, E and
I, J) Quantification of the average ratios of ERK1/2 and Mek1 in modified KSR
amount expressing cells to endogenous levels of KSR1 expressing cells.
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Figure 5.14: KSR1 overexpression increases Mek and ERK response particularly at late
time points of HRG stimulation. (A) Representative Western Blot against total
and activating phospho-sites of Mek1 and ERK1/2 of MCF-7 cells with or without
overexpression of KSR1, stimulated with 100 ng/ml HRG for the indicated time
points. (B) Quantification of the average normalized ratios of phosphorylated to
total ERK1/2 andMek1 (n = 2) of KSR-OE cells. (C) Quantification of the average
ratios of ERK1/2 and Mek1 phosphorylation of KSR-OE to endogenous levels of
KSR1 expressing cells .
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Figure 5.15: ECFP-KSR1 expression promotes Mek1 phosphorylation and distributes
phosphorylated Mek1. Representative images of EGF stimulation (100 ng/ml
each) time course of MCF-7 cells co-transfected with pECFP-KSR1 and mCitrine-
Mek1. For each sample the intensity of mCitrine-Mek1, pECFP-KSR1, PTag-
Cy3.5 and the fraction of phosphorylated mCitrine-ERK2, α , with false-color
look-up table are shown.
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Figure 5.16: KSR1 distributes phosphorylated Mek1. To quantify the distribution of phos-
phorylated mCitrine-ERK2 in presence of ECFP-KSR1 in α maps, cells were
circularized and segmented. 0 min n = 18, 2 min n = 18, 5 min n = 19, 10 min
n = 14, 20 min n = 12, 40 min n = 16.
MCF-7 cells co-expressing pECFP-KSR1 and mCitrine-ERK2 revealed a reduced phospho-
rylation of mCitrine-ERK2 in cells with high ECFP-KSR1 amount. Furthermore, pERK2
seemed to be strongly confined to the PM in presence of ECFP-KSR1. Accordingly, nuclear
mCitrine-ERK2 was less pronounced.
The quantification of ERK2 gradients showed that ERK2 is much less phosphorylated in
cells with ECFP-KSR1. The concentration of KSR1 was therefore in the region of combinato-
rial inhibition. Therefore, KSR1 promotes Mek1 activation but inhibits the signal transduction
to ERK2 by sequestering a major fraction of active Mek1. However, the gradients of active
ERK2 were steeper if KSR1 was present, pointing at constrained activation of ERK2 at the
PM. Regarding the KSR1 - ERK2 interaction it is known that only active ERK2 can bind to
KSR1 via the DEF domain. This interaction is required to exhibit the negative feedback phos-
phorylation on KSR1, which forces the dissociation from Raf. A direct positive effect of KSR1
on ERK2 activation by Mek is not known.
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Figure 5.17: KSR1 overexpression reduces ERK2 activity and constrains active ERK2.
Representative images of EGF stimulation (100 ng/ml) time course of MCF-7
cells co-transfected with pECFP-KSR1 and mCitrine-ERK2. For each sample
the intensity of mCitrine-ERK2, pECFP-KSR1, PTag-Cy3.5 and the fraction of
phosphorylated mCitrine-ERK2, α , with false-color look-up table are shown.
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Figure 5.18: KSR1 constrains phosphorylated ERK2 to PM-proximal regions. To quantify
the distribution of phosphorylated mCitrine-ERK2 in α maps, cells were circular-
ized and segmented. 0 minutes n = 27 cells, 2 minutes EGF n = 9 cells, 5 minutes
EGF n = 16 cells, 10 minutes EGF n = 17 cells, 20 minutes EGF n = 5 cells, 40
minutes EGF n = 11 cells.
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6 Discussion
Signaling of MAPK modules determines cellular fate such as growth, differentiation or apop-
tosis. To respond appropriately to a stimulus, the MAPK activity is regulated in time and space
by the context of the signaling network architecture. While the temporal MAPK response has
been widely studied, a lack of quantitative imaging approaches made the investigation of spa-
tial activity profiles impossible. Here, a versatile approach for the quantitative spatial profiling
of MAPK activity was established, which allowed to study basic principles as well as specific
aspects of MAPK activity organization in human cells as well as yeast.
6.1 PTag-Dye complex as activity sensor for MAPKs in
FRET-FLIM
Common to all MAPKKs and MAPKs, like Mek1 and ERK2, is the activation by dual phos-
phorylation in their activation loop. These phosphorylation sites are a threonine and tyrosine
of a conserved TXY motif in MAPKs and two serines in MAPKKs. In order to design a
generic sensor for MAPK activity, an approach was required which detects protein phospho-
rylation irrespective of the kind of amino acid and maintains specificity towards the kinase
of interest. These demands were fulfilled in PTag FLIM, which combines the universality of
the phospho-binding reagent PTag with the specificity of donor fluorophore-based FRET by
measuring the molecular proximity between the donor fluorophore fused kinase and the dye-
coupled PTag. Single phosphorylation sites on the protein of interest cannot be distinguished
from each other with PTag-FLIM. Although MAPKs have further phosphorylation sites than
the activating ones, the major contribution on the detected decrease in the donor lifetime by
PTag-FLIM comes from the activating phospho-sites. This was confirmed by mutating the
respective sites in mCitrine-ERK2 and the reconstituted temporal activity profile of mCitrine-
Mek1 and -ERK2. Therefore, the application of PTag-FLIM is under the applied, distinctive
conditions a measure of the kinase activity. As a byproduct, PTag-FLIM is the first approach
which can detect the overall phosphorylation of a specific protein of interest in a protein mix-
ture. It can be applied to study the spatial distribution of any protein in its phosphorylated
state.
PTag-FLIM resolved subcellular spatial activity gradients of Mek, ERK2, and the yeast
pheromone MAPK module, demonstrating its versatility and a superior dynamic range over
previously available imaging approaches. Individual activity sensors were beforehand only
available for ERK. However, these ERK activity sensors (chapter 1.4.4) suffered from being
indirect measures of ERK activity, did not provide sufficient signal-to-noise or required the
modification with subcellular localization sequences. Immunostainings of active MAPKs do
not show gradients because these deliver information on the total concentration of the active
protein (active fraction times intensity). Only the fractional activity map can provide the loca-
tions of activation and deactivation of the observed protein.
A drawback of PTag-FLIM is the requirement of fixated and permeabilized cells. The fixa-
tion of cells impairs the observation of single cells throughout a time course and therefore the
correlation between initial and subsequent states. Although it is technically possible to bring
PTag-Dye into the cells, for instance by microinjection, the binding of PTag to all accessi-
ble phosphate-monoesters comprising phosphorylated proteins, ATP and 5’-ends of DNA and
RNA would inhibit all phosphorylation dependent processes and presumably cause cell death.
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6.2 Fus3 activity gradients in the yeast pheromone
response
As many Fus3 targets are localized to the nucleus (e.g. transcription factor Ste12) it remains
arguable how the fully active Fus3 reaches these substrates despite the phosphatases which re-
strain active Fus3 to PM-proximal areas. On the one hand the functions of active Fus3 relocate
in the course of the pheromone response, on the other hand the spatial distribution of active
Fus3 changes. The distance between tip and nucleus increases during growth of the mating
projection. Early after pathway activation and symmetry breaking, the gradient of active Fus3
might extend enough to let a fraction of fully active Fus3 attain the nucleus and start mating
specific transcription. This early transcriptional response induced by Fus3 might be the start-
ing point for further delayed transcriptional responses which are independent of Fus3 activity.
Further functions of Fus3 like cell cycle arrest via Far and polarization of the cytoskeleton via
Bni1 and Bem1 are localized to the cytoplasm. Therefore, in late time points of the mating
response, Fus3 activity might only be required in the shmoo region and no mechanism would
be necessary to overcome the confinement of Fus3 activity. The conditions under which the
Fus3 activity gradient forms change during the pheromone response. Additionally to diffusion
and deactivation rate, an activity gradient is dependent on the cell’s shape. The geometry of
the cell determines the ratio of surface-to-volume and thereby the ratio of activation to de-
activation. The surface of activation at the yeast mating tip can be assumed to be constant,
while the volume changes during the growth of the mating projection. Early after polarization,
the yeast morphology is still roundish with a small projection which could be mathematically
approximated by a cone with a big radius and small height. In later time points the cone’s
radius decreases while the height increases. The ratio of surface-to-volume increases and ac-
cordingly does the rate of activation become stronger relative to deactivation. Therefore, the
gradient might be more restrained in the beginning of polarized growth. However, phosphatase
expression increases during the pheromone response which counteracts this geometrical effect.
The nuclear position could be adjusted by the steepness of the gradient or the total ppFus3
concentration. But the relative yeast cell proportions revealed from the intensity distributions
in figures 4.2 and 4.3 are unaltered in each genetic background disregarding the differences in
the Fus3 phosphorylation gradient. The ppFus3 gradient seemingly does not affect the position
of the nucleus, as previously described [Maeder et al., 2007].
6.2.1 Interplay of network topology, Fus3 activity range and shmoo
morphology
Using PTag-FLIM, the influence of a MAPK network architecture on the activity distribution
of an embedded MAPK was examined for the first time. It was found that the inhibition of a
negative feedback from Fus3 on Ste11 increases the extent of the Fus3 activity gradient. This
broader range of Fus3 activity correlates with broader shmoo tips and an increase in the number
of shmoo tips.
Computations on the dependence of the MAPK activity distribution on the network architec-
ture are confirmed by results showing that the inhibition of the negative feedback from Fus3 on
Ste11 causes a higher amplitude, at least for the double mutant Ste11-S243A,T596I, and shal-
lower gradients. However, the determined differences in the gradient upon feedback inhibition
are not as pronounced as expected from the simulations (see figure 1.3.3.3) [Sun et al., 2014].
The gradient simulations are based on a sequential activation of a three-step cascade in which
only the activation of the MAPKKK is restricted to the PM. The MAPK being third in the hier-
archy therefore builds a tertiary activity gradient. In yeast though, Fus3 activation depends on
the MAPKK Ste7 and the PM-bound scaffold Ste5. Fus3 therefore builds a primary gradient
so that the inhibition of the negative feedback allows only for a subtle extension of the Fus3
activity gradient.
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In Ste11-Ser243Ala expressing cells, Fus3 is at the shmoo tip equally phosphorylated as in
WT cells, demonstrating that the mutation Ser243Ala is not interfering with Ste11 activity.
How can a negative feedback from MAPK to MAPKKK which does not affect the activity
of the target cause a different spatial distribution of the active MAPK? The phosphorylation
of Ste11-Ser243 inhibits the association with Ste5, so that the mutation Ser243Ala allows an
unregulated interaction between Ste11 and Ste5 [Hecker et al., 2014]. The dependencies in the
interplay of network topology, Fus3 activity range and shmoo morphology are discussed: The
negative regulation of the Ste11-Ste5 complex by Fus3 phosphorylation in vegetatively grow-
ing cells decreases the sensitivity and maintains the switch-like response of the pheromone
pathway [Hecker et al., 2014]. Fus3 also down-regulates the Ste5 PM recruitment, further el-
evating the threshold of activation [Yu et al., 2008]. Like the Ste11-Ste5 interaction, the Ste5
PM association and Ste5-Fus3 dissociation upon pheromone stimulation are required to main-
tain the switch-like mating decision [Malleshaiah et al., 2010]. It can be deduced that in the
yeast pheromone pathway, ultrasensitivity is generated at the level of the MAPKKK and is not
an inherent property of the sequential activation in the cascade, as for MAPK signaling in the
maturation of Xenopus oocytes (see also chapter 1.3.3.1) [Huang & Ferrell, 1996]. Cooperative
events of Ste5-Fus3 dissociation, Ste5-Ste11 association and Ste5-PM binding might cause the
activation of the MAPK cascade in an all-or-none manner and further propagate the symmetry
break from the PM to the MAPK cascade. A switch-like Ste11 recruitment to the PM would
deplete a major amount of Ste11 from the cytoplasm, preventing the activation of Ste11 at
multiple polarization clusters. The choice of a polarization cluster would be made after a “first
come, first serve” strategy.
The lower threshold of activation in Ste11-S243A cells may cause a broadened distribution
of Ste5 and Ste11 activation around the polarization core at the PM which results in the exten-
sion of the Fus3 activity gradient. Additionally, active Ste11 can diffuse in complex with Ste5
from the site of action without being regulated by Fus3. The diffusion further enables delocal-
ized signaling to Ste7 and in turn to Fus3. Inhibiting the phosphorylation on Ste11-Ser243 may
lead to a broadened area of active Ste11 which is transduced in a less focussed Fus3 activity.
The mutant Ste11-T596I was known before to be constitutively active [Stevenson et al.,
1992]. The combination of mutation Ser243Ala with Thr596Ile renders Ste11 independent of
any activating signal and enables the unspecific interaction with Ste5. This Ste11 mutant can
therefore signal to each of the three MAPK pathways in which it participates.
The causal link between Fus3 and the polarization of the actin cytoskeleton is largely known
[Matheos et al., 2004, Yu et al., 2008]. Interestingly, Fus3 activity controls the polarized lo-
calization of the actin scaffold Bni1, small GTPase Cdc42 and PAK Ste20 [Matheos et al.,
2004, Yu et al., 2008]. The distribution of active Fus3 presumably defines a spatial probability
distribution of growth. The broadened Fus3 activity causes outspread growth at the mating pro-
jection. Accordingly, the distribution of active Fus3 also orients the mating projection within
the pheromone field. The three-dimensional Fus3 activity gradient would therefore serve as a
cytoplasmic morphogen.
Apart from the theory that the increased range of active Fus3 in the Ste11 mutant strains
stems from a delocalized, active Ste11, also an influence of the cell’s geometry on the gra-
dient can be considered. Let’s assume that an unknown process which is associated with
Ste11-Ser243 but independent of Fus3, causes the morphological defects, e.g. broader mating
projections. The extension of the Fus3 activity gradient in Ste11-S243A cells might either be
caused by an elevated total Fus3 level which saturates the phosphatase, or by a decreased phos-
phatase concentration. As revealed from the intensity profile in 4.2 and 4.3 total Fus3 levels
stay constant. However, if the shmoo morphology of Ste11 mutant expressing cells is broader,
the surface-to-volume ratio decreases in the tip region. Assuming that the expression rate of
activating and deactivating proteins is unaffected by the Ste11 mutations, the phosphatase in
the cytosol would become stronger diluted than the signaling molecules at the membrane of
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the shmoo tip. So, the increase in ppFus3 activity range might be due to a dilution of the phos-
phatase in Ste11-S243A cells caused by the broader shmoos and a lower surface-to-volume
ratio.
The broadened mating projection in Ste11 mutant expressing cells correlates with an ex-
tended and shallower ppFus3 gradient. The question what was first, the chicken or the egg
or their causal dependence, respectively, could not be answered by the experiments presented.
The general advantage of a pointed polarization might lie in the oeconomic viability. The
broader the tip and bigger the volume of the cell, the more energy is required to synthesize the
new cell wall and to maintain the cellular homeostasis, amongst others. If the growing mating
tip is sharply polarized, it needs to be well oriented in the pheromone field to meet precisely
the mating tip of the chosen mating partner. A broader projection can be less well oriented and
still attain the opposite cell. However, further experiments of [Hecker et al., 2014] revealed
that Ste11-SM and -DM cells frequently lyse during shmoo growth, supporting the theory that
a broad shmoo is not favorable.
When Kss1 is deleted, effects of the Ste11 mutants on the gradient become even stronger,
while the deletion of Kss1 alone is not sufficient to cause broader polarization tips. The stronger
differences between the ppFus3 gradient in cells without Kss1 could simply be due to the higher
phosphorylation amplitude. Fus3 and Kss1 are the only substrates of MAPKK Ste7. Their
competition for Ste7 could increase the rate of Fus3 phosphorylation if Kss1 is deleted. An
elevated amount of phosphorylated Fus3 could enhance the effects of the Ste11 mutations on
the cell morphology.
Using PTag-FLIM, the first data on a three-step activation cascade was ascertained. Under
overexpressing conditions, the kinases Ste7 and Ste11 as well as the scaffold Ste5 did show
gradients of phosphorylation, emanating from the projection tip. This shows that Ste5 is also
phosphorylated in late time points of the pheromone response. It is however unclear which
phosphosites on Ste5 contribute to the steep gradient. A phosphorylation gradient point towards
a regulation of Ste5 interactions at the PM.
Given that the respective phosphatases are in natural conditions working at or close to satu-
rating level, the overexpression of the Ste-proteins might lead to an extension of the gradients
towards the distal end of the cell. So, the endogenously expressed Ste7, Ste11 and Ste5 might
in reality be sharply localized to the tip.
6.3 Spatio-temporal regulation of Mek1 and ERK2 in MCF-7
cells
6.3.1 Mek1 and ERK2 activity gradients
Using PTag-FLIM it was shown that the sequential design of the MAPK module indeed impli-
cates extended MAPK activity gradients in mammalian cells, which have been postulated 15
years ago [Brown & Kholodenko, 1999, Kholodenko, 2006].
The cytoplasmic gradients of MAPKs might be just a byproduct of the required spatial signal
propagation from the PM to the nucleus. In this view, the ERK activity gradient acts as a
threshold which has to be overcome [Kholodenko, 2006, Kholodenko, 2002]. However, ERK
has various functions outside of the nucleus, represented by the fact that half of the about 160
targets of ERK are non-nuclear [Yoon & Seger, 2006]. Additionally to the functions in cell fate
decisions, ERK has specialized cytoplasmic roles, like cytoskeletal rearrangements, synaptical
plasticity in neurons or golgi fragmentation [Reszka et al., 1995, Shalin et al., 2006, Acharya
et al., 1998]. To target the soluble ERK specifically to one of these locations, it has to be locally
activated and/or restrained in its diffusion in order to impair the uncontrolled phosphorylation
of targets in the cytoplasm or nucleus. Activity gradients are therefore not only a threshold
which needs to be vanquished, gradients allow to modulate the activity range of ERK.
84
Surprisingly, active ERK2 was in the nucleus also distributed in a gradient which emanated
from the nuclear membrane towards the nucleus’ center. This was unexpected because ERK2
activating proteins are not localized to the nuclear membrane. A source of high ppERK2 con-
centration might be generated by the transport of active ERK2 through the nuclear membrane.
The mechanism of nuclear import and transient nuclear accumulation of active ERK2 is highly
controversial (see chapter 1.1.3). However, the kinetics of nuclear import seem to correlate with
the rate of ERK2 phosphorylation [Caunt & McArdle, 2010, Lidke et al., 2010]. Therefore,
ppERK2 import is favored over ERK2 import, while several nuclear phosphatases, like DUSPs
1, 2, 4 and 5, might serve as a sink for active ERK2 and thereby restrain ppERK2 spreading
in the nucleus [Owens & Keyse, 2007]. The nuclear ppERK2 gradient being much steeper
than the cytoplasmic gradient shows that the nuclear source location of ppERK2 is the nuclear
membrane, while in the cytoplasm the source of the ppERK2 gradient is outspread from the
PM by the sequential built-up of the MAPK cascade. The nuclear gradient of ERK2 activity
suggests that ERK2 activity is primarily required at the nuclear envelope. The nuclear enve-
lope is partitioned in domains of heterochromatin with repression of transcription and nuclear
pore complexes (NPCs) with high transcription [Steglich et al., 2013]. ERK1/2 was shown
to directly and indirectly redistribute domains of heterochromatin by phosphorylating histone
H3 and therefore regulate transcription on a higher level [Martin et al., 2010, Drobic et al.,
2010, Brami-Cherrier et al., 2005, Wiegert & Bading, 2011]. Furthermore, ERK2 associates
with the nuclear envelope protein lamin A, which was shown to have a dual effect [González
et al., 2008, Rodríguez et al., 2010, Adler, 2010, Kwon et al., 2011]. The interaction of ERK2
with lamin promotes cell cycle entry in a mechanism independent of ERK1/2 kinase activity
and additionally seems to facilitate the phosphorylation and release of cFos from lamin, result-
ing in the transcription of IEGs [González et al., 2008, Rodríguez et al., 2010, Adler, 2010].
Therefore, the higher fraction of ERK2 activity in the nuclear periphery might have various
functions in proliferation, transcriptional induction and heterochromatin organization. If nu-
clear ERK2 interactions are primarily located at the nuclear periphery, ERK2 might show a
decreased mobility in this region. Studies on the ERK2 mobility using FCS and FRAP did not
find a difference between the nucleus and cytoplasm [Lidke et al., 2010]. However, it might
be interesting to investigate the ERK2 mobility at higher spatial resolution than in the overall
compartments.
The spatial profiling of mCitrine-pMek1 and -pERK revealed that pMek1 and pERK2 are
early after GF stimulation often laterally polarized in the cytoplasm of HeLa as well as MCF-7
cells. This can be due to the polarized appearance of lamellipodia, which is a thin actin struc-
ture. If the distance between facing PMs, or rather the gradient sources, is smaller than the
gradient’s decay length, the complete structure will exhibit high activity which dissipates if the
distance between membranes increases (see also figure 1.8). However, in the case of ERK2,
the cytoplasmic polarization continued in a nuclear polarization of phosphorylated ERK2. The
nucleus is thought to remain spherical, so here such a distortion of the nuclear shape is un-
likely, the observed lateral polarity is therefore real. As the cell is exposed to a homogenous
concentration of GFs, no extracellular GF gradients should occur which might cause the po-
larized activation of RTKs. The laterally polarized MAPK activation indicates therefore that
spatial cues are prepolarized, which promote local RTK activation upon GF stimulation. These
spatial cues might be the Rho GTPase family and PAK1, which are involved in cytoskeletal
restructuring and are localized to sites of high actin turnover. Rho and PAK1 were further
shown to support ERK1/2 signaling in response to EGFR activation [Eblen et al., 2004, Smith
et al., 2008]. PAK1 for instance phosphorylates Mek on Thr298, priming it for the activation
by Raf [Coles & Shaw, 2002]. In later time points, polarized MAPK activity was less often ob-
served. The occurrence of local activation and lateral phosphorylation propagation was shown
for EGFR [Reynolds et al., 2003]. The emergence of polarized MAPK activity gradients re-
flects first that the active receptor on the PM was activated in a polarized manner and second
85
that the phosphorylated MAPKs deactivated in axial as well as lateral direction.
6.3.2 Differences in EGF vs. HRG induced spatio-temporal activity
profiles of Mek1 and ERK1/2 in MCF-7 cells
The observed difference in the strength of Mek1 activation upon EGF or HRG stimulation can
be attributed to the activation of different receptors. The EGF induced ERB-B1 (EGFR) ex-
presses in MCF-7 cells only to 5000 molecules per cell, which is very low compared to other
cell lines [Goldenberg et al., 1989]. HRG induces additionally to EGFR also the activation
of receptors ERB-B2 - B4 which are equally abundant and therefore might cause an elevated
signal. EGFR is known to be degraded upon EGF binding, while ERB-B2 and B3 are primarily
recycled [Waterman et al., 1998, Lenferink et al., 1998]. GF-specific receptor routing might af-
fect the signaling dynamics of EGF and HRG inMCF-7 cells. However, the dynamic properties
of signaling are thought to arise from the individual GF-specific context of signaling, instead
of the intrinsic features of a specified protein, like the receptor [Santos et al., 2007]. In the
analogues example of EGF vs. NGF signaling in PC-12 cells, a negative feedback from ERK
on SOS upon EGF stimulation causes a transient ERK activity, while a positive feedback from
ERK to Raf upon NGF treatment sustains the ERK activity [Santos et al., 2007]. The positive
feedback is mediated by the integration of PKC into the NGF-induced network. It is likely
that the same switch occurs in the MAPK network topology of MCF-7 cells upon EGF vs.
HRG stimulation [Santos et al., 2007]. Indeed, MCF-7 cells stimulated with EGF and the PKC
activator PMA showed sustained signaling, having reverted the EGF into the HRG dependent
response [Nakakuki et al., 2010]. However, as PKC might directly activate Raf, the inverse
experiment with inhibition of PKC upon HRG treatment is necessary to finally demonstrate
that PKC is also in EGF vs. HRG signaling the distinctive factor of the ERK signal duration
[Kolch et al., 1993]. The newly obtained data indicates that the HRG-induced response recruits
a regulatory interactor which affects the signal transduction from Mek1 to ERK2, based on the
following facts: First, HRG stimulation induced a strongerMek1 activity than EGF stimulation,
although ERK2 activity was equal for both GFs. Therefore, in the HRG induced response the
dose of Mek1 activity was less efficiently converted into a response of ERK2 activity than in the
EGF induced signaling. Such a differential relation between Mek1 and ERK2 activity indicates
a different dose-response from active Mek1 on ERK activation. This could be explained with a
shift in the threshold of activation or with ultrasensitivity from pMek to ERK activation in the
case of EGF stimulation and a graded behaviour upon HRG stimulation. Ultrasensitivity can
arise from the dual phosphorylation required to activate a MAPK, if the two phosphorylation
reactions proceed in a distributive and cooperative manner (for further information on dose-
responses of MAPKs see 1.3.3.1). The EGF induced dose-response might therefore represent
the MAPK cascade inherent signaling mode. Consequently, a scaffold would modify the HRG
induced response and render the ultrasensitive into a graded response. Scaffolds are indeed
thought to promote a graded dose-response by binding the signaling molecules and favouring
a processive dual phosphorylation. Second, the ectopic expression of Mek1 and ERK2 led to a
reduced amplitude in the kinases activity upon HRG stimulation but not after EGF stimulation.
This notion supports the theory of a scaffold in the HRG dependent response, because the rela-
tive levels between scaffold and kinases need to meet an optimum in order to promote signaling
[Locasale et al., 2007]. The ectopic expression of the kinases might exhibit reduced signaling
due to different relative levels between scaffold and kinases. Third, it was shown that the EGF
induced gradients of ERK2 activity were shallower than HRG induced gradients, while the
Mek1 activity gradients were comparable steep for EGF and HRG stimulation. Therefore, it
can be deduced that in the EGF response the shallow ERK2 activity distribution results from
being “passively” derived from the Mek1 activity gradient, while the scaffold in the HRG re-
sponse promotes ERK2 activation in PM-proximal regions. This causes the spatial restriction
of ERK2 activity relative to the Mek1 activity gradient. The differential regulation of Mek1
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and ERK2 activity and especially the steep ERK2 activity gradients from the PM suggest that
the PM scaffold KSR1 is integrated in the HRG induced response. KSR1 could be integrated
additionally to PKC in the HRG-induced network architecture.
6.3.3 Spatio-temporal role of KSR1 in the MCF-7 MAPK response
The role of KSR1 on the spatio-temporal activity profiles of Mek1 and ERK2 was investigated
by the ectopic expression of KSR1. Ectopic KSR1 expression delayed the ERK2 response for
several minutes upon EGF as well as HRG treatment. The delay might be caused by prolonged
KSR1-Raf interaction and signaling. The elevation of KSR1 expression might diminish the
effect of the negative feedback phosphorylation from ERK on KSR1 which causes the KSR1
dissociation from Raf. Furthermore, the ectopic expression of ECFP-KSR1 elevated the ac-
tivity amplitudes of Mek1 and ERK1/2 response upon EGF as well as upon HRG stimulation,
without changing the fundamental transient or sustained trends. However, Mek1 activity was
stronger elevated by KSR1 expression than the ERK2 activity after both GF treatments, show-
ing that KSR1 might indeed be the scaffold responsible for the differential Mek1 and ERK2
activity observed after HRG stimulation. Therefore, KSR1 might not be a temporal switch, but
regulate the spatial propagation of active ERK2.
PTag-FLIM results showed that Mek1 phosphorylation increased with the expression of
KSR1 and was furthermore outspread in the cytoplasm. Therefore, KSR1 stimulates the ac-
tivation of Mek1 and either protects Mek1 from dephosphorylation or activates Mek1 also in
cytoplasm, thereby breaking the spatial separation of activation and deactivation. In contrast,
ERK2 phosphorylation decreased with increasing KSR1 expression, showing that Mek1 which
is bound to KSR1 is impaired to activate ERK2. Therefore, the reduced ERK2 activation
due to overexpression of KSR1 is a case of combinatorial inhibition. However, it is unclear
if KSR1 out-titrates only available active Mek1 or if KSR1 also binds to inactive ERK2 and
thereby diminishes accessible ERK2. An interaction of KSR1 with the inactive ERK2 is how-
ever unknown. However, ERK2 showed a clear gradient with short decay length in presence
of ECFP-KSR1, indicating that ERK2 was still activated at the PM. KSR1 is recruited to the
PM upon GF stimulation and has a binding site for the active ERK2 [Dougherty et al., 2009].
Although the restriction of active ERK2 to the PMmight only be caused by the interaction with
KSR1, the gradient of ERK2 activity indicates that KSR1 has different effects at the PM and in
the cytoplasm. The obtained results indicate that at the PM KSR1 supports, or at least does not
hinder ERK2 activation, while in the cytoplasm KSR1 impairs the activation of ERK2. KSR1
might act as a sequestration factor for active Mek in regions close to the PM, which artificially
constrains the gradient of active and accessible Mek1 and the derived ERK activity gradient.
Therefore, KSR1 might restrain ERK activity doubly by allowing ERK activation at the PM
and inhibiting it in the cytoplasm. The differential action of KSR1 at the PM and the cytoplasm
is likely to depend on a conformational change of KSR1 upon membrane binding. It is known
that in solution, KSR1 binds Mek1 in a mirror-imaged conformation which mutually occupies
the active sites of their kinase’s domain [Brennan et al., 2011]. On the contrary, the PM-bound
dimer of KSR1 and Mek1 might take over an “open” conformation which promotes ERK2 ac-
tivation. The negative feedback from ERK on KSR1 which causes the dissociation of KSR1
from the PMmight therefore dynamically restrict ERK activation. Therefore, ERK2 constrains
its own spatial propagation by the negative feedback. This mechanism does not depend on high
KSR1 expression. Under physiologic conditions where KSR1 levels are low, KSR1 is strongly
recruited to the PM upon GF stimulation causing locally a high concentration [Dougherty et al.,
2009]. Furthermore, ectopic KSR1 expression induced the expression of endogenous KSR1.
If KSR1 induces its own expression, active ERK might become increasingly confined to the
membrane over time. The proposed theory of ERK2 confinement by KSR1 is supported by
results from [Giurisato et al., 2009], who showed that a PM-binding mutant of KSR1 fails to
localize active ERK2 to the synapse in T cells.
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PTag-FLIM enables the comparison of scaffold mechanisms on the spatial distribution of
MAPKs. The only other known intracellular gradient of a MAPK is the Fus3 activity gradient
in the yeast shmoo tip, which is required to transform the pheromone receptor activation into
a focussed mating projection. The scaffold Ste5 is essential to allosterically unlock Fus3 for
the activation by Ste7 [Good et al., 2009]. It thereby completely controls the localization
of Fus3 activation, connecting the symmetry break at the PM into a primary Fus3 activity
gradient. This short and steep gradient does not impair the accumulation of active Fus3 in
the nucleus due to the small size of the yeast cell (see also above 6.2). In the dimensions
of a mammalian cell, such a strict confinement of the ERK activation would inhibit the global
response of ERK in the nucleus. However, as Raf-Mek-ERK response can signal independently
of a scaffold, domains of scaffolded and unscaffolded signaling will occur at the PM. The
unscaffolded MAPKmodule propagates the ERK activity into the nucleus, while the scaffolded
MAPK module confines ERK activity to the PM. This local inhomogeneity of scaffolded and
unscaffolded signaling domains will result in alternate low and high ERK activity which might
promote pattern formation, for example in differentiation. In this case the patterning does not
depend on bi- or multi-stability in the network response but on scaffolded and unscaffolded
signaling domains.
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7 Future Perspectives
A third of the proteome is estimated to be phosphorylated and phosphorylation is often a switch
for protein activity. Therefore, the integration of PTag-FLIM in high throughput screenings for
drug discovery would allow to assay a key parameter of protein function. It might be used to
detect the activity of the target protein or be a read-out for pathway activation. The phospho-
imaging can be combined with redistribution measurements and morphological analyses to
observe and correlate multiple properties of the cellular and protein state.
PTag-FLIM furthermore enables the investigation of MAPK phosphorylation on a larger
scale. It’s becoming more and more evident that the individual properties of scaffolds are
required to appropriately modulate MAPK signaling. A screening of MAPK activity under the
overexpression or knock-down of various scaffolds would give insight in the divers functions
of scaffolds. Such a screen may be combined with the analysis of MAPK signaling from
endosomes. It is expected, that internalized active receptors on endosomes function as signaling
platforms.
In light of the technical optimization of PTag-FLIM, it is conceivable to establish a dual-
donor FLIM using the dark acceptor QC-1 (see also chapter 3.6). With dual-donor FLIM,
the activities of two proteins could be correlated in single cells. For instance, the interplay of
EGFR and ERK activity could be monitored upon EGF stimulation.
In order to follow the phosphorylation of MAPKs in single cells over time, the PTag FLIM
approach should be applied to live cells. The challenge is to circumvent the potential inhibition
of all phosphorylation-dependent processes by binding of PTag. Ideally, the PTag-Dye complex
would bind only to the donor FP fused protein of interest, if this is phosphorylated. PTag
chelates Zn2+, which coordinates to phosphate-monoesters. To circumvent the toxicity of the
PTag-Zn2+ complex, the free, inactive PTag ligand, conjugated to a dye, might be microinjected
into cells. To activate the PTag locally in small doses, a caged Zn2+ might be additionally
administrated, which is uncaged by photo-activation. The free Zn2+ would then be chelated by
the PTag ligand and bind to locally available phosphate-monoesters. Therefore the protein of
interest as well as other phosphorylated molecules would be bound, but the toxicity reduced.
To increase the probability of active PTag complex binding to the protein of interest, the release
of Zn2+ might be induced by the emission of the donor FP fused to the kinase of interest. Then,
active PTag complexes would be constituted only in the proximity to the kinase which would
reduce the toxicity and increase the probability of binding to the kinase of interest. However,
the FP emission is usually not intense enough to cause the uncaging of a chelator.
Furthermore, the Biotin-STV bond might be used to target PTag to the protein of interest.
The protein of interest might be fused to a circular permuted FP, such as cpYFP. This fluo-
rophore is sensitive to changes in its environment and can translate conformational changes
into an increase in fluorophore emission. Additionally to the cpFP, the construct were further
fused to STV on the genomic level. The free, inactive PTag-Biotin would be administrated to
the cells. After binding to the STV, excess PTag would be washed out and free Zn2+ would be
added. This approach is based on a conformational change between phosphorylated and un-
phosphorylated construct. This approach would not enable the fractional observation of phos-
phorylated to total protein, which is possible with FRET. However, the PTag-Biotin reagent
might be modified with a dye which would then serve as FRET acceptor. However, it remains
to be elucidated if the binding of PTag is a reversible process. Reversibility is a requirement to
profile the temporal phosphorylation of a protein.
The yeast MAPK networks provide an attractive model to study determinants of gradient
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properties and the interplay between MAPK network topology and spatial MAPK activity or-
ganization. Yeast genomics open the possibility to manipulate single elements of the MAPK
network, for instance by inhibiting single kinases with gatekeeper mutations, and measure the
spatio-temporal response of the network. Simultaneous computations analyzing the system
response would enable the testing of predictions.
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8 Materials and Methods
8.1 Antibodies, Reagents and Enzymes
Primary antibodies Dilution WB Company (Cat.No.)
ERK1/2 (mouse) 1:2500 Abcam (ab36991)
ppERK1/2 (rabbit) 1:1000 Cell Signaling Technology (9101)
ppERK1/2 (rabbit) R&D Systems (AF1018)
Mek1 (mouse) 1:1000 BD Biosciences (610121)
ppMek1 (rabbit) 1:1000 Cell Signaling Technology (9121)
anti-GapDH (mouse) 1:5000
anti-KSR1 (rabbit) 1:1000 Abcam (ab68483)
Secondary antibodies Dilution WB Company (Cat.No.)
anti-rabbit IR-Dye 800CW (donkey) 1:5000 Licor Biosciences (926-32213)
anti-mouse IR-Dye 680RD (goat) 1:5000 Licor Biosciences (926-68070)
anti-rabbit Alexa-546 Cell Signaling
Phos-tag Biotin BTL-104 Wako Pure Chemical Industries
Streptavidin Sigma-Aldrich
Fluorolink Cy3.5 Monofunctional Dye GE Healthcare (PA23501)
IRDye QC-1 NHS Ester Licor Biosciences (929-70031)
Enzymes and Hormones
Platinum Pfx DNA Polymerase Life Technologies
Accuprime Pfx DNA Polymerase Life Technologies
Platinum Taq DNA Polymerase Life Technologies
PfuUltra High-fidelity DNA Polymerase Agilent Technologies
Lyticase Sigma-Aldrich (L2524)
Epidermal Growth factor Cell Signaling Technology
Heregulin-beta Merck Millipore (01-201)
8.2 Media
Name Ingredients/Company
LB 1 % Bact. Tryptophan, 0.5 % Yeast Extract, 1 % g NaCl
YPD 1 % Yeast Extract, 2 % Bacto-Peptone, 2 % Glucose
SC 0.7 % Yeast nitrogen base with amino acids, 2 % Glucose
DMEM PAN Biotech GmbH (P04-03600)
l-Glutamine Life Technology
FCS PAN Biotech GmbH
91
8.3 Kits and Consumables
Name Company (Cat.No.)
QIAprep Spin Miniprep Kit Qiagen (27106)
Roti-prep Plasmid Mini Roth (HP29)
Nucleo-Bond XtraMidi Plus EF Macherey-Nagel (740422)
DNA clean and concentrator kit Zymo Research (D4004)
Fugene 6 Roche (11814443001)
Dharmafect 1 Thermo Scientific (T-2001)
10x Cell lysis Buffer Cell Signaling (9803S)
Phosphatase Inhibitor Cocktail 2 Sigma-Aldrich (P5726)
Phosphatase Inhibitor Cocktail 3 Sigma-Aldrich (P0044)
Protease Inhibitor Cocktail Tablets Roche (04693132001)
5x siRNA Buffer Thermo Scientific (B-002000-UB-100)
Zeba Spin Desalting Columns 40K MWCO Thermo Scientific (87771)
PBS PAN
PVDF membrane Millipore
Odyssey blocking buffer Licor Biosciences (927-40000)
Amicon 30 kD cut-off
Protein Desalting Spin Columns Thermo Scientific (89862)
Poly-L-Lysine
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8.4 Buffers and solutions
Buffer Ingredients
SORB buffer 100 mM Lithiumacetat Tris/HCl pH 7.8
10 mM EDTA/NaOH pH 8
1 mM Sorbitol
adjusted to pH 8 with acetic acid
PEG 100 mM Lithiumacetat
10 mM Tris
1 mM EDTA/NaOH pH 8
1M PEG 4000
CarrierDNA 10 mg/ml Salmon sperm DNA
1 M KPO4 mix 1 M K2HPO4 and 1 M KH2PO4 to pH 6.5
SP 1.2 M Sorbitol
0.1 M KPO4
PFA for yeast fixation 8% Paraformaldehyde
Drop NaOH
0.2 M KPO4
4% PFA
1x TBS 10 mM Tris
0.1 M NaCl
TBST 1x TBS
0.1% Tween
5x SDS sample buffer 60 mM Tris/HCl pH 6.8
25 % glycerol
2 % SDS
14.4 mM β -Mercaptoethanol
0.1 % bromophenolblue
SDS running buffer 25 mM Tris
192 mM Glycine
0.1 % SDS
Separating gel buffer 1.5 M Tris-HCl pH 8.8
Stacking gel buffer 0.5 M Tris-HCl pH 6.8
Transfer buffer 25 mM Tris
192 mM Glycine
20 % Methanol
8.5 Molecular Biology Techniques
8.5.1 Cloning
DNAwas amplified by PCR using “Accuprime Pfx Polymerase” or “Platinum Pfx Polymerase”
according to the manufacturer’s protocol. Site-directed mutagenesis of DNA constructs was
performed with PfuUltra HF Polymerase and subsequent Dpn1 digest. Oligonucleotides for
PCR were ordered from Eurofins MWG Operon or Sigma-Aldrich. For the generation of new
DNA constructs DNA was site-specifically cleaved with restriction enzymes and ligated by T4
DNA Ligase, enzymes purchased from New England Biolabs. DNA was analysed by elec-
trophoresis in 1% agarose gels in TAE buffer and imaged under UV light. Isolation and con-
centration of DNAwas done with the “DNA clean and concentrator Kit”. DNA constructs were
cloned by transformation in chemically competent E. coli (XL10-Gold Agilent Technologies)
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grown in LB medium with 100 mg/ml ampicillin or 50 mg/ml Kanamycin. For the purpose of
cell transfection, plasmids were purified endotoxin-free from bacteria with the “Nucleo-Bond
Xtra Midi Plus EF Kit” or else with the “Roti-prep Plasmid Mini”. DNA was sequenced with
the Sanger (chain termination) method using “Big dye terminator v3.1 cycle sequencing kit”
and purification kit.
8.5.2 DNA constructs
Plasmid constructs coding for mCitrine-ERK2 and mCitrine-Mek1, KSR-CFP, EGFR-mCitrine
have been described. mTurquoise and mTurquoise2 fusions of ERK2 andMek1 were generated
by cleavage of the coding sequence from mCit-erk2 and insertion into Clontech mTurquoise-
N1 and Clontech mTurquoise2-N1. mCitrine-ERK2-TAYA was generated by site-directed mu-
tagenesis. Yeast plasmids for homologue recombination were kindly provided by Michael
Knop.
8.5.3 Labeling of Streptavidin (STV) and preparation of the
Phos-Tag-Biotin-Streptavidin-Cy3.5 complex
Streptavidin (STV) was dissolved in PBS and washed two times with PBS using an Amicon
30 kD cut-off, resulting in a concentration of about 100 µM, determined by absorption at 280
nm. Protein concentration was calculated according to Lambert-Beer with an extinction coef-
ficient of 165,000 M−1cm−1 for the tetrameric Streptavidin. Bicine (pH 9.3) was added to the
STV solution yielding to a final concentration of 0.1 M. One vial of monofunctional Cy3.5 was
dissolved in 10 µl DMF and the dye concentration determined by absorption measurement at
its absorption peak at 581 nm. The dye was then added in a 10-fold molar excess to STV and
the reaction incubated for 45 min at room temperature. The addition of Tris to 5 mM termi-
nated the conjugation of Cy3.5 to STV. Streptavidin was purified two times by gel exclusion
chromatography using Protein Desalting Spin Columns.
To obtain the Phos-Tag-Biotin-Streptavidin-Cy3.5 complex, Phos-Tag-Biotin was added in
a 200-fold excess to Streptavidin-Cy3.5 in TBST containing 0.4 mM Zn(NO3)2. This solution
was incubated for 30 minutes in the dark at room temperature and purified by gel exclusion
chromatography with Zeba Spin Desalting columns 40kD cut-off.
8.5.4 Preparation of in vitro experiment
The glass beads were washed two times with TBST. Protein mixtures of phosphorylated and
unphosphorylated EphA3 were washed once with TBS using a centrifugal filter (Amicon Ultra,
10 kD cut-off) and had a final concentration of 140 µM in 80 µl. 7.5 µl of each protein
mix were removed for native PAGE. Glass beads were added to the protein mix to a final
concentration of 0.5 mg/ml. The proteins were allowed to immobilize for one hour at 4rˇC,
while shaking at 300 rpm. To wash excessive protein and block the beads, three wash steps
with 0.01 mg/ml BSA in TBST were conducted. The beads were given in a microscopy dish
with TBST to prevent drying of the beads. PTag-Cy3.5 was added in a concentration of and
incubated for 30 minutes. After the staining, beads were washed once with TBST and kept at
4rˇC. FLIM measurement was conducted 16 hours later.
8.6 Cell Biology Techniques
8.6.1 Mammalian Cell culture
HeLa and MCF-7 cells were maintained in DMEM supplemented with 10% FBS and 1% L-
Glutamine, while MCF-7 cell medium additionally contained 1% NEAA. Cells were incubated
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at 37rˇC, 5 % CO2 and 90 % humidity. To keep cells dividing, cultures were split before grown
to confluency by separating cells with Trypsin/EDTA and reseeding in fresh media. Cells were
counted with a Vi-CELL XR cell viability analyzer. Before growth factor stimulation, MCF-7
cells were starved for 5 hours in DMEM containing 1% L-Glutamine and 1% NEAA, Hela
cells were starved over night in DMEM supplemented with 1% L-Glutamine. Transfection of
DNA constructs was performed with Fugene-6 according to the manufacturer’s protocol. Cells
were stimulated with 100 ng/ml EGF or 100 ng/ml HRG.
8.6.2 Preparation of cell lysates
Cells were seeded in a density of 105 cells per well of a 6-well plate. After 72 hours growth,
plasmid DNA was transfected over night. Cells were starved for 5 hours without serum and
subsequently stimulated with growth factors. Stimulation was stopped by the addition of ice-
cold PBS. Cells were scraped from the dish and harvested by centrifugation for 1 min at 800
rpm. The cell pellet was dissolved in 1xCell lysis buffer and homogenized using a Vortex
mixer. The cell extract was centrifuged for 15 min at 14000xg in a cold microfuge and the su-
pernatant transfered to a new tube. The concentration of the resulting cell lysate was measured
by Bradford assay.
8.6.3 Western Blots
For SDS-PAGE with 15 wells, 20 µg protein lysate was mixed with 5x sample buffer and
heated at 95rˇC for 5 minutes. The protein sample was then spun down for 15 seconds at
maximum speed. Gel electrophoresis was performed in SDS running buffer using 10% SDS-
polyacrylamid gels at 150 V until the leading front of the sample buffer reached the gel bottom.
For subsequent immune detection, proteins were transfered to a PVDF membrane in transfer
buffer at constant 200 mA for one hour. The PVDF membrane was incubated in Odyssey
Blocking Buffer to prevent unspecific antibody binding for 3 hours at room temperature or over
night at 4rˇC. Next, the membrane was incubated with primary antibodies diluted in Odyssey
Blocking Buffer at 4rˇC for minimum 14 hours followed by three wash steps with TBST for 10
minutes each. Infrared fluorescent secondary antibodies diluted in Odyssey Blocking Buffer
were added in the dark for one hour to the membrane and afterwards washed three times with
TBST for 5 minutes. Antigen-antibody interactions were imaged using the Odyssey system at
680 nm and 800 nm set to “5” for both channels.
Western blots were analyzed using ImageJ. Background signal was subtracted from the
whole image. For each band a rectangle was drawn, which was used as “region of interest”
in both channels. The integrated density of each “region of interest” was computed and used
for further calculations.
8.6.4 Mammalian Cell fixation for PTag FLIM
Cells were seeded in a density of 104 cells per well of an 8-well LabTek. After 24 hours
of growth plasmid DNA was transfected over night. Cells were starved for 5 hours without
serum and subsequently stimulated. Cells were fixed by the addition of cold 4 % PFA for
10 minutes. After three steps of washing with TBS cells, were permeabilized for 10 minutes
with TBS containing 0.1 % Triton-X. Cells were washed 3 times with TBST and incubated
with a 170 nM concentration of the Phos-Tag-Cy3.5 complex in TBST for one hour at room
temperature, followed by a single wash step with TBST.
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8.6.5 High efficiency transformation in Yeast for homologue
Recombination
Yeast transformation was described elsewhere [Knop et al., 1999]. Genetic manipulations in
yeast were performed using a PCR-based method described in [Janke et al., 2004].
8.6.6 Yeast fixation for PTag-FLIM
Yeast cells grown in liquid culture to an OD of 0.8 were stimulated with 100 ng/ml pheromone
for 3h. Cells were fixed in the presence of 4% fresh formaldehyde solution and 0.1 M KPO4 for
30 minutes at room temperature, followed by three wash steps with SP buffer. Cell walls were
removed by incubation with 0.7 M Lyticase in SP buffer containing 20 mM β -Mercaptoethanol
at 30rˇC for 30-45 minutes. Spheroblasts were washed 3 times with cold SP buffer and stored at
4rˇC. 8-well LabTek chambers were coated with Poly-L-Lysine for 30 minutes at room temper-
ature and washed 3 times with water. Cells were allowed to immobilize in the coated chambers
in TBS buffer for 30 minutes and subsequently permeabilized with TBS containing 0.1% Triton
X-100, followed by 3 times washing with TBST. The chambers were incubated with a 170 nM
concentration the PTag-Cy3.5 complex for 1h and washed once with TBST. Chambers were
used forthrightly for microscopy.
8.6.7 Yeast immunofluorescence
Yeast cell fixation was performed as described 8.6.6. After permeabilizing yeast cells with
TBS containing 0.1% Triton X-100 cells were blocked with 1% BSA in PBS. Antibodies were
incubated in a dilution of 1:150 over night at 4rˇC in blocking buffer. After wahing of excess
primary antibody the secondary antibody anti-rabbit carrying the dye Alexa-546 was added for
one hour at room temperature.
8.7 Microscopy
Confocal images were acquired using a confocal laser-scanning microscope (Fluoview 1000,
Olympus). mCitrine was excited with the 488 nm line of an Argon laser and its emission de-
tected in the range of 500-550 nm. Cy3.5 was excited with the 561 nm line of a DPSS laser and
its emission recorded at wavelengths 570-670 nm. Fluorescence signal was collected through a
water objective (x60/1:35 UPlanSApo, Olympus) with a DM405/488/561/633 dichroic mirror.
Emission light from mCitrine and Cy3.5 was separated by a beam splitter SDM560. ECFP was
excited at 440 nm and its emission recorded in the range of 470-495 nm.
Fluorescence lifetime images were obtained using a confocal laser-scanning microscope
(Fluoview 1000, Olympus) equipped with a TCSPC module (LSM Upgrade Kit, Picoquant).
Photons were detected using a single-photon counting avalanche photodiode (PDM Series,
MPD) and timed with a single-photon counting module (PicoHarp 300, Picoquant). Donor
fluorophores were excited using pulsed diode lasers (Picoquant) with the appropriate wave-
lengths (see table) at 40 MHz repetition. Fluorescence signal was collected through a water
objective (x60/1:35 UPlanSApo, Olympus) and spectrally filtered using narrow-band emission
filters (see table).
8.7.1 FLIM data analysis
Excited state lifetimes in figures 3.3, 3.6 and 3.7 was analyzed by fitting the obtained fluores-
cence lifetime histograms using pFLIM [Walther et al., 2011].
Other presented FLIM data was analyzed by global analysis implemented in MatLab, for
theoretical background see also chapter 1.4.3 [Grecco et al., 2009]. Briefly, for global analysis
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Fluorophore Excitation Emission
mTFP 440 nm 480/20
mCitrine 470 nm 525/15 data from chapter 3
510 nm 530/11 data from chapter 4 and 5
mKate2 532 nm
Table 8.1: Excitation wavelengths and corresponding emission filters for FLIM.
the following steps were conducted: TCSPC histograms of a certain protein (Fus3-mCitrine,
mCitrine-Mek1, mCitrine-ERK2) were pooled together. In the global analysis, pixels with
low intensity were excluded from the analysis. The histograms were then Fourier transformed
from the time domain to the frequency domain. After correction of the Fourier coefficients
for the impulse response function of the instrument, the Fourier coefficients of each pixel are
plotted in the Complex plane. The pixels are weighted according to the photon number to
increase the signal-to-noise ratio. The fitting of a straight line through all pixels reveals the
invariant lifetimes τD and τDA of the donor in presence and absence of the acceptor. The
relative location of a pixel on this line reveals the fraction of molecules in complex with the
acceptor, represented by α , from which an image was reconstructed.
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